window.__IS_SSR__=true
window.__INITIAL_STATE__={
"attachmentsReducer": {
"audio_0": {
"type": "attachments",
"id": "audio_0",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background0.jpg"
}
}
},
"audio_1": {
"type": "attachments",
"id": "audio_1",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background1.jpg"
}
}
},
"audio_2": {
"type": "attachments",
"id": "audio_2",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background2.jpg"
}
}
},
"audio_3": {
"type": "attachments",
"id": "audio_3",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background3.jpg"
}
}
},
"audio_4": {
"type": "attachments",
"id": "audio_4",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background4.jpg"
}
}
},
"placeholder": {
"type": "attachments",
"id": "placeholder",
"imgSizes": {
"thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"medium": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"medium_large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-768x512.jpg",
"width": 768,
"height": 512,
"mimeType": "image/jpeg"
},
"large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"1536x1536": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-lrg": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-med": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"fd-sm": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"post-thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"twentyfourteen-full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1038x576.jpg",
"width": 1038,
"height": 576,
"mimeType": "image/jpeg"
},
"xxsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"xsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"small": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"xlarge": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1920x1280.jpg",
"width": 1920,
"height": 1280,
"mimeType": "image/jpeg"
},
"guest-author-32": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 32,
"height": 32,
"mimeType": "image/jpeg"
},
"guest-author-50": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 50,
"height": 50,
"mimeType": "image/jpeg"
},
"guest-author-64": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 64,
"height": 64,
"mimeType": "image/jpeg"
},
"guest-author-96": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 96,
"height": 96,
"mimeType": "image/jpeg"
},
"guest-author-128": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 128,
"height": 128,
"mimeType": "image/jpeg"
},
"detail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 160,
"height": 160,
"mimeType": "image/jpeg"
},
"kqedFullSize": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1.jpg",
"width": 2000,
"height": 1333
}
}
},
"futureofyou_441707": {
"type": "attachments",
"id": "futureofyou_441707",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "441707",
"found": true
},
"parent": 441705,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-520x352.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 352
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-160x108.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 108
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-960x650.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 650
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-375x254.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 254
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8.jpg",
"width": 1996,
"height": 1352
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-1020x691.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 691
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-1180x799.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 799
},
"complete_open_graph": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-1200x813.jpg",
"width": 1200,
"mimeType": "image/jpeg",
"height": 813
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-800x542.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 542
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-1920x1301.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1301
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-1180x799.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 799
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-1920x1301.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1301
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-768x520.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 520
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/trip-1_enl-35591b6cf9b23646c94dbecff0d1eed5f66491d8-240x163.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 163
}
},
"publishDate": 1526688331,
"modified": 1526688331,
"caption": null,
"description": "Michael Pollan is out with a new book about the science behind psychedelics.",
"title": "Michael Pollan is out with a new book about the science behind psychedelics.",
"credit": null,
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_441701": {
"type": "attachments",
"id": "futureofyou_441701",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "441701",
"found": true
},
"parent": 441697,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-520x293.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 293
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-160x90.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 90
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-960x540.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 540
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-375x211.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 211
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85.jpg",
"width": 1600,
"height": 900
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-1020x574.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 574
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-1180x664.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 664
},
"complete_open_graph": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-1200x675.jpg",
"width": 1200,
"mimeType": "image/jpeg",
"height": 675
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-800x450.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 450
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-1180x664.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 664
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-768x432.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 432
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85-240x135.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 135
}
},
"publishDate": 1526666602,
"modified": 1526666619,
"caption": "Aimovig, a new kind of migraine drug, is injected once a month. The medicine reduced the number of migraines in clinical studies reviewed by the Food and Drug Administration.",
"description": null,
"title": "aimovig_wide-bfd8e17afe4dfa029ea208a0985996410e4be5c2-s1600-c85",
"credit": "Amgen/AP",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_441686": {
"type": "attachments",
"id": "futureofyou_441686",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "441686",
"found": true
},
"parent": 441680,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-520x379.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 379
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-160x117.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 117
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-960x699.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 699
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-375x273.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 273
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038.jpg",
"width": 4760,
"height": 3466
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-1020x743.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 743
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-1180x859.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 859
},
"complete_open_graph": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-1200x874.jpg",
"width": 1200,
"mimeType": "image/jpeg",
"height": 874
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-800x583.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 583
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-1920x1398.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1398
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-1180x859.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 859
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-768x559.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 559
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/GettyImages-634597038-240x175.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 175
}
},
"publishDate": 1526663554,
"modified": 1526663694,
"caption": "Coca-Cola is the world’s most popular carbonated soft drink. The original is made with sugar, but the others contain artificial sweeteners that are now linked to a rise in obesity and diabetes.",
"description": null,
"title": "Coca-Cola Predicts Drop In Profit This Year",
"credit": "George Frey/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_440895": {
"type": "attachments",
"id": "futureofyou_440895",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "440895",
"found": true
},
"parent": 440840,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-520x347.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 347
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"complete_open_graph": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-1200x800.jpg",
"width": 1200,
"mimeType": "image/jpeg",
"height": 800
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/stdstest-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1524237619,
"modified": 1524238245,
"caption": "At-home STD tests are now available from multiple companies.",
"description": "Lesley McClurg tests the at-home, over-the-counter food allergy test at KQED Headquarters in San Francisco, Calif., on Wednesday, April 11, 2018. ",
"title": "OVERTHECOUNTER",
"credit": "Lauren Hanussak/KQED",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_441443": {
"type": "attachments",
"id": "futureofyou_441443",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "441443",
"found": true
},
"parent": 441435,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-520x215.png",
"width": 520,
"mimeType": "image/png",
"height": 215
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-160x66.png",
"width": 160,
"mimeType": "image/png",
"height": 66
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-672x312.png",
"width": 672,
"mimeType": "image/png",
"height": 312
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-375x155.png",
"width": 375,
"mimeType": "image/png",
"height": 155
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread.png",
"width": 754,
"height": 312
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-50x50.png",
"width": 50,
"mimeType": "image/png",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-96x96.png",
"width": 96,
"mimeType": "image/png",
"height": 96
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-64x64.png",
"width": 64,
"mimeType": "image/png",
"height": 64
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-150x150.png",
"width": 150,
"mimeType": "image/png",
"height": 150
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-32x32.png",
"width": 32,
"mimeType": "image/png",
"height": 32
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-128x128.png",
"width": 128,
"mimeType": "image/png",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-240x99.png",
"width": 240,
"mimeType": "image/png",
"height": 99
}
},
"publishDate": 1525908106,
"modified": 1525908156,
"caption": "Tenofovir disoproxil fumarate was sold under the brand name Viread.",
"description": null,
"title": "viread",
"credit": "U.S. Dept. of Health and Human Services",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_441355": {
"type": "attachments",
"id": "futureofyou_441355",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "441355",
"found": true
},
"parent": 441354,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-520x349.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 349
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-960x644.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 644
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-375x251.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 251
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d.jpg",
"width": 1080,
"height": 724
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-1020x684.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 684
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-800x536.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 536
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-768x515.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 515
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/nalaxone-1_enl-314552d44c6999d90663250e0747b1ae4fa5074d-240x161.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 161
}
},
"publishDate": 1525714364,
"modified": 1525714364,
"caption": null,
"description": "The Surgeon General recommends more Americans carry naloxone, the opioid overdose antidote.",
"title": "The Surgeon General recommends more Americans carry naloxone, the opioid overdose antidote.",
"credit": null,
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_441324": {
"type": "attachments",
"id": "futureofyou_441324",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "441324",
"found": true
},
"parent": 441322,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-520x342.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 342
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-160x105.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 105
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-960x631.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 631
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-375x246.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 246
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1.jpg",
"width": 1979,
"height": 1300
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-1020x670.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 670
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-1180x775.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 775
},
"complete_open_graph": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-1200x788.jpg",
"width": 1200,
"mimeType": "image/jpeg",
"height": 788
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-800x526.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 526
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-1920x1261.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1261
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-1180x775.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 775
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-1920x1261.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1261
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-768x504.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 504
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/05/tick-leaf-1_enl-6e01468478084288b5e4a814e3b4656f8b8f5bbe-1-240x158.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 158
}
},
"publishDate": 1525707108,
"modified": 1525713718,
"caption": "Black-legged ticks, also known as deer ticks, can carry Lyme disease.",
"description": "Black-legged ticks, also known as deer ticks, can carry Lyme disease.",
"title": "Black-legged ticks, also known as deer ticks, can carry Lyme disease.",
"credit": null,
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_441026": {
"type": "attachments",
"id": "futureofyou_441026",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "441026",
"found": true
},
"parent": 441018,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-520x347.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 347
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-e1524777153754.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"complete_open_graph": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-1200x800.jpg",
"width": 1200,
"mimeType": "image/jpeg",
"height": 800
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/RS30400_ATHOMETEST_050-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1524777066,
"modified": 1525104512,
"caption": "Patient pricks her finger for an at-home test to collect blood. ",
"description": null,
"title": "OVERTHECOUNTER",
"credit": "Lauren Hanussak/KQED",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_440862": {
"type": "attachments",
"id": "futureofyou_440862",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "440862",
"found": true
},
"parent": 440861,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-520x347.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 347
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492.jpg",
"width": 4000,
"height": 2667
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"complete_open_graph": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-1200x800.jpg",
"width": 1200,
"mimeType": "image/jpeg",
"height": 800
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/iStock-856184492-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1524167040,
"modified": 1524167091,
"caption": "A prominent biomedical ethics expert says that in 20 to 40 years, many prospective parents may choose from dozens of embryos to become their babies and would be provided with genetic information about each embryo to help make the choice. ",
"description": null,
"title": "A child from a test tube or artificial insemination. Family holding hands",
"credit": "iStock",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_440707": {
"type": "attachments",
"id": "futureofyou_440707",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "440707",
"found": true
},
"parent": 440706,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-520x293.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 293
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-160x90.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 90
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-960x540.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 540
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-375x211.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 211
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7.jpg",
"width": 1278,
"height": 719
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-1020x574.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 574
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-1180x664.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 664
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-800x450.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 450
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-1180x664.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 664
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-768x432.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 432
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/exercises001_sideeffects_wide-cb4d4354dd708fc49a8fe77ee7549e8f81b5b4a7-240x135.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 135
}
},
"publishDate": 1523298454,
"modified": 1523298550,
"caption": "Physical therapist Ingrid Peele coaches Kim Brown through strengthening exercises to help her with her chronic pain, at the OSF Central Illinois Pain Center in Peoria.",
"description": "Physical therapist Ingrid Peele coaches Kim Brown through strengthening exercises to help her with her chronic pain, at the OSF Central Illinois Pain Center in Peoria.",
"title": "Physical therapist Ingrid Peele coaches Kim Brown through strengthening exercises to help her with her chronic pain, at the OSF Central Illinois Pain Center in Peoria.",
"credit": "Kyle Travers/WFYI",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_440673": {
"type": "attachments",
"id": "futureofyou_440673",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "440673",
"found": true
},
"parent": 440672,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-520x389.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 389
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-160x120.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 120
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-960x719.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 719
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-375x281.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 281
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf.jpg",
"width": 1442,
"height": 1080
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-1020x764.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 764
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-1180x884.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 884
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-800x599.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 599
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-1180x884.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 884
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-768x575.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 575
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/04/daydreaming-10-ca7f66512da6a0384891d7f2d0f7d7e7c7ab89bf-240x180.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 180
}
},
"publishDate": 1523034142,
"modified": 1523034396,
"caption": null,
"description": "M spends so much time daydreaming that it interferes with her life.",
"title": "M spends so much time daydreaming that it interferes with her life.",
"credit": "NPR",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_440513": {
"type": "attachments",
"id": "futureofyou_440513",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "440513",
"found": true
},
"parent": 440512,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-520x292.png",
"width": 520,
"mimeType": "image/png",
"height": 292
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-160x90.png",
"width": 160,
"mimeType": "image/png",
"height": 90
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-672x372.png",
"width": 672,
"mimeType": "image/png",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-375x211.png",
"width": 375,
"mimeType": "image/png",
"height": 211
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3.png",
"width": 783,
"height": 440
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-50x50.png",
"width": 50,
"mimeType": "image/png",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-96x96.png",
"width": 96,
"mimeType": "image/png",
"height": 96
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-64x64.png",
"width": 64,
"mimeType": "image/png",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-32x32.png",
"width": 32,
"mimeType": "image/png",
"height": 32
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-150x150.png",
"width": 150,
"mimeType": "image/png",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-768x432.png",
"width": 768,
"mimeType": "image/png",
"height": 432
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-128x128.png",
"width": 128,
"mimeType": "image/png",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2018/03/goats-antibiotic-promo_wide-41706bf634a4e923d8d1fd3e9691198b0971b4c3-240x135.png",
"width": 240,
"mimeType": "image/png",
"height": 135
}
},
"publishDate": 1522178177,
"modified": 1522178177,
"caption": null,
"description": null,
"title": "Chart of antibiotic use over time",
"credit": null,
"status": "inherit",
"isLoading": false,
"fetchFailed": false
}
},
"audioPlayerReducer": {
"postId": "stream_live",
"isPaused": true,
"isPlaying": false,
"pfsActive": false,
"pledgeModalIsOpen": true,
"playerDrawerIsOpen": false,
"liveAudioPlayStartedAt": 0,
"liveAudioPlayContext": ""
},
"authorsReducer": {
"byline_futureofyou_441705": {
"type": "authors",
"id": "byline_futureofyou_441705",
"meta": {
"override": true
},
"slug": "byline_futureofyou_441705",
"name": "Terry Gross, NPR",
"isLoading": false
},
"byline_futureofyou_441697": {
"type": "authors",
"id": "byline_futureofyou_441697",
"meta": {
"override": true
},
"slug": "byline_futureofyou_441697",
"name": "Richard Harris, NPR",
"isLoading": false
},
"byline_futureofyou_441680": {
"type": "authors",
"id": "byline_futureofyou_441680",
"meta": {
"override": true
},
"slug": "byline_futureofyou_441680",
"name": "Eunice Zhang, University of Michigan, For\u003cbr />The Conversation\u003cimg src=\"https://counter.theconversation.com/content/91452/count.gif?distributor=republish-lightbox-advanced\" alt=\"The Conversation\" width=\"1\" height=\"1\" />",
"isLoading": false
},
"byline_futureofyou_441354": {
"type": "authors",
"id": "byline_futureofyou_441354",
"meta": {
"override": true
},
"slug": "byline_futureofyou_441354",
"name": "Jake Harper\u003cbr />NPR Shots",
"isLoading": false
},
"byline_futureofyou_441322": {
"type": "authors",
"id": "byline_futureofyou_441322",
"meta": {
"override": true
},
"slug": "byline_futureofyou_441322",
"name": "Allison Aubrey\u003cbr />NPR Shots",
"isLoading": false
},
"byline_futureofyou_440861": {
"type": "authors",
"id": "byline_futureofyou_440861",
"meta": {
"override": true
},
"slug": "byline_futureofyou_440861",
"name": "Malcolm Ritter\u003cbr />The Associated Press",
"isLoading": false
},
"byline_futureofyou_440706": {
"type": "authors",
"id": "byline_futureofyou_440706",
"meta": {
"override": true
},
"slug": "byline_futureofyou_440706",
"name": "Christine Herman\u003cbr />NPR Shots",
"isLoading": false
},
"byline_futureofyou_440672": {
"type": "authors",
"id": "byline_futureofyou_440672",
"meta": {
"override": true
},
"slug": "byline_futureofyou_440672",
"name": "Meredith Rizzo\u003cbr />NPR Shots",
"isLoading": false
},
"byline_futureofyou_440512": {
"type": "authors",
"id": "byline_futureofyou_440512",
"meta": {
"override": true
},
"slug": "byline_futureofyou_440512",
"name": "Jason Beaubien\u003cbr />NPR Goats and Soda",
"isLoading": false
},
"lesleymcclurg": {
"type": "authors",
"id": "11229",
"meta": {
"index": "authors_1716337520",
"id": "11229",
"found": true
},
"name": "Lesley McClurg",
"firstName": "Lesley",
"lastName": "McClurg",
"slug": "lesleymcclurg",
"email": "lmcclurg@KQED.org",
"display_author_email": false,
"staff_mastheads": [
"news",
"science"
],
"title": "KQED Health Correspondent",
"bio": "Lesley McClurg is a health correspondent and fill-in host whose work is regularly rebroadcast on NPR and PBS programs. She’s earned multiple regional Emmy awards, a national and a regional Edward R. Murrow award, and was named Best Beat Reporter by the Association of Health Care Journalists. The Society of Professional Journalists has recognized her work several times, and the Society of Environmental Journalists spotlighted her coverage of California’s historic drought.\r\n\r\nBefore joining KQED in 2016, Lesley covered food and sustainability for Capital Public Radio, environmental issues for Colorado Public Radio, and reported for KUOW and KCTS 9 in Seattle. Away from the newsroom, she loves skiing with her daughter, mountain biking with her partner, and playing with Ollie, the family’s goldendoodle. On deadline, she runs almost entirely on chocolate chips.\r\n\r\n ",
"avatar": "https://secure.gravatar.com/avatar/bab49e972ea10c774fe0f5e29dba1722b158f7c0d58a360923d1389d380b2978?s=600&d=blank&r=g",
"twitter": "lesleywmcclurg",
"bluesky": null,
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "arts",
"roles": [
"author"
]
},
{
"site": "news",
"roles": [
"editor"
]
},
{
"site": "futureofyou",
"roles": [
"editor"
]
},
{
"site": "stateofhealth",
"roles": [
"author"
]
},
{
"site": "science",
"roles": [
"editor"
]
},
{
"site": "quest",
"roles": [
"subscriber"
]
},
{
"site": "forum",
"roles": [
"administrator"
]
},
{
"site": "liveblog",
"roles": [
"author"
]
}
],
"headData": {
"title": "Lesley McClurg | KQED",
"description": "KQED Health Correspondent",
"ogImgSrc": "https://secure.gravatar.com/avatar/bab49e972ea10c774fe0f5e29dba1722b158f7c0d58a360923d1389d380b2978?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/bab49e972ea10c774fe0f5e29dba1722b158f7c0d58a360923d1389d380b2978?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/lesleymcclurg"
},
"aahmed": {
"type": "authors",
"id": "11428",
"meta": {
"index": "authors_1716337520",
"id": "11428",
"found": true
},
"name": "Amel Ahmed",
"firstName": "Amel",
"lastName": "Ahmed",
"slug": "aahmed",
"email": "aahmed@kqed.org",
"display_author_email": false,
"staff_mastheads": [],
"title": "KQED Contributor",
"bio": "Amel Ahmed is a reporter for KQED. Prior to joining KQED, Amel worked at Al Jazeera America, Al Jazeera English, Democracy Now! and Punched Productions. She also helped produce \u003cem>Changing Face of Harlem\u003c/em>, a documentary that tracked gentrification in Harlem over a period of ten years. She is a 2013 graduate of Brooklyn Law School and is currently researching war on terror prosecutions for an upcoming book.",
"avatar": "https://secure.gravatar.com/avatar/c8b48ebc98e770640f3013c470d23f3e?s=600&d=blank&r=g",
"twitter": "amelscript",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "futureofyou",
"roles": []
},
{
"site": "science",
"roles": []
}
],
"headData": {
"title": "Amel Ahmed | KQED",
"description": "KQED Contributor",
"ogImgSrc": "https://secure.gravatar.com/avatar/c8b48ebc98e770640f3013c470d23f3e?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/c8b48ebc98e770640f3013c470d23f3e?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/aahmed"
}
},
"pagesReducer": {
"futureofyou_category_diy-health": {
"type": "terms",
"id": "futureofyou_1060",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1060",
"score": 13.892162
},
"featImg": null,
"name": "DIY Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "DIY Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1060,
"slug": "diy-health",
"isLoading": false,
"title": "DIY Health",
"pageMeta": {
"site": "futureofyou",
"WpPageTemplate": "page-topic-editorial",
"currentPage": 9
},
"blocks": [
{
"blockName": "kqed/post-list",
"attrs": {
"layout": "cardArticle2",
"query": "posts/futureofyou?category=diy-health",
"seeMore": false,
"paginated": true,
"page": 9
}
},
{
"blockName": "kqed/ad"
}
]
}
},
"pfsSessionReducer": {},
"postsReducer": {
"stream_live": {
"type": "live",
"id": "stream_live",
"audioUrl": "https://streams.kqed.org/kqedradio",
"title": "Live Stream",
"excerpt": "Live Stream information currently unavailable.",
"link": "/radio",
"featImg": "",
"label": {
"name": "KQED Live",
"link": "/"
}
},
"stream_kqedNewscast": {
"type": "posts",
"id": "stream_kqedNewscast",
"audioUrl": "https://www.kqed.org/.stream/anon/radio/RDnews/newscast.mp3?_=1",
"title": "KQED Newscast",
"featImg": "",
"label": {
"name": "88.5 FM",
"link": "/"
}
},
"futureofyou_441705": {
"type": "posts",
"id": "futureofyou_441705",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "441705",
"score": null,
"sort": [
1526691602000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1526691602,
"format": "standard",
"disqusTitle": "Michael Pollan Embraces The 'New Science' Of Psychedelics",
"title": "Michael Pollan Embraces The 'New Science' Of Psychedelics",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>Author Michael Pollan had always been curious about psychoactive plants, but his interest skyrocketed when he heard about a \u003ca href=\"https://www.npr.org/sections/health-shots/2016/12/03/504136736/how-a-psychedelic-drug-helps-cancer-patients-overcome-anxiety\" target=\"_blank\" rel=\"noopener\">research study\u003c/a> in which people with terminal cancer were given a psychedelic called \u003ca href=\"https://www.npr.org/tags/140958387/psilocybin\" target=\"_blank\" rel=\"noopener\">psilocybin \u003c/a>— the active ingredient in \"magic mushrooms\" — to help them deal with their distress.\u003c/p>\n\u003cp>\"This seemed like such a crazy idea that I began looking into it,\" Pollan says. \"Why should a drug from a mushroom help people deal with their mortality?\"\u003c/p>\n\u003cp>Pollan, whose previous books include \u003ca href=\"https://www.npr.org/books/titles/137946336/the-omnivores-dilemma-a-natural-history-of-four-meals\" target=\"_blank\" rel=\"noopener\">The Omnivore's Dilemma\u003c/a> and \u003ca href=\"https://www.npr.org/templates/story/story.php?storyId=17725932\" target=\"_blank\" rel=\"noopener\">In Defense Of Food\u003c/a>, started researching different experimental therapeutic uses of psychedelics, and found that the drugs were being used to treat depression, addiction and the fear of death.\u003c/p>\n\u003cp>Then he decided to go one step further: A self-described \"reluctant psychonaut,\" Pollan enlisted guides to help him experiment with LSD, psilocybin and 5-MeO-DMT, a substance in the venom of the Sonoran Desert toad.\u003c/p>\n\u003cp>Each of Pollan's experiences with psychedelics was preceded by worry and self-doubt. But, he says, \"I realized later that was my ego trying to convince me not to do this thing that was going to challenge my ego.\"\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Pollan's new book, \u003cem>How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence\u003c/em>, recounts his experiences with the drugs and also examines the history of psychedelics as well as their possible therapeutic uses.\u003c/p>\n\u003chr>\n\u003cp>\u003cstrong>Interview Highlights\u003c/strong>\u003c/p>\n\u003cp>\u003cstrong>On how the psychedelic psilocybin is administered in therapy for depression \u003c/strong>\u003c/p>\n\u003cp>The way [psilocybin is] being used is in a very controlled or guided setting. ... They don't just give you a pill and send you home; you're in a room. You're with two guides, one male, one female. You're lying down on a comfortable couch. You're wearing headphones listening to a really carefully curated playlist of music — instrumental compositions for the most part — and you're wearing eyeshades, all of which is to encourage a very inward journey.\u003c/p>\n\u003cp>Someone is kind of looking out for you, and they prepare you very carefully in advance. They give you a set of \"flight instructions,\" as they call them, which is what to do if you get really scared or you're beginning to have a bad trip. If you see a monster, for example, don't try to run away. Walk right up to it, plant your feet and say, \"What do you have to teach me? What are you doing in my mind?\" And if you do that, according to the flight instructions, your fear will morph into something much more positive very quickly.\u003c/p>\n\u003cp>\u003cstrong>On how psychedelics can help change the stories we tell about ourselves \u003c/strong>\u003c/p>\n\u003cp>The drugs foster new perspectives on old problems. One of the things our mind does is tell stories about ourselves. If you're depressed, you're being told a story perhaps that you're worthless, that no one could possibly love you, you're not worthy of love, that life will not get better. And these stories — which are enforced by our egos really — trap us in these ruminative loops that are very hard to get out of. They're very destructive patterns of thought.\u003c/p>\n\u003cp>What the drugs appear to do is disable for a period of time the part of the brain where the self talks to itself. It's called the \u003ca href=\"https://www.npr.org/tags/482443062/default-mode-network\" target=\"_blank\" rel=\"noopener\">default mode network\u003c/a>, and it's a group of structures that connect parts of the cortex — the evolutionarily most recent part of the brain — to deeper levels where emotion and memory reside. And it's a very important hub in the brain and lots of important things happen there: self-reflection and rumination, time travel. It's where we go to think about the future or the past, and theory of mind, the ability to imagine the mental states of other beings and, I think, most importantly, the autobiographical self. It's the part of the brain, it appears, where we incorporate things that happen to us, new information, with a sense of who we are, who we were and who we want to be. And that's where these stories get generated. And these stories can be really destructive, they trap us. ...\u003c/p>\n\u003cp>This network is downregulated [with psychedelics], it sort of goes offline for a period of time. And that's why you experience this dissolution of self or ego, which can be a terrifying or liberating thing, depending on your mindset. This is what allows people, I think, to have those new perspectives on themselves, to realize that they needn't be trapped in those stories and they might actually be able to write some new stories about themselves. That's what's liberating, I think, about the experience when it works.\u003c/p>\n\u003cp>\u003cstrong>On how psychedelics can help dying people face their deaths \u003c/strong>\u003c/p>\n\u003cp>\u003ca href=\"https://www.npr.org/tags/125941537/prozac\">Prozac\u003c/a> doesn't help when you're confronting your mortality. But here we have something that occasions an experience in people — a mystical experience — that somehow makes it easier to let go. And I think some of it has to do with the fact that you do experience the \"extinction\" of yourself and it's kind of a rehearsal for death. And I think that may be part of what helps people, that they expand their sense of what is your self-interest and your self-interest is something larger than what is contained by your skin. And when you have that recognition, I think dying becomes a little easier. ...\u003c/p>\n\u003cp>There's no way to prove this, obviously, and it's a question that really troubled me as an old-fashioned materialist skeptical journalist. It's like, \"What if these drugs are inducing an illusion in people?\" I got a variety of answers to that question from the researchers. One was, \"Who cares if it helps them?\" And I can see the point of that. The other was, \"Hey, this is beyond my pay grade; none of us know what happens after we die.\" And others say, \"Well, this is an open frontier.\" ...\u003c/p>\n\u003cp>The experiences that people have are very real to them — they're psychological facts. And one of the really interesting qualities of psychedelic experience is that the insights you have on them have a durability ... This isn't just an opinion, this is revealed truth, so the confidence people have is hard to shake, actually.\u003c/p>\n\u003cp>\u003cstrong>On a \u003c/strong>\u003ca href=\"https://www.hopkinsmedicine.org/news/stories/mushrooms_quit_smoking.html\" target=\"_blank\" rel=\"noopener\">\u003cstrong>Johns Hopkins study\u003c/strong>\u003c/a>\u003cstrong> on the use of psilocybin to help people quit smoking \u003c/strong>\u003c/p>\n\u003cp>Smoking is a very hard addiction to break. It's one of the hardest addictions to break. [I wanted to understand] how, after a single psilocybin trip, they could decide \"I'm never going to smoke again\" based on the perspective they had achieved. And they would say things like, \"Well, I had this amazing experience. I died three times. I sprouted wings. I flew through European histories. I beheld all these wonders. I saw my body on a funeral pyre on the Ganges. And I realized, the universe is so amazing and there's so much to do in it that killing myself seemed really stupid.\" And that was the insight. Yes, killing yourself is really stupid — but it had an authority it had never had. And that, I think, is the gift of these psychedelics.\u003c/p>\n\u003cp>\u003cstrong>On his own experience tripping on mushrooms \u003c/strong>\u003c/p>\n\u003cp>I had an experience that was by turns frightening and ecstatic and weird. ... I found myself in this place where I could no longer control my perceptions at all, and I felt my sense of self scatter to the wind — almost as if a pile of post-its had been released to the wind — but I was fine with it. I didn't feel any desire to pile the papers back together into my customary self ...\u003c/p>\n\u003cp>Then I looked out and saw myself spread over the landscape like a coat of paint or butter. I was outside myself, beside myself, literally, and the consciousness that beheld this ... was not my normal consciousness, it was completely unperturbed. It was dispassionate. It was content, as I watched myself dissolve over the landscape.\u003c/p>\n\u003cp>What I brought back from that experience was that I'm not identical to my ego, that there is another ground on which to plant our feet and that our ego is kind of this character that is chattering neurotically in our minds. And it's good for lots of things. I mean, the ego got the book written, but it also can be very harsh, and it's liberating to have some distance on it. And that was a great gift, I think.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>\u003cem>Sam Briger and Seth Kelley produced and edited this interview for broadcast. Bridget Bentz, Molly Seavy-Nesper and Scott Hensley adapted it for the Web.\u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 Fresh Air. To see more, visit \u003ca href=\"http://www.npr.org/programs/fresh-air/\" target=\"_blank\" rel=\"noopener\">Fresh Air\u003c/a>.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=%27Reluctant+Psychonaut%27+Michael+Pollan+Embraces+The+%27New+Science%27+Of+Psychedelics+&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "441705 https://ww2.kqed.org/futureofyou/?p=441705",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/05/18/reluctant-psychonaut-michael-pollan-embraces-the-new-science-of-psychedelics/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1487,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 27
},
"modified": 1526688571,
"excerpt": "Author Michael Pollan, who experimented with mushrooms, LSD and other psychedelics while researching his latest book, says: \"I had an experience that was by turns frightening and ecstatic and weird.\"",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Author Michael Pollan, who experimented with mushrooms, LSD and other psychedelics while researching his latest book, says: "I had an experience that was by turns frightening and ecstatic and weird."",
"title": "Michael Pollan Embraces The 'New Science' Of Psychedelics | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Michael Pollan Embraces The 'New Science' Of Psychedelics",
"datePublished": "2018-05-18T18:00:02-07:00",
"dateModified": "2018-05-18T17:09:31-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "reluctant-psychonaut-michael-pollan-embraces-the-new-science-of-psychedelics",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=611225541&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprStoryDate": "Tue, 15 May 2018 13:17:00 -0400",
"nprLastModifiedDate": "Fri, 18 May 2018 16:43:05 -0400",
"nprHtmlLink": "https://www.npr.org/sections/health-shots/2018/05/15/611225541/reluctant-psychonaut-michael-pollan-embraces-the-new-science-of-psychedelics?ft=nprml&f=611225541",
"nprAudio": "https://ondemand.npr.org/anon.npr-mp3/npr/fa/2018/05/20180515_fa_01.mp3?orgId=427869011&topicId=1066&d=2549&p=13&story=611225541&ft=nprml&f=611225541",
"nprImageAgency": "Getty Images",
"source": "Health",
"nprAudioM3u": "http://api.npr.org/m3u/1611333046-6f3747.m3u?orgId=427869011&topicId=1066&d=2549&p=13&story=611225541&ft=nprml&f=611225541",
"nprStoryId": "611225541",
"nprByline": "Terry Gross, NPR",
"nprImageCredit": "Images Etc Ltd",
"nprRetrievedStory": "1",
"nprPubDate": "Fri, 18 May 2018 16:43:00 -0400",
"path": "/futureofyou/441705/reluctant-psychonaut-michael-pollan-embraces-the-new-science-of-psychedelics",
"audioUrl": "https://ondemand.npr.org/anon.npr-mp3/npr/fa/2018/05/20180515_fa_01.mp3?orgId=427869011&topicId=1066&d=2549&p=13&story=611225541&ft=nprml&f=611225541",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Author Michael Pollan had always been curious about psychoactive plants, but his interest skyrocketed when he heard about a \u003ca href=\"https://www.npr.org/sections/health-shots/2016/12/03/504136736/how-a-psychedelic-drug-helps-cancer-patients-overcome-anxiety\" target=\"_blank\" rel=\"noopener\">research study\u003c/a> in which people with terminal cancer were given a psychedelic called \u003ca href=\"https://www.npr.org/tags/140958387/psilocybin\" target=\"_blank\" rel=\"noopener\">psilocybin \u003c/a>— the active ingredient in \"magic mushrooms\" — to help them deal with their distress.\u003c/p>\n\u003cp>\"This seemed like such a crazy idea that I began looking into it,\" Pollan says. \"Why should a drug from a mushroom help people deal with their mortality?\"\u003c/p>\n\u003cp>Pollan, whose previous books include \u003ca href=\"https://www.npr.org/books/titles/137946336/the-omnivores-dilemma-a-natural-history-of-four-meals\" target=\"_blank\" rel=\"noopener\">The Omnivore's Dilemma\u003c/a> and \u003ca href=\"https://www.npr.org/templates/story/story.php?storyId=17725932\" target=\"_blank\" rel=\"noopener\">In Defense Of Food\u003c/a>, started researching different experimental therapeutic uses of psychedelics, and found that the drugs were being used to treat depression, addiction and the fear of death.\u003c/p>\n\u003cp>Then he decided to go one step further: A self-described \"reluctant psychonaut,\" Pollan enlisted guides to help him experiment with LSD, psilocybin and 5-MeO-DMT, a substance in the venom of the Sonoran Desert toad.\u003c/p>\n\u003cp>Each of Pollan's experiences with psychedelics was preceded by worry and self-doubt. But, he says, \"I realized later that was my ego trying to convince me not to do this thing that was going to challenge my ego.\"\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Pollan's new book, \u003cem>How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence\u003c/em>, recounts his experiences with the drugs and also examines the history of psychedelics as well as their possible therapeutic uses.\u003c/p>\n\u003chr>\n\u003cp>\u003cstrong>Interview Highlights\u003c/strong>\u003c/p>\n\u003cp>\u003cstrong>On how the psychedelic psilocybin is administered in therapy for depression \u003c/strong>\u003c/p>\n\u003cp>The way [psilocybin is] being used is in a very controlled or guided setting. ... They don't just give you a pill and send you home; you're in a room. You're with two guides, one male, one female. You're lying down on a comfortable couch. You're wearing headphones listening to a really carefully curated playlist of music — instrumental compositions for the most part — and you're wearing eyeshades, all of which is to encourage a very inward journey.\u003c/p>\n\u003cp>Someone is kind of looking out for you, and they prepare you very carefully in advance. They give you a set of \"flight instructions,\" as they call them, which is what to do if you get really scared or you're beginning to have a bad trip. If you see a monster, for example, don't try to run away. Walk right up to it, plant your feet and say, \"What do you have to teach me? What are you doing in my mind?\" And if you do that, according to the flight instructions, your fear will morph into something much more positive very quickly.\u003c/p>\n\u003cp>\u003cstrong>On how psychedelics can help change the stories we tell about ourselves \u003c/strong>\u003c/p>\n\u003cp>The drugs foster new perspectives on old problems. One of the things our mind does is tell stories about ourselves. If you're depressed, you're being told a story perhaps that you're worthless, that no one could possibly love you, you're not worthy of love, that life will not get better. And these stories — which are enforced by our egos really — trap us in these ruminative loops that are very hard to get out of. They're very destructive patterns of thought.\u003c/p>\n\u003cp>What the drugs appear to do is disable for a period of time the part of the brain where the self talks to itself. It's called the \u003ca href=\"https://www.npr.org/tags/482443062/default-mode-network\" target=\"_blank\" rel=\"noopener\">default mode network\u003c/a>, and it's a group of structures that connect parts of the cortex — the evolutionarily most recent part of the brain — to deeper levels where emotion and memory reside. And it's a very important hub in the brain and lots of important things happen there: self-reflection and rumination, time travel. It's where we go to think about the future or the past, and theory of mind, the ability to imagine the mental states of other beings and, I think, most importantly, the autobiographical self. It's the part of the brain, it appears, where we incorporate things that happen to us, new information, with a sense of who we are, who we were and who we want to be. And that's where these stories get generated. And these stories can be really destructive, they trap us. ...\u003c/p>\n\u003cp>This network is downregulated [with psychedelics], it sort of goes offline for a period of time. And that's why you experience this dissolution of self or ego, which can be a terrifying or liberating thing, depending on your mindset. This is what allows people, I think, to have those new perspectives on themselves, to realize that they needn't be trapped in those stories and they might actually be able to write some new stories about themselves. That's what's liberating, I think, about the experience when it works.\u003c/p>\n\u003cp>\u003cstrong>On how psychedelics can help dying people face their deaths \u003c/strong>\u003c/p>\n\u003cp>\u003ca href=\"https://www.npr.org/tags/125941537/prozac\">Prozac\u003c/a> doesn't help when you're confronting your mortality. But here we have something that occasions an experience in people — a mystical experience — that somehow makes it easier to let go. And I think some of it has to do with the fact that you do experience the \"extinction\" of yourself and it's kind of a rehearsal for death. And I think that may be part of what helps people, that they expand their sense of what is your self-interest and your self-interest is something larger than what is contained by your skin. And when you have that recognition, I think dying becomes a little easier. ...\u003c/p>\n\u003cp>There's no way to prove this, obviously, and it's a question that really troubled me as an old-fashioned materialist skeptical journalist. It's like, \"What if these drugs are inducing an illusion in people?\" I got a variety of answers to that question from the researchers. One was, \"Who cares if it helps them?\" And I can see the point of that. The other was, \"Hey, this is beyond my pay grade; none of us know what happens after we die.\" And others say, \"Well, this is an open frontier.\" ...\u003c/p>\n\u003cp>The experiences that people have are very real to them — they're psychological facts. And one of the really interesting qualities of psychedelic experience is that the insights you have on them have a durability ... This isn't just an opinion, this is revealed truth, so the confidence people have is hard to shake, actually.\u003c/p>\n\u003cp>\u003cstrong>On a \u003c/strong>\u003ca href=\"https://www.hopkinsmedicine.org/news/stories/mushrooms_quit_smoking.html\" target=\"_blank\" rel=\"noopener\">\u003cstrong>Johns Hopkins study\u003c/strong>\u003c/a>\u003cstrong> on the use of psilocybin to help people quit smoking \u003c/strong>\u003c/p>\n\u003cp>Smoking is a very hard addiction to break. It's one of the hardest addictions to break. [I wanted to understand] how, after a single psilocybin trip, they could decide \"I'm never going to smoke again\" based on the perspective they had achieved. And they would say things like, \"Well, I had this amazing experience. I died three times. I sprouted wings. I flew through European histories. I beheld all these wonders. I saw my body on a funeral pyre on the Ganges. And I realized, the universe is so amazing and there's so much to do in it that killing myself seemed really stupid.\" And that was the insight. Yes, killing yourself is really stupid — but it had an authority it had never had. And that, I think, is the gift of these psychedelics.\u003c/p>\n\u003cp>\u003cstrong>On his own experience tripping on mushrooms \u003c/strong>\u003c/p>\n\u003cp>I had an experience that was by turns frightening and ecstatic and weird. ... I found myself in this place where I could no longer control my perceptions at all, and I felt my sense of self scatter to the wind — almost as if a pile of post-its had been released to the wind — but I was fine with it. I didn't feel any desire to pile the papers back together into my customary self ...\u003c/p>\n\u003cp>Then I looked out and saw myself spread over the landscape like a coat of paint or butter. I was outside myself, beside myself, literally, and the consciousness that beheld this ... was not my normal consciousness, it was completely unperturbed. It was dispassionate. It was content, as I watched myself dissolve over the landscape.\u003c/p>\n\u003cp>What I brought back from that experience was that I'm not identical to my ego, that there is another ground on which to plant our feet and that our ego is kind of this character that is chattering neurotically in our minds. And it's good for lots of things. I mean, the ego got the book written, but it also can be very harsh, and it's liberating to have some distance on it. And that was a great gift, I think.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cem>Sam Briger and Seth Kelley produced and edited this interview for broadcast. Bridget Bentz, Molly Seavy-Nesper and Scott Hensley adapted it for the Web.\u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 Fresh Air. To see more, visit \u003ca href=\"http://www.npr.org/programs/fresh-air/\" target=\"_blank\" rel=\"noopener\">Fresh Air\u003c/a>.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=%27Reluctant+Psychonaut%27+Michael+Pollan+Embraces+The+%27New+Science%27+Of+Psychedelics+&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/441705/reluctant-psychonaut-michael-pollan-embraces-the-new-science-of-psychedelics",
"authors": [
"byline_futureofyou_441705"
],
"categories": [
"futureofyou_1060",
"futureofyou_1"
],
"tags": [
"futureofyou_56",
"futureofyou_952",
"futureofyou_1432"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_441707",
"label": "source_futureofyou_441705"
},
"futureofyou_441697": {
"type": "posts",
"id": "futureofyou_441697",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "441697",
"score": null,
"sort": [
1526677236000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1526677236,
"format": "standard",
"disqusTitle": "New Type Of Drug To Prevent Migraines Heads To Market",
"title": "New Type Of Drug To Prevent Migraines Heads To Market",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>The Food and Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines among people prone to these sometimes crippling headaches.[contextly_sidebar id=\"eVSpdADwfHP9wNaEEpapPJOooMFjlmTD\"]\u003c/p>\n\u003cp>That's welcome news to some of the millions of Americans who suffer from these \u003ca href=\"https://www.ninds.nih.gov/Disorders/All-Disorders/Migraine-Information-Page\" target=\"_blank\" rel=\"noopener\">potentially debilitating headaches\u003c/a>. Much more common in women than men, these throbbing headaches can also come with nausea, visual disturbances and sensitivity to light. People who suffer them frequently sometimes find themselves anxious, depressed and even disabled.\u003c/p>\n\u003cp>Most of the drugs on the market today are used to control the symptoms of migraine.\u003c/p>\n\u003cp>The new drug, Aimovig was \u003ca href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm608120.htm\" target=\"_blank\" rel=\"noopener\">approved by the FDA on Thursday\u003c/a>. It's the first medicine in a new class that's designed to reduce the number of migraines among people who suffer them frequently. The medicine, known generically as erenumab-aooe, is being sold by Amgen in the U.S.\u003c/p>\n\u003cp>Aimovig and several other migraine drugs in development are based on research begun in the 1980s. Scientists found people having migraine attacks have high levels of something called \"calcitonin gene–related peptide,\" or CGRP, in their blood, as Lauren Gravitz \u003ca href=\"https://www.npr.org/sections/health-shots/2018/02/03/581092093/gone-with-a-shot-hopeful-new-signs-of-relief-for-migraine-sufferers\" target=\"_blank\" rel=\"noopener\">reported for Shots in February\u003c/a>.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>When the peptide was injected in people prone to migraines, it triggered headaches. People not prone to migraines were unaffected by the peptide injections.\u003c/p>\n\u003cp>With this insight in hand, drugmakers worked to make antibodies to block the peptide's activity inside the body as a way to prevent migraines.\u003c/p>\n\u003cp>In \u003ca href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1705848\" target=\"_blank\" rel=\"noopener\">one of the large studies\u003c/a> that set the stage for FDA approval of Aimovig, the number of migraines per month dropped from eight to fewer than five, on average. Patients taking dummy \"placebo\" shots also had fewer migraines.\u003c/p>\n\u003cp>Patients in Aimovig studies reported generally mild side effects, though any long-term or rarer risks from Aimovig could come to light only over time.[contextly_sidebar id=\"qA38kZhQPznYkiyYxVV7PlTRdiD9ko0z\"]\u003c/p>\n\u003cp>People inject the drug themselves using a pen-like device, like those used for insulin.\u003c/p>\n\u003cp>Aimovig is an expensive type of medication called a monoclonal antibody. Antibodies are produced in living cells rather than in a chemical laboratory.\u003c/p>\n\u003cp>Drugmaker \u003ca href=\"https://www.amgen.com/media/news-releases/2018/05/fda-approves-aimovig-erenumabaooe-a-novel-treatment-developed-specifically-for-migraine-prevention/\" target=\"_blank\" rel=\"noopener\">Amgen says is has set the list price\u003c/a> at $6,900 a year.\u003c/p>\n\u003cp>Some analysts had expected the initial price of this drug to be set substantially higher – at $10,000 a year or more. But high prices have recently been generating political backlash, and \u003ca href=\"https://www.statnews.com/2016/10/28/cholesterol-drug-failure/\" target=\"_blank\" rel=\"noopener\">some expensive drugs have fizzled\u003c/a> after insurance companies sharply limited which patients they would cover.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>With the new migraine drug, those questions will come to the fore quickly, as Amgen says it's ready to put the drug on the market within a week, and has programs in place to help ease the cost to some patients.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=New+Type+Of+Drug+To+Prevent+Migraines+Heads+To+Market&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "441697 https://ww2.kqed.org/futureofyou/?p=441697",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/05/18/new-type-of-drug-to-prevent-migraines-heads-to-market/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 466,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 16
},
"modified": 1526666631,
"excerpt": "An antibody-based drug reduces the frequency of migraine headaches, according to data reviewed by the Food and Drug Administration. The agency approved Aimovig, priced at about $6,900 a year.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "An antibody-based drug reduces the frequency of migraine headaches, according to data reviewed by the Food and Drug Administration. The agency approved Aimovig, priced at about $6,900 a year.",
"title": "New Type Of Drug To Prevent Migraines Heads To Market | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "New Type Of Drug To Prevent Migraines Heads To Market",
"datePublished": "2018-05-18T14:00:36-07:00",
"dateModified": "2018-05-18T11:03:51-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "new-type-of-drug-to-prevent-migraines-heads-to-market",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=612296263&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Richard Harris, NPR",
"nprStoryDate": "Fri, 18 May 2018 11:09:05 -0400",
"nprLastModifiedDate": "Fri, 18 May 2018 13:21:50 -0400",
"nprHtmlLink": "https://www.npr.org/sections/health-shots/2018/05/18/612296263/new-type-of-drug-to-prevent-migraines-heads-to-market?ft=nprml&f=612296263",
"source": "Health",
"nprStoryId": "612296263",
"nprRetrievedStory": "1",
"nprPubDate": "Fri, 18 May 2018 13:21:00 -0400",
"path": "/futureofyou/441697/new-type-of-drug-to-prevent-migraines-heads-to-market",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>The Food and Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines among people prone to these sometimes crippling headaches.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>That's welcome news to some of the millions of Americans who suffer from these \u003ca href=\"https://www.ninds.nih.gov/Disorders/All-Disorders/Migraine-Information-Page\" target=\"_blank\" rel=\"noopener\">potentially debilitating headaches\u003c/a>. Much more common in women than men, these throbbing headaches can also come with nausea, visual disturbances and sensitivity to light. People who suffer them frequently sometimes find themselves anxious, depressed and even disabled.\u003c/p>\n\u003cp>Most of the drugs on the market today are used to control the symptoms of migraine.\u003c/p>\n\u003cp>The new drug, Aimovig was \u003ca href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm608120.htm\" target=\"_blank\" rel=\"noopener\">approved by the FDA on Thursday\u003c/a>. It's the first medicine in a new class that's designed to reduce the number of migraines among people who suffer them frequently. The medicine, known generically as erenumab-aooe, is being sold by Amgen in the U.S.\u003c/p>\n\u003cp>Aimovig and several other migraine drugs in development are based on research begun in the 1980s. Scientists found people having migraine attacks have high levels of something called \"calcitonin gene–related peptide,\" or CGRP, in their blood, as Lauren Gravitz \u003ca href=\"https://www.npr.org/sections/health-shots/2018/02/03/581092093/gone-with-a-shot-hopeful-new-signs-of-relief-for-migraine-sufferers\" target=\"_blank\" rel=\"noopener\">reported for Shots in February\u003c/a>.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>When the peptide was injected in people prone to migraines, it triggered headaches. People not prone to migraines were unaffected by the peptide injections.\u003c/p>\n\u003cp>With this insight in hand, drugmakers worked to make antibodies to block the peptide's activity inside the body as a way to prevent migraines.\u003c/p>\n\u003cp>In \u003ca href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1705848\" target=\"_blank\" rel=\"noopener\">one of the large studies\u003c/a> that set the stage for FDA approval of Aimovig, the number of migraines per month dropped from eight to fewer than five, on average. Patients taking dummy \"placebo\" shots also had fewer migraines.\u003c/p>\n\u003cp>Patients in Aimovig studies reported generally mild side effects, though any long-term or rarer risks from Aimovig could come to light only over time.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>People inject the drug themselves using a pen-like device, like those used for insulin.\u003c/p>\n\u003cp>Aimovig is an expensive type of medication called a monoclonal antibody. Antibodies are produced in living cells rather than in a chemical laboratory.\u003c/p>\n\u003cp>Drugmaker \u003ca href=\"https://www.amgen.com/media/news-releases/2018/05/fda-approves-aimovig-erenumabaooe-a-novel-treatment-developed-specifically-for-migraine-prevention/\" target=\"_blank\" rel=\"noopener\">Amgen says is has set the list price\u003c/a> at $6,900 a year.\u003c/p>\n\u003cp>Some analysts had expected the initial price of this drug to be set substantially higher – at $10,000 a year or more. But high prices have recently been generating political backlash, and \u003ca href=\"https://www.statnews.com/2016/10/28/cholesterol-drug-failure/\" target=\"_blank\" rel=\"noopener\">some expensive drugs have fizzled\u003c/a> after insurance companies sharply limited which patients they would cover.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>With the new migraine drug, those questions will come to the fore quickly, as Amgen says it's ready to put the drug on the market within a week, and has programs in place to help ease the cost to some patients.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=New+Type+Of+Drug+To+Prevent+Migraines+Heads+To+Market&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/441697/new-type-of-drug-to-prevent-migraines-heads-to-market",
"authors": [
"byline_futureofyou_441697"
],
"categories": [
"futureofyou_1060",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_952",
"futureofyou_38",
"futureofyou_61",
"futureofyou_1056",
"futureofyou_1407"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_441701",
"label": "source_futureofyou_441697"
},
"futureofyou_441680": {
"type": "posts",
"id": "futureofyou_441680",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "441680",
"score": null,
"sort": [
1526664113000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1526664113,
"format": "standard",
"disqusTitle": "Mounting Evidence Shows Diet Soda May Be Hurting Your Diet — Here's How",
"title": "Mounting Evidence Shows Diet Soda May Be Hurting Your Diet — Here's How",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>Artificial sweeteners are everywhere, but the jury is still out on whether these chemicals are harmless. Also called non-nutritive sweeteners, these can be synthetic – such as saccharin and aspartame – or naturally derived, such as steviol, which comes from the Stevia plant. To date, the U.S. Food and Drug Administration has approved \u003ca href=\"https://www.fda.gov/Food/IngredientsPackagingLabeling/FoodAdditivesIngredients/ucm397725.htm\" target=\"_blank\" rel=\"noopener\">six types of artificial and two types of natural non-nutritive sweeteners\u003c/a> for use in food.[contextly_sidebar id=\"9cHOWFJBVWEQQfvraluyBJ45Elnnkn5i\"]\u003c/p>\n\u003cp>That’s been great news for those working hard to curb their sugar consumption. \u003ca href=\"https://doi.org/10.3945/ajcn.111.030833\" target=\"_blank\" rel=\"noopener\">Aspartame\u003c/a>, for example, is found in more than 6,000 foods worldwide, and about 5,000-5,500 tons are consumed every year in the United States alone.\u003c/p>\n\u003cp>The American Diabetes Association – the most well-respected professional group focusing on diabetes – \u003ca href=\"http://www.diabetes.org/food-and-fitness/food/what-can-i-eat/making-healthy-food-choices/what-can-i-drink.html\" target=\"_blank\" rel=\"noopener\">officially recommends diet soda as an alternative\u003c/a> to sugar-sweetened beverages. To date, seven U.S. municipalities have imposed a sugary beverage tax to discourage consumption.\u003c/p>\n\u003cp>However, recent medical studies suggest that policymakers eager to implement a soda tax may also want to include diet drinks because these sweeteners may be contributing to chronic diabetes and cardiovascular diseases as well.\u003c/p>\n\u003cp>\u003cstrong>Why Are These Sweeteners Calorie-Free?\u003c/strong>\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>The key to these virtually calorie-free sweeteners is that they are not broken down during digestion into natural sugars like glucose, fructose and galactose, which are then either used for energy or converted into fat.\u003c/p>\n\u003cp>Non-nutritive sweeteners have different byproducts that are not converted into calories. Aspartame, for example, undergoes a different metabolic process that doesn’t yield simple sugars. Others such as saccharin and sucralose are not broken down at all, but instead are absorbed directly into the bloodstream and excreted in the urine.\u003c/p>\n\u003cp>Theoretically, these sweeteners should be a “better” choice than sugar for diabetics. Glucose stimulates release of insulin, a hormone that regulates blood sugar levels. Type 2 diabetes occurs when the body no longer responds as well to insulin as it should, leading to higher levels of glucose in the blood that damages the nerves, kidneys, blood vessels and heart. Since non-nutritive sweeteners aren’t actually sugar, they should sidestep this problem.\u003c/p>\n\u003cp>\u003cstrong>Artificial Sweeteners, Your Brain and Your Microbiome\u003c/strong>\u003c/p>\n\u003cp>However, there is growing evidence over the last decade that these sweeteners can alter healthy metabolic processes in other ways, specifically in the gut.\u003c/p>\n\u003cp>Long-term use of these sweeteners has \u003ca href=\"https://doi.org/10.2337/dc08-1799\" target=\"_blank\" rel=\"noopener\">been associated with a higher risk of Type 2 diabetes\u003c/a>. Sweeteners, such as saccharin, have been shown to \u003ca href=\"http://doi.org/10.1038/nature13793\" target=\"_blank\" rel=\"noopener\">change the type and function of the gut microbiome\u003c/a>, the community of microorganisms that live in the intestine. Aspartame \u003ca href=\"https://doi.org/10.1139/apnm-2016-0346\" target=\"_blank\" rel=\"noopener\">decreases the activity of a gut enzyme\u003c/a> that is normally protective against Type 2 diabetes. Furthermore, this response may be exacerbated by the “mismatch” between the body perceiving something as tasting sweet and the expected associated calories. The greater the discrepancy between the sweetness and actual caloric content, the \u003ca href=\"http://doi.org/10.1016/j.cub.2017.07.018\" target=\"_blank\" rel=\"noopener\">greater the metabolic dysregulation\u003c/a>.[contextly_sidebar id=\"1WiRRvjeXSgRFmENuLBZhCvtglNEvId8\"]\u003c/p>\n\u003cp>Sweeteners have also been shown to change brain activity associated with eating sweet foods. A functional MRI exam, which studies brain activity by measuring blood flow, has shown that sucralose, compared to regular sugar, \u003ca href=\"https://doi.org/10.1016/j.appet.2011.12.001\">decreases activity in the amygdala\u003c/a>, a part of the brain involved with taste perception and the experience of eating.\u003c/p>\n\u003cp>Another study revealed that longer-term and higher diet soda consumption are linked to \u003ca href=\"https://doi.org/10.1016/j.physbeh.2012.05.006\">lower activity in the brain’s “caudate head,”\u003c/a> a region that mediates the reward pathway and is necessary for generating a feeling of satisfaction. Researchers have hypothesized that this decreased activity could lead a diet soda drinker to compensate for the lack of pleasure they now derive from the food by increasing their consumption of all foods, not just soda.\u003c/p>\n\u003cp>Together these cellular and brain studies may explain why people who consume sweeteners still have a \u003ca href=\"https://doi.org/10.1371/journal.pone.0167241\">higher risk of obesity\u003c/a> than individuals who don’t consume these products.\u003c/p>\n\u003cp>\u003ca href=\"https://doi.org/10.1503/cmaj.161390\">As this debate on the pros and cons of these sugar substitutes rages on\u003c/a>, we must view these behavioral studies with a grain of salt (or sugar) because many diet soda drinkers – or any health-conscious individual who consumes zero-calorie sweeteners – already has the risk factors for obesity, diabetes, hypertension or heart disease. Those who are already overweight or obese may turn toward low-calorie drinks, making it look as though the diet sodas are causing their weight gain.\u003c/p>\n\u003cp>This same group may also be less likely to moderate their consumption. For example, those people may think that having a diet soda multiple times a week is much healthier than drinking one case of soda with sugar.[contextly_sidebar id=\"nPADPRMuF9gHM8AprlV1Wgo1Jciefs8f\"]\u003c/p>\n\u003cp>These findings signal that consumers and health practitioners all need to check our assumptions about the health benefits of these products. Sweeteners are everywhere, from beverages to salad dressing, from cookies to yogurt, and we must recognize that there is no guarantee that these chemicals won’t increase the burden of metabolic diseases in the future.\u003c/p>\n\u003cp>As a physician of internal medicine specializing in general prevention and public health, I would like to be able to tell my patients what the true risks and benefits are if they drink diet soda instead of water.\u003c/p>\n\u003cp>Legislators considering soda taxes to encourage better dietary habits perhaps should think about including foods with non-nutritive sweeteners. Of course, there is an argument to be made for being realistic and pursuing the lesser of two evils. But even if the negative consequences of sugar substitutes doesn’t sway our tax policy – for now – at least the medical community should be honest with the public about what they stand to lose or gain, consuming these foods.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>\u003cspan class=\"fn author-name\">Eunice Zhang is a c\u003c/span>linical fellow of preventive medicine at the University of Michigan. This article was originally published on \u003ca href=\"https://theconversation.com/diet-soda-may-be-hurting-your-diet-96181\" target=\"_blank\" rel=\"noopener\">The Conversation\u003c/a>.\u003c/em>\u003c/p>\n\n",
"disqusIdentifier": "441680 https://ww2.kqed.org/futureofyou/?p=441680",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/05/18/diet-soda-may-be-hurting-your-diet/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 993,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 22
},
"modified": 1526664530,
"excerpt": "There is growing evidence that artificial sweeteners can alter healthy metabolic processes, specifically in the gut.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "There is growing evidence that artificial sweeteners can alter healthy metabolic processes, specifically in the gut.",
"title": "Mounting Evidence Shows Diet Soda May Be Hurting Your Diet — Here's How | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Mounting Evidence Shows Diet Soda May Be Hurting Your Diet — Here's How",
"datePublished": "2018-05-18T10:21:53-07:00",
"dateModified": "2018-05-18T10:28:50-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "diet-soda-may-be-hurting-your-diet",
"status": "publish",
"nprByline": "Eunice Zhang, University of Michigan, For\u003cbr />The Conversation\u003cimg src=\"https://counter.theconversation.com/content/91452/count.gif?distributor=republish-lightbox-advanced\" alt=\"The Conversation\" width=\"1\" height=\"1\" />",
"source": "Health",
"path": "/futureofyou/441680/diet-soda-may-be-hurting-your-diet",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Artificial sweeteners are everywhere, but the jury is still out on whether these chemicals are harmless. Also called non-nutritive sweeteners, these can be synthetic – such as saccharin and aspartame – or naturally derived, such as steviol, which comes from the Stevia plant. To date, the U.S. Food and Drug Administration has approved \u003ca href=\"https://www.fda.gov/Food/IngredientsPackagingLabeling/FoodAdditivesIngredients/ucm397725.htm\" target=\"_blank\" rel=\"noopener\">six types of artificial and two types of natural non-nutritive sweeteners\u003c/a> for use in food.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>That’s been great news for those working hard to curb their sugar consumption. \u003ca href=\"https://doi.org/10.3945/ajcn.111.030833\" target=\"_blank\" rel=\"noopener\">Aspartame\u003c/a>, for example, is found in more than 6,000 foods worldwide, and about 5,000-5,500 tons are consumed every year in the United States alone.\u003c/p>\n\u003cp>The American Diabetes Association – the most well-respected professional group focusing on diabetes – \u003ca href=\"http://www.diabetes.org/food-and-fitness/food/what-can-i-eat/making-healthy-food-choices/what-can-i-drink.html\" target=\"_blank\" rel=\"noopener\">officially recommends diet soda as an alternative\u003c/a> to sugar-sweetened beverages. To date, seven U.S. municipalities have imposed a sugary beverage tax to discourage consumption.\u003c/p>\n\u003cp>However, recent medical studies suggest that policymakers eager to implement a soda tax may also want to include diet drinks because these sweeteners may be contributing to chronic diabetes and cardiovascular diseases as well.\u003c/p>\n\u003cp>\u003cstrong>Why Are These Sweeteners Calorie-Free?\u003c/strong>\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>The key to these virtually calorie-free sweeteners is that they are not broken down during digestion into natural sugars like glucose, fructose and galactose, which are then either used for energy or converted into fat.\u003c/p>\n\u003cp>Non-nutritive sweeteners have different byproducts that are not converted into calories. Aspartame, for example, undergoes a different metabolic process that doesn’t yield simple sugars. Others such as saccharin and sucralose are not broken down at all, but instead are absorbed directly into the bloodstream and excreted in the urine.\u003c/p>\n\u003cp>Theoretically, these sweeteners should be a “better” choice than sugar for diabetics. Glucose stimulates release of insulin, a hormone that regulates blood sugar levels. Type 2 diabetes occurs when the body no longer responds as well to insulin as it should, leading to higher levels of glucose in the blood that damages the nerves, kidneys, blood vessels and heart. Since non-nutritive sweeteners aren’t actually sugar, they should sidestep this problem.\u003c/p>\n\u003cp>\u003cstrong>Artificial Sweeteners, Your Brain and Your Microbiome\u003c/strong>\u003c/p>\n\u003cp>However, there is growing evidence over the last decade that these sweeteners can alter healthy metabolic processes in other ways, specifically in the gut.\u003c/p>\n\u003cp>Long-term use of these sweeteners has \u003ca href=\"https://doi.org/10.2337/dc08-1799\" target=\"_blank\" rel=\"noopener\">been associated with a higher risk of Type 2 diabetes\u003c/a>. Sweeteners, such as saccharin, have been shown to \u003ca href=\"http://doi.org/10.1038/nature13793\" target=\"_blank\" rel=\"noopener\">change the type and function of the gut microbiome\u003c/a>, the community of microorganisms that live in the intestine. Aspartame \u003ca href=\"https://doi.org/10.1139/apnm-2016-0346\" target=\"_blank\" rel=\"noopener\">decreases the activity of a gut enzyme\u003c/a> that is normally protective against Type 2 diabetes. Furthermore, this response may be exacerbated by the “mismatch” between the body perceiving something as tasting sweet and the expected associated calories. The greater the discrepancy between the sweetness and actual caloric content, the \u003ca href=\"http://doi.org/10.1016/j.cub.2017.07.018\" target=\"_blank\" rel=\"noopener\">greater the metabolic dysregulation\u003c/a>.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Sweeteners have also been shown to change brain activity associated with eating sweet foods. A functional MRI exam, which studies brain activity by measuring blood flow, has shown that sucralose, compared to regular sugar, \u003ca href=\"https://doi.org/10.1016/j.appet.2011.12.001\">decreases activity in the amygdala\u003c/a>, a part of the brain involved with taste perception and the experience of eating.\u003c/p>\n\u003cp>Another study revealed that longer-term and higher diet soda consumption are linked to \u003ca href=\"https://doi.org/10.1016/j.physbeh.2012.05.006\">lower activity in the brain’s “caudate head,”\u003c/a> a region that mediates the reward pathway and is necessary for generating a feeling of satisfaction. Researchers have hypothesized that this decreased activity could lead a diet soda drinker to compensate for the lack of pleasure they now derive from the food by increasing their consumption of all foods, not just soda.\u003c/p>\n\u003cp>Together these cellular and brain studies may explain why people who consume sweeteners still have a \u003ca href=\"https://doi.org/10.1371/journal.pone.0167241\">higher risk of obesity\u003c/a> than individuals who don’t consume these products.\u003c/p>\n\u003cp>\u003ca href=\"https://doi.org/10.1503/cmaj.161390\">As this debate on the pros and cons of these sugar substitutes rages on\u003c/a>, we must view these behavioral studies with a grain of salt (or sugar) because many diet soda drinkers – or any health-conscious individual who consumes zero-calorie sweeteners – already has the risk factors for obesity, diabetes, hypertension or heart disease. Those who are already overweight or obese may turn toward low-calorie drinks, making it look as though the diet sodas are causing their weight gain.\u003c/p>\n\u003cp>This same group may also be less likely to moderate their consumption. For example, those people may think that having a diet soda multiple times a week is much healthier than drinking one case of soda with sugar.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>These findings signal that consumers and health practitioners all need to check our assumptions about the health benefits of these products. Sweeteners are everywhere, from beverages to salad dressing, from cookies to yogurt, and we must recognize that there is no guarantee that these chemicals won’t increase the burden of metabolic diseases in the future.\u003c/p>\n\u003cp>As a physician of internal medicine specializing in general prevention and public health, I would like to be able to tell my patients what the true risks and benefits are if they drink diet soda instead of water.\u003c/p>\n\u003cp>Legislators considering soda taxes to encourage better dietary habits perhaps should think about including foods with non-nutritive sweeteners. Of course, there is an argument to be made for being realistic and pursuing the lesser of two evils. But even if the negative consequences of sugar substitutes doesn’t sway our tax policy – for now – at least the medical community should be honest with the public about what they stand to lose or gain, consuming these foods.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>\u003cspan class=\"fn author-name\">Eunice Zhang is a c\u003c/span>linical fellow of preventive medicine at the University of Michigan. This article was originally published on \u003ca href=\"https://theconversation.com/diet-soda-may-be-hurting-your-diet-96181\" target=\"_blank\" rel=\"noopener\">The Conversation\u003c/a>.\u003c/em>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/441680/diet-soda-may-be-hurting-your-diet",
"authors": [
"byline_futureofyou_441680"
],
"categories": [
"futureofyou_1060",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_312",
"futureofyou_309",
"futureofyou_38",
"futureofyou_426",
"futureofyou_61",
"futureofyou_1071"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_441686",
"label": "source_futureofyou_441680"
},
"futureofyou_440840": {
"type": "posts",
"id": "futureofyou_440840",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "440840",
"score": null,
"sort": [
1526396432000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1526396432,
"format": "audio",
"disqusTitle": "STD Testing Using a Home Kit: Pros and Cons",
"title": "STD Testing Using a Home Kit: Pros and Cons",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>When I heard about home testing for sexually transmitted diseases, I was intrigued. Who doesn't despise that particularly awkward conversation with their doctor? And who doesn't want to skip the waiting room and long line at the lab?\u003c/p>\n\u003caside class=\"pullquote alignright\">A 15-minute procedure in the privacy of your own home. But the kits can get pricey.\u003c/aside>\n\u003cp>The kit I used is available online for $189 from a company called myLAB Box. Many other companies offer similar tests -- EverlyWell and LetsGetChecked, to name two. The kits cost anywhere from $100 to $400, depending on the number of diseases you're tested for.\u003c/p>\n\u003cp>\u003cstrong>Simple Steps\u003c/strong>\u003c/p>\n\u003cp>After opening my kit, I saw everything I needed packed neatly into a box about the size of my palm. Following the steps outlined in pictures on the instruction sheet, the entire procedure took less than 15 minutes. First I used a giant Q-tip as a vaginal swab. I doused my ring finger with alcohol and pricked it with a plastic lancet, carefully letting droplets of blood land in circles on a white collection card. After sealing both samples in separate biohazard bags, I shipped the specimens off in a prepaid envelope.\u003c/p>\n\u003cfigure id=\"attachment_440848\" class=\"wp-caption alignright\" style=\"max-width: 411px\">\u003ca href=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/04/RS30399_ATHOMETEST_035-e1524194755230.jpg\">\u003cimg class=\" wp-image-440848\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/04/RS30399_ATHOMETEST_035-1020x1528.jpg\" alt=\"\" width=\"411\" height=\"616\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Lesley McClurg uses a lancet to get a blood sample for a home STD test. \u003ccite>(Lauren Hanussak/KQED)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>I had ordered tests for chlamydia, gonorrhea, HIV and trichomoniasis -- the basic package. A few days later I received an email confirming that my results were negative. (Unlike \u003ca href=\"https://www.youtube.com/watch?v=bv26dLnbi9g\" target=\"_blank\" rel=\"noopener\">George Costanza\u003c/a>, of \"Seinfeld\" fame, I knew that \"negative\" is good in this context.)\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>If any of the tests had come back positive, myLAB Box would have connected me with a physician for a free telemedicine consultation.\u003c/p>\n\u003cp>\u003cstrong>Accelerating STD Rates\u003c/strong>\u003c/p>\n\u003cp>Health officials think home testing of STDs has the potential to curb accelerating transmission rates. The Centers for Disease Control and Prevention \u003ca href=\"https://www.cdc.gov/std/stats16/default.htm\" target=\"_blank\" rel=\"noopener\">reported\u003c/a> all-time highs for STDs in 2016, and an estimated \u003ca href=\"https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/std-trends-508.pdf\" target=\"_blank\" rel=\"noopener\">20 million Americans\u003c/a> contract an infection through sexual contact every year. Meanwhile, in California, numerous public testing clinics have closed over the past decade, according to the state's Department of Health.\u003c/p>\n\u003caside class=\"pullquote alignright\">'Patient surveys have demonstrated that individuals don't always feel comfortable talking to their regular medical provider about their risk for STD or interest in STD testing.'\u003ccite>California Department of Public Health\u003c/cite>\u003c/aside>\n\u003cp>\"Many people still face significant challenges getting high-quality sexual health services, including STD testing,\" a spokesperson said in an email. \"This is particularly true of youth, males, and sexual minorities. Patient surveys have demonstrated that individuals don't always feel comfortable talking to their regular medical provider about their risk for STD or interest in STD testing.\"\u003c/p>\n\u003cp>Dr. Jennifer Conti, a gynecologist and clinical assistant professor at Stanford University, agrees that home testing increases access. \"I think anyone can prick their finger or pee on a stick,\" she said.\u003c/p>\n\u003cp>Conti recommends testing every six months if you're sexually active with multiple partners. This can get pricey if you're paying out of pocket. Though insurance companies are required to pay for preventative STD screening under the Affordable Care Act, most providers will not reimburse patients for home tests.\u003c/p>\n\u003cp>\u003cstrong>No FDA Approval\u003c/strong>\u003c/p>\n\u003cp>If you do decide to purchase a home test, you should know the Food and Drug Administration has only approved \u003ca href=\"https://www.cdc.gov/hiv/testing/hometests.html\" target=\"_blank\" rel=\"noopener\">two HIV tests\u003c/a> for the home market. Anything beyond that, the quality of different products may vary.\u003c/p>\n\u003cp>“The people who draw your blood in a hospital or in clinic are all trained, and they obtain specimens that have no inconsistency,\" said Dr. Norman Paradis, an emergency room physician who teaches at the Geisel School of Medicine at Dartmouth College. \"But some of the new devices for doing this on yourself at home haven't been validated to the same extent.”\u003c/p>\n\u003cp>The CEO of myLab Box, Lora Ivanova, said results are tested in a lab meeting the standards of the \u003ca href=\"https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/index.html?redirect=/CLIA/\" target=\"_blank\" rel=\"noopener\">Clinical Laboratory Improvement Amendments, \u003c/a>used by the federal government to certify labs.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Paradis says the benefits of home testing far outweigh the risks, as long as patients see a doctor when a test comes back positive and when experiencing abnormal symptoms.\u003c/p>\n\n",
"disqusIdentifier": "440840 https://ww2.kqed.org/futureofyou/?p=440840",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/05/15/my-home-std-test-was-a-positive-experience-that-is/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 696,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 18
},
"modified": 1547234096,
"excerpt": "Home testing kits for STDs have hit the market, and reporter Lesley McClurg tried one out.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Home testing kits for STDs have hit the market, and reporter Lesley McClurg tried one out.",
"title": "STD Testing Using a Home Kit: Pros and Cons | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "STD Testing Using a Home Kit: Pros and Cons",
"datePublished": "2018-05-15T08:00:32-07:00",
"dateModified": "2019-01-11T11:14:56-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "my-home-std-test-was-a-positive-experience-that-is",
"status": "publish",
"audioUrl": "https://www.kqed.org/.stream/anon/radio/science/2018/05/McClurgSTDHomeTesting.mp3",
"source": "DIY Health",
"path": "/futureofyou/440840/my-home-std-test-was-a-positive-experience-that-is",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>When I heard about home testing for sexually transmitted diseases, I was intrigued. Who doesn't despise that particularly awkward conversation with their doctor? And who doesn't want to skip the waiting room and long line at the lab?\u003c/p>\n\u003caside class=\"pullquote alignright\">A 15-minute procedure in the privacy of your own home. But the kits can get pricey.\u003c/aside>\n\u003cp>The kit I used is available online for $189 from a company called myLAB Box. Many other companies offer similar tests -- EverlyWell and LetsGetChecked, to name two. The kits cost anywhere from $100 to $400, depending on the number of diseases you're tested for.\u003c/p>\n\u003cp>\u003cstrong>Simple Steps\u003c/strong>\u003c/p>\n\u003cp>After opening my kit, I saw everything I needed packed neatly into a box about the size of my palm. Following the steps outlined in pictures on the instruction sheet, the entire procedure took less than 15 minutes. First I used a giant Q-tip as a vaginal swab. I doused my ring finger with alcohol and pricked it with a plastic lancet, carefully letting droplets of blood land in circles on a white collection card. After sealing both samples in separate biohazard bags, I shipped the specimens off in a prepaid envelope.\u003c/p>\n\u003cfigure id=\"attachment_440848\" class=\"wp-caption alignright\" style=\"max-width: 411px\">\u003ca href=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/04/RS30399_ATHOMETEST_035-e1524194755230.jpg\">\u003cimg class=\" wp-image-440848\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/04/RS30399_ATHOMETEST_035-1020x1528.jpg\" alt=\"\" width=\"411\" height=\"616\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Lesley McClurg uses a lancet to get a blood sample for a home STD test. \u003ccite>(Lauren Hanussak/KQED)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>I had ordered tests for chlamydia, gonorrhea, HIV and trichomoniasis -- the basic package. A few days later I received an email confirming that my results were negative. (Unlike \u003ca href=\"https://www.youtube.com/watch?v=bv26dLnbi9g\" target=\"_blank\" rel=\"noopener\">George Costanza\u003c/a>, of \"Seinfeld\" fame, I knew that \"negative\" is good in this context.)\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>If any of the tests had come back positive, myLAB Box would have connected me with a physician for a free telemedicine consultation.\u003c/p>\n\u003cp>\u003cstrong>Accelerating STD Rates\u003c/strong>\u003c/p>\n\u003cp>Health officials think home testing of STDs has the potential to curb accelerating transmission rates. The Centers for Disease Control and Prevention \u003ca href=\"https://www.cdc.gov/std/stats16/default.htm\" target=\"_blank\" rel=\"noopener\">reported\u003c/a> all-time highs for STDs in 2016, and an estimated \u003ca href=\"https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/std-trends-508.pdf\" target=\"_blank\" rel=\"noopener\">20 million Americans\u003c/a> contract an infection through sexual contact every year. Meanwhile, in California, numerous public testing clinics have closed over the past decade, according to the state's Department of Health.\u003c/p>\n\u003caside class=\"pullquote alignright\">'Patient surveys have demonstrated that individuals don't always feel comfortable talking to their regular medical provider about their risk for STD or interest in STD testing.'\u003ccite>California Department of Public Health\u003c/cite>\u003c/aside>\n\u003cp>\"Many people still face significant challenges getting high-quality sexual health services, including STD testing,\" a spokesperson said in an email. \"This is particularly true of youth, males, and sexual minorities. Patient surveys have demonstrated that individuals don't always feel comfortable talking to their regular medical provider about their risk for STD or interest in STD testing.\"\u003c/p>\n\u003cp>Dr. Jennifer Conti, a gynecologist and clinical assistant professor at Stanford University, agrees that home testing increases access. \"I think anyone can prick their finger or pee on a stick,\" she said.\u003c/p>\n\u003cp>Conti recommends testing every six months if you're sexually active with multiple partners. This can get pricey if you're paying out of pocket. Though insurance companies are required to pay for preventative STD screening under the Affordable Care Act, most providers will not reimburse patients for home tests.\u003c/p>\n\u003cp>\u003cstrong>No FDA Approval\u003c/strong>\u003c/p>\n\u003cp>If you do decide to purchase a home test, you should know the Food and Drug Administration has only approved \u003ca href=\"https://www.cdc.gov/hiv/testing/hometests.html\" target=\"_blank\" rel=\"noopener\">two HIV tests\u003c/a> for the home market. Anything beyond that, the quality of different products may vary.\u003c/p>\n\u003cp>“The people who draw your blood in a hospital or in clinic are all trained, and they obtain specimens that have no inconsistency,\" said Dr. Norman Paradis, an emergency room physician who teaches at the Geisel School of Medicine at Dartmouth College. \"But some of the new devices for doing this on yourself at home haven't been validated to the same extent.”\u003c/p>\n\u003cp>The CEO of myLab Box, Lora Ivanova, said results are tested in a lab meeting the standards of the \u003ca href=\"https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/index.html?redirect=/CLIA/\" target=\"_blank\" rel=\"noopener\">Clinical Laboratory Improvement Amendments, \u003c/a>used by the federal government to certify labs.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Paradis says the benefits of home testing far outweigh the risks, as long as patients see a doctor when a test comes back positive and when experiencing abnormal symptoms.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/440840/my-home-std-test-was-a-positive-experience-that-is",
"authors": [
"11229"
],
"categories": [
"futureofyou_1060",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_80",
"futureofyou_447"
],
"featImg": "futureofyou_440895",
"label": "source_futureofyou_440840"
},
"futureofyou_441435": {
"type": "posts",
"id": "futureofyou_441435",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "441435",
"score": null,
"sort": [
1525907695000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou"
},
"blocks": [],
"publishDate": 1525907695,
"format": "aside",
"disqusTitle": "HIV Patients Say Gilead Suppressed Safer Drug to Preserve Profits",
"title": "HIV Patients Say Gilead Suppressed Safer Drug to Preserve Profits",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>A group of HIV patients based in California filed two separate lawsuits on Wednesday against Bay Area drugmaker Gilead Sciences for promoting a drug they say caused permanent kidney and bone damage. The \u003ca href=\"https://www.aidshealth.org/wp-content/uploads/2018/05/gilead-personal-injury-final.pdf\" target=\"_blank\" rel=\"noopener\">personal injury\u003c/a> and\u003ca href=\"https://www.aidshealth.org/wp-content/uploads/2018/05/class-action-complaint-final.pdf\" target=\"_blank\" rel=\"noopener\"> class action\u003c/a> suits, filed in a Los Angeles district court, accuse the company of shelving a safer version of the drug in order to maximize profits and extend the sales of its existing drug tenofovir disoproxil fumarate.\u003c/p>\n\u003cfigure id=\"attachment_441443\" class=\"wp-caption aligncenter\" style=\"max-width: 796px\">\u003ca href=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/05/viread.png\">\u003cimg class=\" wp-image-441443\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/05/viread.png\" alt=\"\" width=\"796\" height=\"329\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread.png 754w, https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-160x66.png 160w, https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-240x99.png 240w, https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-375x155.png 375w, https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-520x215.png 520w\" sizes=\"(max-width: 796px) 100vw, 796px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Tenofovir disoproxil fumarate was sold under the brand name Viread. \u003ccite>(U.S. Dept. of Health and Human Services)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Both complaints say the company knew as far back as 2001 that TDF was highly toxic but failed to warn patients of the dangerous side effects. The drug was originally sold under the brand name Viread.\u003c/p>\n\u003cp>\"A company I trusted with my life took advantage of that trust by misrepresenting the side effects of TDF, calling it the ‘Miracle Drug’ and using other deceptive marketing strategies,\" said Michael Lujano, from Los Angeles, one of two plaintiffs in the personal injury suit. \"Gilead shelved a far safer drug called tenofovir alafenamide fumarate simply to increase its long-term profits.\"\u003c/p>\n\u003cp>Another plaintiff in the class action suit, Ricardo Wohler, says he has lost 17 teeth in just three years due to the drug. The 52 year-old real estate agent from Marin took TDF for 12 years and was never made aware of its potential side effects, he said.\u003c/p>\n\u003cp>\"I learned how to smile without opening my mouth, how to speak without showing my teeth. This had an entire impact on my life, my self security, my self esteem, but also on my finances.\"\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Gilead said it is \"thoroughly reviewing the complaints and will not provide comment until that process is complete.\"\u003c/p>\n\u003cp>The suits accuse Gilead of deceptive marketing practices and putting profits before the health of its customers. The complaint says the company made $18 billion in profits in 2015.\u003c/p>\n\u003cp>\"Under these circumstances, the laws must be read to protect public health from corporate greed,” says Liza Brereton, attorney for plaintiffs and in-house counsel for the AIDS Healthcare Foundation.\u003c/p>\n\u003cp>AHF, which filed both lawsuits with co-counsel Rutherford Law, says it is funding the litigation and will not accept any financial recovery in excess of its actual costs.\u003c/p>\n\u003cp>Two other Californians filed a separate class action lawsuit on behalf of all patients living in California who were prescribed the drug from Oct. 26, 2001 through the present and were exposed to Gilead’s alleged misrepresentations, either directly or through their doctor.\u003c/p>\n\u003cp>The Food and Drug Administration reportedly issued two warning letters to Gilead for false misrepresentations about the drug's risks, according to the personal injury complaint.\u003c/p>\n\u003cp>A warning letter issued in 2002 accused a company sales representatives of falsely stating that TDF had “no toxicities” and was “benign” and “extremely safe.\" The company was slapped with another warning letter one year later, requiring Gilead to retrain its sales representatives.\u003c/p>\n\u003cp>The drugmaker began funding research of an alternative drug called TAF in 2001 but suppressed findings that showed it was far less toxic, according to the class action complaint.\u003c/p>\n\u003cp>Faced with a sharp decrease in profits, the complaint says, the drugmaker eventually released those findings in 2014, when Gilead’s patent on TDF was approaching expiration.\u003c/p>\n\u003cp>From the \u003ca href=\"http://www.latimes.com/business/la-fi-gilead-hiv-drug-lawsuit-20180509-story.html\" target=\"_blank\" rel=\"noopener\">Los Angeles Times\u003c/a>:\u003c/p>\n\u003cblockquote>\u003cp>In April 2001, the scientists published research on a different chemical version of the medicine called tenofovir alafenamide fumarate, or TAF.\u003c/p>\n\u003cp>That animal study showed TAF had a thousand-fold greater activity against HIV than the original medicine invented in Europe, raising the possibility that it would have far less toxicity.\u003c/p>\n\u003cp>Gilead then paid doctors across the country to give TAF to patients in small clinical trials. The positive results of those studies were not published for years — secrecy that the lawsuits filed Tuesday say was \"an act of extreme malice.\"\u003c/p>\n\u003cp>Instead, in October 2004, Gilead abruptly announced that it was ending research on TAF after an \"internal business review.\" And it continued to pour money into selling the older drug, which was bringing in billions of dollars each year.\u003c/p>\u003c/blockquote>\n\u003cp>\u003c/p>\n\u003cp>A previous federal lawsuit filed in 2016 is currently pending following the publication of a previous \u003ca href=\"http://www.latimes.com/business/la-fi-gilead-20160529-snap-story.html\" target=\"_blank\" rel=\"noopener\">Los Angeles Times article\u003c/a> that accused the company of stifling development of the safer drug.\u003c/p>\n\n",
"disqusIdentifier": "441435 https://ww2.kqed.org/futureofyou/?p=441435",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/05/09/hiv-patients-say-gilead-suppressed-safer-drug-to-preserve-profits/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 730,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 22
},
"modified": 1525971366,
"excerpt": "Gilead promoted a drug that caused kidney and bone damage while shelving a far safer drug, says the lawsuit.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Gilead promoted a drug that caused kidney and bone damage while shelving a far safer drug, says the lawsuit.",
"title": "HIV Patients Say Gilead Suppressed Safer Drug to Preserve Profits | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "HIV Patients Say Gilead Suppressed Safer Drug to Preserve Profits",
"datePublished": "2018-05-09T16:14:55-07:00",
"dateModified": "2018-05-10T09:56:06-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "hiv-patients-say-gilead-suppressed-safer-drug-to-preserve-profits",
"status": "publish",
"path": "/futureofyou/441435/hiv-patients-say-gilead-suppressed-safer-drug-to-preserve-profits",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>A group of HIV patients based in California filed two separate lawsuits on Wednesday against Bay Area drugmaker Gilead Sciences for promoting a drug they say caused permanent kidney and bone damage. The \u003ca href=\"https://www.aidshealth.org/wp-content/uploads/2018/05/gilead-personal-injury-final.pdf\" target=\"_blank\" rel=\"noopener\">personal injury\u003c/a> and\u003ca href=\"https://www.aidshealth.org/wp-content/uploads/2018/05/class-action-complaint-final.pdf\" target=\"_blank\" rel=\"noopener\"> class action\u003c/a> suits, filed in a Los Angeles district court, accuse the company of shelving a safer version of the drug in order to maximize profits and extend the sales of its existing drug tenofovir disoproxil fumarate.\u003c/p>\n\u003cfigure id=\"attachment_441443\" class=\"wp-caption aligncenter\" style=\"max-width: 796px\">\u003ca href=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/05/viread.png\">\u003cimg class=\" wp-image-441443\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/05/viread.png\" alt=\"\" width=\"796\" height=\"329\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread.png 754w, https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-160x66.png 160w, https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-240x99.png 240w, https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-375x155.png 375w, https://ww2.kqed.org/app/uploads/sites/13/2018/05/viread-520x215.png 520w\" sizes=\"(max-width: 796px) 100vw, 796px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Tenofovir disoproxil fumarate was sold under the brand name Viread. \u003ccite>(U.S. Dept. of Health and Human Services)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Both complaints say the company knew as far back as 2001 that TDF was highly toxic but failed to warn patients of the dangerous side effects. The drug was originally sold under the brand name Viread.\u003c/p>\n\u003cp>\"A company I trusted with my life took advantage of that trust by misrepresenting the side effects of TDF, calling it the ‘Miracle Drug’ and using other deceptive marketing strategies,\" said Michael Lujano, from Los Angeles, one of two plaintiffs in the personal injury suit. \"Gilead shelved a far safer drug called tenofovir alafenamide fumarate simply to increase its long-term profits.\"\u003c/p>\n\u003cp>Another plaintiff in the class action suit, Ricardo Wohler, says he has lost 17 teeth in just three years due to the drug. The 52 year-old real estate agent from Marin took TDF for 12 years and was never made aware of its potential side effects, he said.\u003c/p>\n\u003cp>\"I learned how to smile without opening my mouth, how to speak without showing my teeth. This had an entire impact on my life, my self security, my self esteem, but also on my finances.\"\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Gilead said it is \"thoroughly reviewing the complaints and will not provide comment until that process is complete.\"\u003c/p>\n\u003cp>The suits accuse Gilead of deceptive marketing practices and putting profits before the health of its customers. The complaint says the company made $18 billion in profits in 2015.\u003c/p>\n\u003cp>\"Under these circumstances, the laws must be read to protect public health from corporate greed,” says Liza Brereton, attorney for plaintiffs and in-house counsel for the AIDS Healthcare Foundation.\u003c/p>\n\u003cp>AHF, which filed both lawsuits with co-counsel Rutherford Law, says it is funding the litigation and will not accept any financial recovery in excess of its actual costs.\u003c/p>\n\u003cp>Two other Californians filed a separate class action lawsuit on behalf of all patients living in California who were prescribed the drug from Oct. 26, 2001 through the present and were exposed to Gilead’s alleged misrepresentations, either directly or through their doctor.\u003c/p>\n\u003cp>The Food and Drug Administration reportedly issued two warning letters to Gilead for false misrepresentations about the drug's risks, according to the personal injury complaint.\u003c/p>\n\u003cp>A warning letter issued in 2002 accused a company sales representatives of falsely stating that TDF had “no toxicities” and was “benign” and “extremely safe.\" The company was slapped with another warning letter one year later, requiring Gilead to retrain its sales representatives.\u003c/p>\n\u003cp>The drugmaker began funding research of an alternative drug called TAF in 2001 but suppressed findings that showed it was far less toxic, according to the class action complaint.\u003c/p>\n\u003cp>Faced with a sharp decrease in profits, the complaint says, the drugmaker eventually released those findings in 2014, when Gilead’s patent on TDF was approaching expiration.\u003c/p>\n\u003cp>From the \u003ca href=\"http://www.latimes.com/business/la-fi-gilead-hiv-drug-lawsuit-20180509-story.html\" target=\"_blank\" rel=\"noopener\">Los Angeles Times\u003c/a>:\u003c/p>\n\u003cblockquote>\u003cp>In April 2001, the scientists published research on a different chemical version of the medicine called tenofovir alafenamide fumarate, or TAF.\u003c/p>\n\u003cp>That animal study showed TAF had a thousand-fold greater activity against HIV than the original medicine invented in Europe, raising the possibility that it would have far less toxicity.\u003c/p>\n\u003cp>Gilead then paid doctors across the country to give TAF to patients in small clinical trials. The positive results of those studies were not published for years — secrecy that the lawsuits filed Tuesday say was \"an act of extreme malice.\"\u003c/p>\n\u003cp>Instead, in October 2004, Gilead abruptly announced that it was ending research on TAF after an \"internal business review.\" And it continued to pour money into selling the older drug, which was bringing in billions of dollars each year.\u003c/p>\u003c/blockquote>\n\u003cp>\u003c/p>\n\u003cp>A previous federal lawsuit filed in 2016 is currently pending following the publication of a previous \u003ca href=\"http://www.latimes.com/business/la-fi-gilead-20160529-snap-story.html\" target=\"_blank\" rel=\"noopener\">Los Angeles Times article\u003c/a> that accused the company of stifling development of the safer drug.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/441435/hiv-patients-say-gilead-suppressed-safer-drug-to-preserve-profits",
"authors": [
"11428"
],
"categories": [
"futureofyou_1060",
"futureofyou_452",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_952",
"futureofyou_651",
"futureofyou_80",
"futureofyou_1056",
"futureofyou_931"
],
"featImg": "futureofyou_441443",
"label": "futureofyou"
},
"futureofyou_441354": {
"type": "posts",
"id": "futureofyou_441354",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "441354",
"score": null,
"sort": [
1525726800000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1525726800,
"format": "standard",
"disqusTitle": "Reversing An Overdose Isn't Complicated, But Getting The Antidote Can Be",
"title": "Reversing An Overdose Isn't Complicated, But Getting The Antidote Can Be",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>A few months ago, Kourtnaye Sturgeon helped save someone's life. She was driving in downtown Indianapolis when she saw people gathered around a car on the side of the road. Sturgeon pulled over and a man told her there was nothing she could do: Two men had overdosed on opioids and appeared to be dead.[contextly_sidebar id=\"HkPN1j5HI7DwfkcHFXdJSPtWQTk7V2zs\"]\u003c/p>\n\u003cp>\"I kind of recall saying, 'No man, I've got Narcan,' \" she says, referring to the brand- name version of the opioid overdose antidote, naloxone. \"Which sounds so silly, but I'm pretty sure that's what came out.\"\u003c/p>\n\u003cp>Sturgeon sprayed a dose of the drug up the driver's nose, and waited for it to take effect. About a minute later, she says, the paramedics showed up.\u003c/p>\n\u003cp>\"As they were walking towards us, the driver started slowly moving,\" she says. Both people survived.\u003c/p>\n\u003cp>Sturgeon had the drug with her because she works for Overdose Lifeline, a non-profit devoted to distributing naloxone, but many bystanders would be unprepared to help.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Last month, U.S. Surgeon General Jerome Adams\u003ca href=\"https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html\"> issued an advisory\u003c/a> urging more Americans to learn to use naloxone, and carry it with them in case they encounter someone who has overdosed.\u003c/p>\n\u003cp>With the increase in overdoses nationwide, the advisory suggests that lay responders — people who may witness an overdose before police or EMS arrive — can play a critical role in saving lives.\u003c/p>\n\u003cp>But if you're not a medical professional, getting a dose of naloxone can be difficult. It is a prescription drug and normally a doctor or nurse would have to directly prescribe it for the person at risk of overdosing. \u003ca href=\"http://www.healthlaw.org/about/staff/corey-davis\">Corey Davis\u003c/a>, an attorney for the National Health Law Program, says that creates a barrier for people with addiction.\u003c/p>\n\u003cp>\"A lot of people at risk of an overdose don't have contact with a medical provider or they're afraid because of stigma,\" he says.\u003c/p>\n\u003cp>To broaden access, every state and Washington, D.C., have\u003ca href=\"https://www.networkforphl.org/_asset/qz5pvn/legal-interventions-to-reduce-overdose.pdf\"> passed laws\u003c/a> making it easier for friends and family members or bystanders to get and use naloxone. Just how easy it is still depends on your state, or even the pharmacy you go to.[contextly_sidebar id=\"OLtZshPozlILTWQu7Kb7ffUBScI9pFPe\"]\u003c/p>\n\u003cp>Davis says most states allow something called third-party prescribing, which lets doctors prescribe naloxone to someone who knows the person at risk of an overdose. And most states have also passed \u003ca href=\"http://www.ncsl.org/research/civil-and-criminal-justice/drug-overdose-immunity-good-samaritan-laws.aspx#Calling%20911\">some kind of Good Samaritan law \u003c/a>providing legal immunity for people who administer the drug or call 911.\u003c/p>\n\u003cp>Davis says another type of law allows a kind of prescription called a standing order.\u003c/p>\n\u003cp>\"But instead of having a person's name on it, it has a group of people,\" says Davis.\u003c/p>\n\u003cp>A standing order could apply, for example, to anyone who takes opioid painkillers, or suffers from addiction. Or, Davis says, \"Anybody who might be in a position to assist someone, which unfortunately, today means essentially everybody.\"\u003c/p>\n\u003cp>In his home state of Indiana, Jerome Adams signed a statewide standing order in 2016, while serving as the state's health commissioner. It allows pharmacies, local health departments or nonprofits that register with the state and follow certain requirements to dispense the drug to anyone who requests it.\u003c/p>\n\u003cp>But two years later, only about half of Indiana pharmacies are registered, and local advocates say many people, even some pharmacists, are still unaware of the law.\u003c/p>\n\u003cp>Even if you understand the laws regulating naloxone in your state — and you feel comfortable asking for it at the pharmacy counter — there's still the cost, which has \u003ca href=\"https://www.npr.org/sections/health-shots/2017/08/08/541626627/first-responders-spending-more-on-overdose-reversal-drug\">gone up\u003c/a> in recent years. Two pharmacies near WFYI in Indianapolis, stock naloxone. One charged $80 for two doses of the generic form of the drug. The other charged $95 for two doses of Narcan, the brand-name version.\u003c/p>\n\u003cp>\"It's expensive,\" says Brad Ray, a researcher at Indiana University's School of Public and Environmental Affairs. \"People who are users are scraping money together to buy drugs. They're not prepared to buy naloxone with that money.\"\u003c/p>\n\u003cp>Several U.S. Senators have signed on to a\u003ca href=\"https://www.stabenow.senate.gov/news/stabenow-peters-call-on-administration-to-take-immediate-action-to-reduce-price-of-naloxone-a-life-saving-opioid-overdose-reversal-drug\"> letter\u003c/a> urging Health and Human Services Secretary Alex Azar to negotiate with drug companies to lower the price of naloxone.\u003c/p>\n\u003cp>For people who can't afford the drug, Ray says health departments and nonprofits can help. Laws in many states allow these organizations to dispense naloxone to lay responders.\u003c/p>\n\u003cp>Indiana's health department used federal and state funds to purchase nearly 14,000 naloxone kits since 2016, the state reports. The state distributes those free doses through county health departments. But nearly half of Indiana counties didn't request kits. And the majority of the kits went to first responders.[contextly_sidebar id=\"QGKuFYIV9TrVnnf8y5d9ZQaPW24b1pNM\"]\u003c/p>\n\u003cp>Local health departments, Ray says, need to work harder to get naloxone to people who might use it. People who use drugs, after all, may not feel comfortable going to the government for naloxone.\u003c/p>\n\u003cp>\"Getting it in the hands of users — that's the trick we need to figure out,\" Ray says.\u003c/p>\n\u003cp>Corey Davis says there is one change that could really help. The Food and Drug Administration or Congress could make naloxone an over-the-counter medication to make it easier to access, and maybe cheaper. FDA Commissioner Scott Gottlieb has the authority to do so, Davis says, but so far he has not.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>This story is part of a reporting partnership with NPR, WFYI, \u003c/em>\u003ca href=\"http://sideeffectspublicmedia.org/\">\u003cem>Side Effects Public Media\u003c/em>\u003c/a>\u003cem> and \u003c/em>\u003ca href=\"http://www.kaiserhealthnews.org\">\u003cem>Kaiser Health News\u003c/em>\u003c/a>\u003cem>. \u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 Side Effects Public Media. To see more, visit \u003ca>Side Effects Public Media\u003c/a>.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Reversing+An+Overdose+Isn%27t+Complicated%2C+But+Getting+The+Antidote+Can+Be+&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "441354 https://ww2.kqed.org/futureofyou/?p=441354",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/05/07/reversing-an-overdose-isnt-complicated-but-getting-the-antidote-can-be/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 924,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 27
},
"modified": 1525716124,
"excerpt": "The U.S. surgeon general has recommended that naloxone, the opioid overdose reversal drug, be widely available to consumers. But there are several barriers to consumers' ability to acquire it.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The U.S. surgeon general has recommended that naloxone, the opioid overdose reversal drug, be widely available to consumers. But there are several barriers to consumers' ability to acquire it.",
"title": "Reversing An Overdose Isn't Complicated, But Getting The Antidote Can Be | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Reversing An Overdose Isn't Complicated, But Getting The Antidote Can Be",
"datePublished": "2018-05-07T14:00:00-07:00",
"dateModified": "2018-05-07T11:02:04-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "reversing-an-overdose-isnt-complicated-but-getting-the-antidote-can-be",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=607760827&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Jake Harper\u003cbr />NPR Shots",
"nprStoryDate": "Mon, 07 May 2018 05:01:00 -0400",
"nprLastModifiedDate": "Mon, 07 May 2018 08:00:54 -0400",
"nprHtmlLink": "https://www.npr.org/sections/health-shots/2018/05/07/607760827/reversing-an-overdose-isnt-complicated-but-getting-the-antidote-can-be?ft=nprml&f=607760827",
"nprAudio": "https://ondemand.npr.org/anon.npr-mp3/npr/me/2018/05/20180507_me_reversing_an_overdose_isnt_complicated_but_getting_the_antidote_can_be_.mp3?orgId=4780019&topicId=1128&d=199&p=3&story=607760827&ft=nprml&f=607760827",
"nprImageAgency": "Jake Harper/Side Effects Public Media",
"source": "Health",
"nprAudioM3u": "http://api.npr.org/m3u/1609019604-cc65cb.m3u?orgId=4780019&topicId=1128&d=199&p=3&story=607760827&ft=nprml&f=607760827",
"nprStoryId": "607760827",
"nprRetrievedStory": "1",
"nprPubDate": "Mon, 07 May 2018 07:55:00 -0400",
"path": "/futureofyou/441354/reversing-an-overdose-isnt-complicated-but-getting-the-antidote-can-be",
"audioUrl": "https://ondemand.npr.org/anon.npr-mp3/npr/me/2018/05/20180507_me_reversing_an_overdose_isnt_complicated_but_getting_the_antidote_can_be_.mp3?orgId=4780019&topicId=1128&d=199&p=3&story=607760827&ft=nprml&f=607760827",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>A few months ago, Kourtnaye Sturgeon helped save someone's life. She was driving in downtown Indianapolis when she saw people gathered around a car on the side of the road. Sturgeon pulled over and a man told her there was nothing she could do: Two men had overdosed on opioids and appeared to be dead.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\"I kind of recall saying, 'No man, I've got Narcan,' \" she says, referring to the brand- name version of the opioid overdose antidote, naloxone. \"Which sounds so silly, but I'm pretty sure that's what came out.\"\u003c/p>\n\u003cp>Sturgeon sprayed a dose of the drug up the driver's nose, and waited for it to take effect. About a minute later, she says, the paramedics showed up.\u003c/p>\n\u003cp>\"As they were walking towards us, the driver started slowly moving,\" she says. Both people survived.\u003c/p>\n\u003cp>Sturgeon had the drug with her because she works for Overdose Lifeline, a non-profit devoted to distributing naloxone, but many bystanders would be unprepared to help.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Last month, U.S. Surgeon General Jerome Adams\u003ca href=\"https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html\"> issued an advisory\u003c/a> urging more Americans to learn to use naloxone, and carry it with them in case they encounter someone who has overdosed.\u003c/p>\n\u003cp>With the increase in overdoses nationwide, the advisory suggests that lay responders — people who may witness an overdose before police or EMS arrive — can play a critical role in saving lives.\u003c/p>\n\u003cp>But if you're not a medical professional, getting a dose of naloxone can be difficult. It is a prescription drug and normally a doctor or nurse would have to directly prescribe it for the person at risk of overdosing. \u003ca href=\"http://www.healthlaw.org/about/staff/corey-davis\">Corey Davis\u003c/a>, an attorney for the National Health Law Program, says that creates a barrier for people with addiction.\u003c/p>\n\u003cp>\"A lot of people at risk of an overdose don't have contact with a medical provider or they're afraid because of stigma,\" he says.\u003c/p>\n\u003cp>To broaden access, every state and Washington, D.C., have\u003ca href=\"https://www.networkforphl.org/_asset/qz5pvn/legal-interventions-to-reduce-overdose.pdf\"> passed laws\u003c/a> making it easier for friends and family members or bystanders to get and use naloxone. Just how easy it is still depends on your state, or even the pharmacy you go to.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Davis says most states allow something called third-party prescribing, which lets doctors prescribe naloxone to someone who knows the person at risk of an overdose. And most states have also passed \u003ca href=\"http://www.ncsl.org/research/civil-and-criminal-justice/drug-overdose-immunity-good-samaritan-laws.aspx#Calling%20911\">some kind of Good Samaritan law \u003c/a>providing legal immunity for people who administer the drug or call 911.\u003c/p>\n\u003cp>Davis says another type of law allows a kind of prescription called a standing order.\u003c/p>\n\u003cp>\"But instead of having a person's name on it, it has a group of people,\" says Davis.\u003c/p>\n\u003cp>A standing order could apply, for example, to anyone who takes opioid painkillers, or suffers from addiction. Or, Davis says, \"Anybody who might be in a position to assist someone, which unfortunately, today means essentially everybody.\"\u003c/p>\n\u003cp>In his home state of Indiana, Jerome Adams signed a statewide standing order in 2016, while serving as the state's health commissioner. It allows pharmacies, local health departments or nonprofits that register with the state and follow certain requirements to dispense the drug to anyone who requests it.\u003c/p>\n\u003cp>But two years later, only about half of Indiana pharmacies are registered, and local advocates say many people, even some pharmacists, are still unaware of the law.\u003c/p>\n\u003cp>Even if you understand the laws regulating naloxone in your state — and you feel comfortable asking for it at the pharmacy counter — there's still the cost, which has \u003ca href=\"https://www.npr.org/sections/health-shots/2017/08/08/541626627/first-responders-spending-more-on-overdose-reversal-drug\">gone up\u003c/a> in recent years. Two pharmacies near WFYI in Indianapolis, stock naloxone. One charged $80 for two doses of the generic form of the drug. The other charged $95 for two doses of Narcan, the brand-name version.\u003c/p>\n\u003cp>\"It's expensive,\" says Brad Ray, a researcher at Indiana University's School of Public and Environmental Affairs. \"People who are users are scraping money together to buy drugs. They're not prepared to buy naloxone with that money.\"\u003c/p>\n\u003cp>Several U.S. Senators have signed on to a\u003ca href=\"https://www.stabenow.senate.gov/news/stabenow-peters-call-on-administration-to-take-immediate-action-to-reduce-price-of-naloxone-a-life-saving-opioid-overdose-reversal-drug\"> letter\u003c/a> urging Health and Human Services Secretary Alex Azar to negotiate with drug companies to lower the price of naloxone.\u003c/p>\n\u003cp>For people who can't afford the drug, Ray says health departments and nonprofits can help. Laws in many states allow these organizations to dispense naloxone to lay responders.\u003c/p>\n\u003cp>Indiana's health department used federal and state funds to purchase nearly 14,000 naloxone kits since 2016, the state reports. The state distributes those free doses through county health departments. But nearly half of Indiana counties didn't request kits. And the majority of the kits went to first responders.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Local health departments, Ray says, need to work harder to get naloxone to people who might use it. People who use drugs, after all, may not feel comfortable going to the government for naloxone.\u003c/p>\n\u003cp>\"Getting it in the hands of users — that's the trick we need to figure out,\" Ray says.\u003c/p>\n\u003cp>Corey Davis says there is one change that could really help. The Food and Drug Administration or Congress could make naloxone an over-the-counter medication to make it easier to access, and maybe cheaper. FDA Commissioner Scott Gottlieb has the authority to do so, Davis says, but so far he has not.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>This story is part of a reporting partnership with NPR, WFYI, \u003c/em>\u003ca href=\"http://sideeffectspublicmedia.org/\">\u003cem>Side Effects Public Media\u003c/em>\u003c/a>\u003cem> and \u003c/em>\u003ca href=\"http://www.kaiserhealthnews.org\">\u003cem>Kaiser Health News\u003c/em>\u003c/a>\u003cem>. \u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 Side Effects Public Media. To see more, visit \u003ca>Side Effects Public Media\u003c/a>.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Reversing+An+Overdose+Isn%27t+Complicated%2C+But+Getting+The+Antidote+Can+Be+&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/441354/reversing-an-overdose-isnt-complicated-but-getting-the-antidote-can-be",
"authors": [
"byline_futureofyou_441354"
],
"categories": [
"futureofyou_1060",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_828",
"futureofyou_190",
"futureofyou_952",
"futureofyou_38",
"futureofyou_61",
"futureofyou_938"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_441355",
"label": "source_futureofyou_441354"
},
"futureofyou_441322": {
"type": "posts",
"id": "futureofyou_441322",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "441322",
"score": null,
"sort": [
1525707602000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1525707602,
"format": "standard",
"disqusTitle": "Lyme Disease Is On The Rise Again. Here's How To Prevent It",
"title": "Lyme Disease Is On The Rise Again. Here's How To Prevent It",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>Lyme disease was once unheard of in western Pennsylvania, where \u003ca href=\"http://entomology.umd.edu/thorne-barbara-l.html\" target=\"_blank\" rel=\"noopener\">Barbara Thorne\u003c/a>, now an entomologist at the University of Maryland, spent time as a kid.[contextly_sidebar id=\"E5lWczNbOj0QujgLs3u3AfAeFh9XRm6X\"]\u003c/p>\n\u003cp>Thorne knew that if black-legged ticks are infected with bacteria called \u003cem>Borrelia burgdorferi\u003c/em>, they can \u003ca href=\"https://www.cdc.gov/lyme/index.html\" target=\"_blank\" rel=\"noopener\">transmit Lyme to people\u003c/a> and, that if untreated, symptoms can range from fever, fatigue and a rash, to serious damage to the joints, heart and nervous system.\u003c/p>\n\u003cp>But she didn't realize that ticks in that part of Pennsylvania had become broadly infected with the bacteria. That is, until she was bitten during a family reunion weekend.\u003c/p>\n\u003cp>She never saw the tick on her body. But about eight or nine days later, after returning home, she became suspicious.\u003c/p>\n\u003cp>\"I noticed a \u003ca href=\"https://phpa.health.maryland.gov/OIDEOR/CZVBD/Shared%20Documents/Lyme_MD_poster_FINAL.pdf\" target=\"_blank\" rel=\"noopener\">roundish red rash\u003c/a> above my waistline and it expanded each day,\" she recalls. \"I was also feeling sick with exhaustion and achiness.\"\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Her primary care doctor diagnosed her with Lyme disease and prescribed a course of antibiotics. After a few months, she felt better.\u003c/p>\n\u003cp>\"I felt very lucky to have had the rash appear as literally a red flag,\" Thorne says. It's a telltale warning sign of the disease.\u003c/p>\n\u003cp>But not everyone with a Lyme infection develops a rash. And other symptoms, such as fatigue and aches, overlap with common illnesses. So, spotting Lyme disease can be tricky. Some people don't realize they're infected and don't seek medical treatment.\u003c/p>\n\u003cp>The Centers for Disease Control and Prevention estimates the actual prevalence of Lyme disease infections is 10 times higher than the number of reported cases.\u003c/p>\n\u003cp>Tick-borne diseases have been \"steadily going up every year ... as the diseases expand to new areas around the country,\" Lyle Peterson of the CDC told reporters in a recent conference call announcing the updated infection \u003ca href=\"https://www.cdc.gov/vitalsigns/vector-borne/\" target=\"_blank\" rel=\"noopener\">estimates\u003c/a>. Lyme disease accounts for about 80 percent of the \u003ca href=\"https://www.cdc.gov/ticks/Diseases/\" target=\"_blank\" rel=\"noopener\">tick-borne illnesses\u003c/a> in the U.S.[contextly_sidebar id=\"BEEx9bfux3jHbZOJBeYj9WisqBPO0MxG\"]\u003c/p>\n\u003cp>Another factor that can contribute to the underreporting of cases is a lack of effective surveillance and tracking.\u003c/p>\n\u003cp>\"People just go to their local doctor to be treated,\" says Peterson, and the doctor may not report the case to the local or state health department. Or, if the case \u003cem>is\u003c/em> reported by the doctor, he says, sometimes \"state health departments have a very difficult time keeping up with the sheer number of cases reports.\"\u003c/p>\n\u003cp>There's another factor at play, too: shortcomings in the way the infection is diagnosed.\u003c/p>\n\u003cp>\"Many of the tests for Lyme disease are negative at the time that patients first visit their doctor,\" says \u003ca href=\"https://medicine.yale.edu/pathology/people/PNF2.profile\" target=\"_blank\" rel=\"noopener\">Dr. Paul Fiedler\u003c/a>, a clinical pathologist on Yale School of Medicine's faculty who also heads the department of pathology at Western Connecticut Health Network.\u003c/p>\n\u003cp>Blood tests to detect Lyme disease rely on a person's immune response, Fiedler explains, and after infection with the bacteria, it takes time — sometimes as long as 10 to 30 days — for the body to mount a measurable response. The blood tests detect Lyme-specific antibodies.\u003c/p>\n\u003cp>If somebody is tested before the immune system has produced enough antibodies, the result will be a false negative.\u003c/p>\n\u003cp>\"And the diagnosis could be missed,\" Fiedler says. The subsequent lack of treatment after a missed diagnosis can lead to \u003ca href=\"https://www.cdc.gov/lyme/resources/brochure/lymediseasebrochure.pdf\" target=\"_blank\" rel=\"noopener\">serious health problems\u003c/a>.\u003c/p>\n\u003cp>But Thorne says it's possible to take steps to help prevent Lyme disease if you're meticulous.\u003c/p>\n\u003cp>In the spring, \u003ca href=\"http://wnpr.org/post/six-things-know-about-ticks-and-lyme-disease\" target=\"_blank\" rel=\"noopener\">tick nymphs\u003c/a> — young versions that transmit most of the Lyme infections — are abundant. They're tiny, no bigger than a pinhead or poppy seed, and tend to hang out in or near wooded areas, in brush or tall grass.[contextly_sidebar id=\"f5MAXyeLkwMp2ontpm3K4PW45yEGQUWn\"]\u003c/p>\n\u003cp>The ticks need a blood meal to stay alive. They tend to \u003ca href=\"https://www.cdc.gov/ticks/life_cycle_and_hosts.html\">feed \u003c/a>on small mammals, such as mice, or birds. But if you happen to brush against a stick, blade or stem they're clinging to, they can easily hitch a ride on you. And you won't feel a thing.\u003c/p>\n\u003cp>If you're hiking in or near a wooded area, it's wise to be on the lookout for nymphs on your skin or clothing when you get home. \"They're small, but they're not invisible,\" Thorne says.\u003c/p>\n\u003cp>She recommends light-colored clothing (to increase likelihood you'll notice the darker fleck of an insect) and long sleeves. Insect repellent may help, but Thorne says the most effective strategy is a thorough tick check of your body after you've been in tick-infested areas.\u003c/p>\n\u003cp>\"The ticks do tend to climb upward — like they climb up your legs,\" Thorne says. \"They often attach where there was a constriction of clothing, like around the waistline.\" (She's compiled personal protection \u003ca href=\"https://extension.umd.edu/sites/extension.umd.edu/files/_images/programs/hgic/Publications/non_HGIC_FS/FS595.pdf\" target=\"_blank\" rel=\"noopener\">tips in this bulletin\u003c/a>.)\u003c/p>\n\u003cp>Other favorite hiding spots include armpits, or behind your ears. If you do find one attached to your body, use a pair of narrow tweezers to \u003ca href=\"https://www.cdc.gov/ticks/removing_a_tick.html\" target=\"_blank\" rel=\"noopener\">grasp the tick very near the surface of the skin\u003c/a> and tug upward with steady pressure.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Don't freak out if the insect's been attached a few hours. In general, the CDC says, ticks need to be attached for 36 to 48 hours before they can transmit the bacteria that cause Lyme disease.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Lyme+Disease+Is+On+The+Rise+Again.+Here%27s+How+To+Prevent+It&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "441322 https://ww2.kqed.org/futureofyou/?p=441322",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/05/07/lyme-disease-is-on-the-rise-again-heres-how-to-prevent-it/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 878,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 27
},
"modified": 1525717613,
"excerpt": "The tick-borne illness is spreading north and south — about 300,000 U.S. cases a year. As scientists work on better diagnostic tests and surveillance tools, you can take steps to cut your risk. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The tick-borne illness is spreading north and south — about 300,000 U.S. cases a year. As scientists work on better diagnostic tests and surveillance tools, you can take steps to cut your risk. ",
"title": "Lyme Disease Is On The Rise Again. Here's How To Prevent It | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Lyme Disease Is On The Rise Again. Here's How To Prevent It",
"datePublished": "2018-05-07T08:40:02-07:00",
"dateModified": "2018-05-07T11:26:53-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "lyme-disease-is-on-the-rise-again-heres-how-to-prevent-it",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=607782359&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprStoryDate": "Mon, 07 May 2018 05:00:00 -0400",
"nprLastModifiedDate": "Mon, 07 May 2018 11:06:32 -0400",
"nprHtmlLink": "https://www.npr.org/sections/health-shots/2018/05/07/607782359/lyme-disease-is-on-the-rise-again-heres-how-to-prevent-it?ft=nprml&f=607782359",
"nprAudio": "https://ondemand.npr.org/anon.npr-mp3/npr/me/2018/05/20180507_me_lyme_disease_is_on_the_rise_again_heres_how_to_prevent_it.mp3?orgId=1&topicId=1128&d=192&p=3&story=607782359&ft=nprml&f=607782359",
"nprImageAgency": "Science Source/Getty Images",
"source": "Health",
"nprAudioM3u": "http://api.npr.org/m3u/1609019598-a66888.m3u?orgId=1&topicId=1128&d=192&p=3&story=607782359&ft=nprml&f=607782359",
"nprStoryId": "607782359",
"nprByline": "Allison Aubrey\u003cbr />NPR Shots",
"nprImageCredit": "Kenneth H Thomas",
"nprRetrievedStory": "1",
"nprPubDate": "Mon, 07 May 2018 11:06:00 -0400",
"path": "/futureofyou/441322/lyme-disease-is-on-the-rise-again-heres-how-to-prevent-it",
"audioUrl": "https://ondemand.npr.org/anon.npr-mp3/npr/me/2018/05/20180507_me_lyme_disease_is_on_the_rise_again_heres_how_to_prevent_it.mp3?orgId=1&topicId=1128&d=192&p=3&story=607782359&ft=nprml&f=607782359",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Lyme disease was once unheard of in western Pennsylvania, where \u003ca href=\"http://entomology.umd.edu/thorne-barbara-l.html\" target=\"_blank\" rel=\"noopener\">Barbara Thorne\u003c/a>, now an entomologist at the University of Maryland, spent time as a kid.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Thorne knew that if black-legged ticks are infected with bacteria called \u003cem>Borrelia burgdorferi\u003c/em>, they can \u003ca href=\"https://www.cdc.gov/lyme/index.html\" target=\"_blank\" rel=\"noopener\">transmit Lyme to people\u003c/a> and, that if untreated, symptoms can range from fever, fatigue and a rash, to serious damage to the joints, heart and nervous system.\u003c/p>\n\u003cp>But she didn't realize that ticks in that part of Pennsylvania had become broadly infected with the bacteria. That is, until she was bitten during a family reunion weekend.\u003c/p>\n\u003cp>She never saw the tick on her body. But about eight or nine days later, after returning home, she became suspicious.\u003c/p>\n\u003cp>\"I noticed a \u003ca href=\"https://phpa.health.maryland.gov/OIDEOR/CZVBD/Shared%20Documents/Lyme_MD_poster_FINAL.pdf\" target=\"_blank\" rel=\"noopener\">roundish red rash\u003c/a> above my waistline and it expanded each day,\" she recalls. \"I was also feeling sick with exhaustion and achiness.\"\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Her primary care doctor diagnosed her with Lyme disease and prescribed a course of antibiotics. After a few months, she felt better.\u003c/p>\n\u003cp>\"I felt very lucky to have had the rash appear as literally a red flag,\" Thorne says. It's a telltale warning sign of the disease.\u003c/p>\n\u003cp>But not everyone with a Lyme infection develops a rash. And other symptoms, such as fatigue and aches, overlap with common illnesses. So, spotting Lyme disease can be tricky. Some people don't realize they're infected and don't seek medical treatment.\u003c/p>\n\u003cp>The Centers for Disease Control and Prevention estimates the actual prevalence of Lyme disease infections is 10 times higher than the number of reported cases.\u003c/p>\n\u003cp>Tick-borne diseases have been \"steadily going up every year ... as the diseases expand to new areas around the country,\" Lyle Peterson of the CDC told reporters in a recent conference call announcing the updated infection \u003ca href=\"https://www.cdc.gov/vitalsigns/vector-borne/\" target=\"_blank\" rel=\"noopener\">estimates\u003c/a>. Lyme disease accounts for about 80 percent of the \u003ca href=\"https://www.cdc.gov/ticks/Diseases/\" target=\"_blank\" rel=\"noopener\">tick-borne illnesses\u003c/a> in the U.S.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Another factor that can contribute to the underreporting of cases is a lack of effective surveillance and tracking.\u003c/p>\n\u003cp>\"People just go to their local doctor to be treated,\" says Peterson, and the doctor may not report the case to the local or state health department. Or, if the case \u003cem>is\u003c/em> reported by the doctor, he says, sometimes \"state health departments have a very difficult time keeping up with the sheer number of cases reports.\"\u003c/p>\n\u003cp>There's another factor at play, too: shortcomings in the way the infection is diagnosed.\u003c/p>\n\u003cp>\"Many of the tests for Lyme disease are negative at the time that patients first visit their doctor,\" says \u003ca href=\"https://medicine.yale.edu/pathology/people/PNF2.profile\" target=\"_blank\" rel=\"noopener\">Dr. Paul Fiedler\u003c/a>, a clinical pathologist on Yale School of Medicine's faculty who also heads the department of pathology at Western Connecticut Health Network.\u003c/p>\n\u003cp>Blood tests to detect Lyme disease rely on a person's immune response, Fiedler explains, and after infection with the bacteria, it takes time — sometimes as long as 10 to 30 days — for the body to mount a measurable response. The blood tests detect Lyme-specific antibodies.\u003c/p>\n\u003cp>If somebody is tested before the immune system has produced enough antibodies, the result will be a false negative.\u003c/p>\n\u003cp>\"And the diagnosis could be missed,\" Fiedler says. The subsequent lack of treatment after a missed diagnosis can lead to \u003ca href=\"https://www.cdc.gov/lyme/resources/brochure/lymediseasebrochure.pdf\" target=\"_blank\" rel=\"noopener\">serious health problems\u003c/a>.\u003c/p>\n\u003cp>But Thorne says it's possible to take steps to help prevent Lyme disease if you're meticulous.\u003c/p>\n\u003cp>In the spring, \u003ca href=\"http://wnpr.org/post/six-things-know-about-ticks-and-lyme-disease\" target=\"_blank\" rel=\"noopener\">tick nymphs\u003c/a> — young versions that transmit most of the Lyme infections — are abundant. They're tiny, no bigger than a pinhead or poppy seed, and tend to hang out in or near wooded areas, in brush or tall grass.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>The ticks need a blood meal to stay alive. They tend to \u003ca href=\"https://www.cdc.gov/ticks/life_cycle_and_hosts.html\">feed \u003c/a>on small mammals, such as mice, or birds. But if you happen to brush against a stick, blade or stem they're clinging to, they can easily hitch a ride on you. And you won't feel a thing.\u003c/p>\n\u003cp>If you're hiking in or near a wooded area, it's wise to be on the lookout for nymphs on your skin or clothing when you get home. \"They're small, but they're not invisible,\" Thorne says.\u003c/p>\n\u003cp>She recommends light-colored clothing (to increase likelihood you'll notice the darker fleck of an insect) and long sleeves. Insect repellent may help, but Thorne says the most effective strategy is a thorough tick check of your body after you've been in tick-infested areas.\u003c/p>\n\u003cp>\"The ticks do tend to climb upward — like they climb up your legs,\" Thorne says. \"They often attach where there was a constriction of clothing, like around the waistline.\" (She's compiled personal protection \u003ca href=\"https://extension.umd.edu/sites/extension.umd.edu/files/_images/programs/hgic/Publications/non_HGIC_FS/FS595.pdf\" target=\"_blank\" rel=\"noopener\">tips in this bulletin\u003c/a>.)\u003c/p>\n\u003cp>Other favorite hiding spots include armpits, or behind your ears. If you do find one attached to your body, use a pair of narrow tweezers to \u003ca href=\"https://www.cdc.gov/ticks/removing_a_tick.html\" target=\"_blank\" rel=\"noopener\">grasp the tick very near the surface of the skin\u003c/a> and tug upward with steady pressure.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Don't freak out if the insect's been attached a few hours. In general, the CDC says, ticks need to be attached for 36 to 48 hours before they can transmit the bacteria that cause Lyme disease.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Lyme+Disease+Is+On+The+Rise+Again.+Here%27s+How+To+Prevent+It&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/441322/lyme-disease-is-on-the-rise-again-heres-how-to-prevent-it",
"authors": [
"byline_futureofyou_441322"
],
"categories": [
"futureofyou_1060",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_141",
"futureofyou_61",
"futureofyou_759",
"futureofyou_1056"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_441324",
"label": "source_futureofyou_441322"
},
"futureofyou_441018": {
"type": "posts",
"id": "futureofyou_441018",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "441018",
"score": null,
"sort": [
1525098642000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou"
},
"blocks": [],
"publishDate": 1525098642,
"format": "audio",
"disqusTitle": "Little Evidence Popular Food Intolerance Tests Work",
"title": "Little Evidence Popular Food Intolerance Tests Work",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>Numerous online companies are trying to drive a revolution\u003cstrong> \u003c/strong>in lab testing by making it possible for you to skip the doctor and test for fertility, sleep hormones and even vitamin deficiencies -- all from the privacy of your bathroom -- no lab visit required.\u003c/p>\n\u003cp>Do-it-yourself testing kits cost anywhere from about $35 for an individual test to $450 for a battery of tests.\u003c/p>\n\u003caside class=\"pullquote alignright\">'It is important to understand that this test has never been scientifically proven to be able to accomplish what it reports to do.'\u003ccite>American Academy of Allergy, Asthma & Immunology\u003c/cite>\u003c/aside>\n\u003cp>Last November on \"Shark Tank,\" the reality show featuring budding entrepreneurs who think they have a hot idea, contestant Julia Cheek hawked her company's home-testing kits to the program's panel of investors.\u003c/p>\n\u003cp>\"EverlyWell is transforming lab testing — a $25 billion market — to be simple, convenient and useful for you,\" Cheek pitched.\u003c/p>\n\u003cp>\"I think the product is brilliantly crafted,\" said Lori Greiner, who is also known as \"The Queen of QVC.\"\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\"I think this gives people an empowered way to check on some things.\"\u003c/p>\n\u003cp>Cheek walked away from the show with a million-dollar commitment for her Austin-based company.\u003c/p>\n\u003cp>But that was TV, of course. Some doctors worry EveryWell is promising more than it can deliver.\u003c/p>\n\u003cp>\u003cstrong>One Woman's Success Story\u003c/strong>\u003c/p>\n\u003caside class=\"pullquote alignright\">'EverlyWell recognizes that the AAAAI does not support any form of food sensitivity testing ... but they are not the entire 'medical community,' and AAAAI does not speak for all health care providers.' \u003ccite>EverlyWell \u003c/cite>\u003c/aside>\n\u003cp>The company's food-sensitivity test is its best seller, and the kit is especially hot in the Bay Area. San Francisco resident Regina Du says the test has changed her life. For years Du missed work due to stomachaches, headaches and inflamed welts.\u003c/p>\n\u003cp>“I just felt crummy,\" said Du. \"I would just like uncontrollably scratch myself because I was so itchy.\"\u003c/p>\n\u003cp>Doctors couldn’t figure out what was wrong. Eventually Du landed under the care of an allergist, who ordered a test. But Du balked when she learned her insurance wouldn’t cover the $700 cost.\u003c/p>\n\u003cp>“I just had total sticker shock,\" Du said.\u003c/p>\n\u003cp>So, she poked around online and found EverlyWell's food sensitivity kit for a couple hundred bucks.\u003c/p>\n\u003cp>Instructions inside the neatly packed kit explain how to prick your finger and dribble drops of blood onto a white collection card. Du completed the test in less than 20 minutes during her lunch break. A few days later she got an email suggesting she avoid gluten, dairy and green beans.\u003c/p>\n\u003cp>Almost immediately: Du started feeling better. Within a few weeks she felt normal for the first time in eight years.\u003c/p>\n\u003cp>\u003cb>Does it Work?\u003c/b>\u003c/p>\n\u003cp>The test is supposed to measure whether a person’s immune system reacts to certain foods by making an antibody called Immunoglobulin G (IgG), which EverlyWell describes on its website as the potential cause of symptoms like migraines or irritable bowel syndrome according to some small \u003ca href=\"https://www.everlywell.com/food-sensitivity-and-you/\" target=\"_blank\" rel=\"noopener\">studies\u003c/a>.\u003c/p>\n\u003cfigure id=\"attachment_441036\" class=\"wp-caption alignright\" style=\"max-width: 800px\">\u003cimg class=\"size-medium wp-image-441036\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-800x599.png\" alt=\"\" width=\"800\" height=\"599\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-800x599.png 800w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-160x120.png 160w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-768x575.png 768w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-240x180.png 240w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-375x281.png 375w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-520x389.png 520w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM.png 884w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">Julia Cheek, CEO of EverlyWell, on a November 2017 episode of 'Shark Tank.' \u003ccite>(Courtesy ABC/Sony Pictures Television)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>The American Academy of Allergy, Asthma & Immunology does not recognize the validity of IgG tests in diagnosing food sensitivity, also called food intolerance.\u003c/p>\n\u003cp>\"It is important to understand that this test has never been scientifically proven to be able to accomplish what it reports to do,\" the AAAAI \u003ca href=\"https://www.aaaai.org/conditions-and-treatments/library/allergy-library/IgG-food-test\" target=\"_blank\" rel=\"noopener\">writes on its website\u003c/a>. \"The scientific studies that are provided to support the use of this test are often out of date, in non-reputable journals and many have not even used the IgG test in question. The presence of IgG is likely a normal response of the immune system to exposure to food.\"\u003c/p>\n\u003cp>Dr. Neha Shah, a rheumatologist and immunologist at Stanford University, is one doctor who is skeptical.\u003c/p>\n\u003cp>“What we don’t have is proof that having a high IgG level against a particular food item means that that food is causing your symptoms,\" said Shah.\u003c/p>\n\u003cp>Shah shares the story of her sister, who bought a test and then was told to avoid swordfish.\u003c/p>\n\u003cp>“We’ve been vegetarians all our whole lives,\" said Shah. \"And there was really no reason why she had a high sensitivity, a high IgG level against swordfish.”\u003c/p>\n\u003cp>Shah also says IgG levels can elevate simply because you eat a specific food, so it doesn't necessarily mean that your body is reacting negatively. For all these reasons, Shah does not administer food sensitivity tests in her practice. She suggests patients save the money and go straight to an elimination diet\u003cb>, \u003c/b>where you remove commonly reactive foods like gluten or dairy and see if you feel better.\u003c/p>\n\u003caside class=\"pullquote alignright\">\u003c/aside>\n\u003cp>\u003cstrong>Test for Heavy Metals, Stress or Metabolism\u003c/strong>\u003c/p>\n\u003cp>Dr. Marra Francis, EverlyWell's executive medical director, stands by its products as a valuable first step for patients to take their health into their own hands.\u003c/p>\n\u003cp>\"A lot of times this testing can be a bridge between vague symptoms and an actual plan that you create with your provider,\" she said. EverlyWell does recommend patients\u003cb> \u003c/b>double-check test results with an elimination diet.\u003c/p>\n\u003cp>Tina Heilman, a spokesperson for EverlyWell, wrote in an email:\u003c/p>\n\u003cp>\"EverlyWell recognizes that the AAAAI does not support any form of food sensitivity testing (which is not just limited to IgG testing), but they are not the entire 'medical community,' and AAAAI does not speak for all health care providers. IgG tests are currently ordered by thousands of medical providers in the U.S.\"\u003c/p>\n\u003cp>\u003cstrong>No Oversight\u003c/strong>\u003c/p>\n\u003cp>Besides its IgG test, the company markets 22 other home wellness tests, everything from cholesterol to testosterone. Internet ventures like LetsGetChecked, Thorne and Health Test Express offer a similar array.\u003c/p>\n\u003cp>But some doctors worry about a booming market that's not regulated by the Food and Drug Administration.\u003c/p>\n\u003cp>“A lot of this kind of huxterist testing is keying off of the placebo effect,\" said Dr. Norman Paradis, a clinical lab expert who teaches at the Geisel School of Medicine at Dartmouth College, referring to the industry in general and not to a particular product.\u003c/p>\n\u003cp>In other words, just believing a test is valid and taking action on it may make you feel better. Paradis is also worried that home tests could inspire patients to overreact to results. Hypothetically, a patient may discover she's deficient in vitamin d and compensate by taking toxic doses, he said. Or a test result may inspire a patient to seek medical care they don’t need.\u003c/p>\n\u003cp>“For instance, let’s say a test inaccurately said you may have colon cancer,\" said Paradis. \"And then you went and got a colonoscopy and were injured during the colonoscopy. Well the test actually created that harm.”\u003c/p>\n\u003cp>Dr. Gilbert Welch, the author of \"Overdiagnosed: Making People Sick in Pursuit of Health\u003cem>,\" \u003c/em>said, \"You can't test your way to health.\"\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>For unexplained symptoms he suggested starting with the long-ignored advice from your grandmother: Eat real food, set a regular sleep schedule, and get some exercise.\u003c/p>\n\n",
"disqusIdentifier": "441018 https://ww2.kqed.org/futureofyou/?p=441018",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/04/30/company-of-shark-tank-winner-offers-food-sensitivity-tests-but-do-they-work/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1193,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 40
},
"modified": 1531439127,
"excerpt": "EverlyWell says it can determine which foods to avoid through an at-home blood test, but experts say the science is shaky. The company was funded after winning on the TV show 'Shark Tank.'",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "EverlyWell says it can determine which foods to avoid through an at-home blood test, but experts say the science is shaky. The company was funded after winning on the TV show 'Shark Tank.'",
"title": "Little Evidence Popular Food Intolerance Tests Work | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Little Evidence Popular Food Intolerance Tests Work",
"datePublished": "2018-04-30T07:30:42-07:00",
"dateModified": "2018-07-12T16:45:27-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "company-of-shark-tank-winner-offers-food-sensitivity-tests-but-do-they-work",
"status": "publish",
"audioUrl": "https://www.kqed.org/.stream/anon/radio/science/2018/04/FORWEBhometesting.mp3",
"path": "/futureofyou/441018/company-of-shark-tank-winner-offers-food-sensitivity-tests-but-do-they-work",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Numerous online companies are trying to drive a revolution\u003cstrong> \u003c/strong>in lab testing by making it possible for you to skip the doctor and test for fertility, sleep hormones and even vitamin deficiencies -- all from the privacy of your bathroom -- no lab visit required.\u003c/p>\n\u003cp>Do-it-yourself testing kits cost anywhere from about $35 for an individual test to $450 for a battery of tests.\u003c/p>\n\u003caside class=\"pullquote alignright\">'It is important to understand that this test has never been scientifically proven to be able to accomplish what it reports to do.'\u003ccite>American Academy of Allergy, Asthma & Immunology\u003c/cite>\u003c/aside>\n\u003cp>Last November on \"Shark Tank,\" the reality show featuring budding entrepreneurs who think they have a hot idea, contestant Julia Cheek hawked her company's home-testing kits to the program's panel of investors.\u003c/p>\n\u003cp>\"EverlyWell is transforming lab testing — a $25 billion market — to be simple, convenient and useful for you,\" Cheek pitched.\u003c/p>\n\u003cp>\"I think the product is brilliantly crafted,\" said Lori Greiner, who is also known as \"The Queen of QVC.\"\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\"I think this gives people an empowered way to check on some things.\"\u003c/p>\n\u003cp>Cheek walked away from the show with a million-dollar commitment for her Austin-based company.\u003c/p>\n\u003cp>But that was TV, of course. Some doctors worry EveryWell is promising more than it can deliver.\u003c/p>\n\u003cp>\u003cstrong>One Woman's Success Story\u003c/strong>\u003c/p>\n\u003caside class=\"pullquote alignright\">'EverlyWell recognizes that the AAAAI does not support any form of food sensitivity testing ... but they are not the entire 'medical community,' and AAAAI does not speak for all health care providers.' \u003ccite>EverlyWell \u003c/cite>\u003c/aside>\n\u003cp>The company's food-sensitivity test is its best seller, and the kit is especially hot in the Bay Area. San Francisco resident Regina Du says the test has changed her life. For years Du missed work due to stomachaches, headaches and inflamed welts.\u003c/p>\n\u003cp>“I just felt crummy,\" said Du. \"I would just like uncontrollably scratch myself because I was so itchy.\"\u003c/p>\n\u003cp>Doctors couldn’t figure out what was wrong. Eventually Du landed under the care of an allergist, who ordered a test. But Du balked when she learned her insurance wouldn’t cover the $700 cost.\u003c/p>\n\u003cp>“I just had total sticker shock,\" Du said.\u003c/p>\n\u003cp>So, she poked around online and found EverlyWell's food sensitivity kit for a couple hundred bucks.\u003c/p>\n\u003cp>Instructions inside the neatly packed kit explain how to prick your finger and dribble drops of blood onto a white collection card. Du completed the test in less than 20 minutes during her lunch break. A few days later she got an email suggesting she avoid gluten, dairy and green beans.\u003c/p>\n\u003cp>Almost immediately: Du started feeling better. Within a few weeks she felt normal for the first time in eight years.\u003c/p>\n\u003cp>\u003cb>Does it Work?\u003c/b>\u003c/p>\n\u003cp>The test is supposed to measure whether a person’s immune system reacts to certain foods by making an antibody called Immunoglobulin G (IgG), which EverlyWell describes on its website as the potential cause of symptoms like migraines or irritable bowel syndrome according to some small \u003ca href=\"https://www.everlywell.com/food-sensitivity-and-you/\" target=\"_blank\" rel=\"noopener\">studies\u003c/a>.\u003c/p>\n\u003cfigure id=\"attachment_441036\" class=\"wp-caption alignright\" style=\"max-width: 800px\">\u003cimg class=\"size-medium wp-image-441036\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-800x599.png\" alt=\"\" width=\"800\" height=\"599\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-800x599.png 800w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-160x120.png 160w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-768x575.png 768w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-240x180.png 240w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-375x281.png 375w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM-520x389.png 520w, https://ww2.kqed.org/app/uploads/sites/13/2018/04/Screen-Shot-2018-04-26-at-4.31.33-PM.png 884w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">Julia Cheek, CEO of EverlyWell, on a November 2017 episode of 'Shark Tank.' \u003ccite>(Courtesy ABC/Sony Pictures Television)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>The American Academy of Allergy, Asthma & Immunology does not recognize the validity of IgG tests in diagnosing food sensitivity, also called food intolerance.\u003c/p>\n\u003cp>\"It is important to understand that this test has never been scientifically proven to be able to accomplish what it reports to do,\" the AAAAI \u003ca href=\"https://www.aaaai.org/conditions-and-treatments/library/allergy-library/IgG-food-test\" target=\"_blank\" rel=\"noopener\">writes on its website\u003c/a>. \"The scientific studies that are provided to support the use of this test are often out of date, in non-reputable journals and many have not even used the IgG test in question. The presence of IgG is likely a normal response of the immune system to exposure to food.\"\u003c/p>\n\u003cp>Dr. Neha Shah, a rheumatologist and immunologist at Stanford University, is one doctor who is skeptical.\u003c/p>\n\u003cp>“What we don’t have is proof that having a high IgG level against a particular food item means that that food is causing your symptoms,\" said Shah.\u003c/p>\n\u003cp>Shah shares the story of her sister, who bought a test and then was told to avoid swordfish.\u003c/p>\n\u003cp>“We’ve been vegetarians all our whole lives,\" said Shah. \"And there was really no reason why she had a high sensitivity, a high IgG level against swordfish.”\u003c/p>\n\u003cp>Shah also says IgG levels can elevate simply because you eat a specific food, so it doesn't necessarily mean that your body is reacting negatively. For all these reasons, Shah does not administer food sensitivity tests in her practice. She suggests patients save the money and go straight to an elimination diet\u003cb>, \u003c/b>where you remove commonly reactive foods like gluten or dairy and see if you feel better.\u003c/p>\n\u003caside class=\"pullquote alignright\">\u003c/aside>\n\u003cp>\u003cstrong>Test for Heavy Metals, Stress or Metabolism\u003c/strong>\u003c/p>\n\u003cp>Dr. Marra Francis, EverlyWell's executive medical director, stands by its products as a valuable first step for patients to take their health into their own hands.\u003c/p>\n\u003cp>\"A lot of times this testing can be a bridge between vague symptoms and an actual plan that you create with your provider,\" she said. EverlyWell does recommend patients\u003cb> \u003c/b>double-check test results with an elimination diet.\u003c/p>\n\u003cp>Tina Heilman, a spokesperson for EverlyWell, wrote in an email:\u003c/p>\n\u003cp>\"EverlyWell recognizes that the AAAAI does not support any form of food sensitivity testing (which is not just limited to IgG testing), but they are not the entire 'medical community,' and AAAAI does not speak for all health care providers. IgG tests are currently ordered by thousands of medical providers in the U.S.\"\u003c/p>\n\u003cp>\u003cstrong>No Oversight\u003c/strong>\u003c/p>\n\u003cp>Besides its IgG test, the company markets 22 other home wellness tests, everything from cholesterol to testosterone. Internet ventures like LetsGetChecked, Thorne and Health Test Express offer a similar array.\u003c/p>\n\u003cp>But some doctors worry about a booming market that's not regulated by the Food and Drug Administration.\u003c/p>\n\u003cp>“A lot of this kind of huxterist testing is keying off of the placebo effect,\" said Dr. Norman Paradis, a clinical lab expert who teaches at the Geisel School of Medicine at Dartmouth College, referring to the industry in general and not to a particular product.\u003c/p>\n\u003cp>In other words, just believing a test is valid and taking action on it may make you feel better. Paradis is also worried that home tests could inspire patients to overreact to results. Hypothetically, a patient may discover she's deficient in vitamin d and compensate by taking toxic doses, he said. Or a test result may inspire a patient to seek medical care they don’t need.\u003c/p>\n\u003cp>“For instance, let’s say a test inaccurately said you may have colon cancer,\" said Paradis. \"And then you went and got a colonoscopy and were injured during the colonoscopy. Well the test actually created that harm.”\u003c/p>\n\u003cp>Dr. Gilbert Welch, the author of \"Overdiagnosed: Making People Sick in Pursuit of Health\u003cem>,\" \u003c/em>said, \"You can't test your way to health.\"\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>For unexplained symptoms he suggested starting with the long-ignored advice from your grandmother: Eat real food, set a regular sleep schedule, and get some exercise.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/441018/company-of-shark-tank-winner-offers-food-sensitivity-tests-but-do-they-work",
"authors": [
"11229"
],
"categories": [
"futureofyou_1060",
"futureofyou_1062",
"futureofyou_1",
"futureofyou_73",
"futureofyou_1575"
],
"tags": [
"futureofyou_1275",
"futureofyou_426",
"futureofyou_1493",
"futureofyou_1492",
"futureofyou_798",
"futureofyou_1484",
"futureofyou_102",
"futureofyou_1496"
],
"featImg": "futureofyou_441026",
"label": "futureofyou"
},
"futureofyou_440861": {
"type": "posts",
"id": "futureofyou_440861",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "440861",
"score": null,
"sort": [
1524244072000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1524244072,
"format": "standard",
"disqusTitle": "Parenting of the Future: Converting Ordinary Cells Into Sperm and Eggs",
"title": "Parenting of the Future: Converting Ordinary Cells Into Sperm and Eggs",
"headTitle": "Future of You | KQED Future of You | KQED Science",
"content": "\u003cp>So you want to have a baby.\u003c/p>\n\u003cp>Would you like a dark-haired girl with a high risk of someday getting colon cancer, but a good chance of above-average music ability?[contextly_sidebar id=\"hGdwiHda2M4gvFM3sXPeB5lpQehOV9JO\"]\u003c/p>\n\u003cp>Or would you prefer a girl with a good prospect for high SAT scores and a good shot at being athletic, but who also is likely to run an above-average risk of bipolar disorder and lupus as an adult?\u003c/p>\n\u003cp>How about a boy with a good shot at having musical ability and dodging asthma, but who also would be predisposed to cataracts and type 2 diabetes?\u003c/p>\n\u003cp>Confused? You’re just getting started. There are dozens more choices for which of your embryos should be placed in the womb to become your child.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>That’s the future a biomedical ethics expert envisions for 20 to 40 years from now — soon enough that today’s children may face it when they start their own families.\u003c/p>\n\u003cp>“The majority of babies of people who have good health coverage will be conceived this way,” predicts Henry Greely, a Stanford University law professor who works in bioethics.\u003c/p>\n\u003cp>You’ve probably read about concerns over “designer babies,” whose DNA is shaped by gene editing. Greely is focused on a different technology that has gotten much less attention: In a startling bit of biological alchemy, scientists have shown that in mice, they can turn ordinary cells into sperm and eggs.\u003c/p>\n\u003cp class=\"caption\">[contextly_sidebar id=\"eTManZd4WaqVP8G2asFbvl91UNkETnUW\"]A prominent biomedical ethics expert says that in 20 to 40 years, many prospective parents may choose from dozens of embryos to become their babies and would be provided with genetic information about each embryo to help make the choice. (April 18)\u003c/p>\n\u003cp>It’s too soon to know if it could be done in people. But if it can, it could become a powerful infertility treatment, permitting genetic parenthood for people who can’t make their own sperm or eggs.\u003c/p>\n\u003cp>It also would mean that a woman who wants to get pregnant could produce dozens more eggs per attempt than with the current procedure of harvesting some from her ovaries.\u003c/p>\n\u003cp>And that means a lot of choices.\u003c/p>\n\u003cp>\u003cstrong>An Array of Embryos\u003c/strong>\u003cbr>\nHere’s what Greely envisions: A man and woman walk into a fertility clinic. The man drops off some sperm. The woman leaves some skin cells, which are turned into eggs and fertilized with the man’s sperm.\u003c/p>\n\u003cp>Unlike in vitro fertilization today, which typically yields around eight eggs per try, the new method could result in 100 embryos.\u003c/p>\n\u003cp>The embryos’ complete library of DNA would be decoded and analyzed to reveal genetic predispositions, both for disease and personal traits. The man and woman would get dossiers on the embryos that pass minimum tests for suitability.\u003c/p>\n\u003cp>Out of, say, 80 suitable embryos, the couple would then choose one or two to implant.\u003c/p>\n\u003cp>The possibilities don’t stop there. The technology might also help open the door to same-sex couples having children genetically related to both of them, though the additional twist of making eggs from men or sperm from women would be a huge biological challenge.[contextly_sidebar id=\"SrDdSI0zE6VxuvIcDgGVohz7igj80GaU\"]\u003c/p>\n\u003cp>More worrisome is the so-called Brad Pitt scenario: We all shed a bit of sloughed-off DNA every day, like on the lip of a coffee cup. Such discarded material could be secretly snatched up to turn an unwitting celebrity into a genetic parent.\u003c/p>\n\u003cp>It is a long way in the future, but real life is already creeping toward it. Some scientists are trying to make human eggs and sperm in the lab. They are working with “iPS cells,” which are ordinary body cells that have been morphed into a malleable state.\u003c/p>\n\u003cp>Amander Clark of the University of California, Los Angeles, says her goal is to aid basic research into why some people are infertile. She acknowledges the technique might itself be used to treat some infertility, particularly in young people made sterile by cancer treatments.\u003c/p>\n\u003cp>As for decoding the complete DNA library of embryos, Dr. Louanne Hudgins, who studies prenatal genetic screening and diagnosis at Stanford, says some pregnant patients there say they’ve already had fertility clinics do that. They didn’t reveal why, Hudgins said.\u003c/p>\n\u003cp>Hudgins, who’s president of the American College of Medical Genetics and Genomics, said no national medical association has endorsed decoding all the DNA of an embryo, which is called its genome. So she believes no insurance company would pay for that now.\u003c/p>\n\u003cp>\u003cstrong>‘Easy' Prenatal Diagnosis\u003c/strong>\u003cbr>\nGreely, who lays out his ideas in a book called “The End of Sex and the Future of Human Reproduction,” calls his vision “easy PGD,” or prenatal genetic diagnosis.\u003c/p>\n\u003cp>Ordinary PGD has been done for decades. When a couple is known to be at risk for having a child with a specific genetic disorder, such as cystic fibrosis or sickle cell anemia, the woman undergoes a procedure to remove some eggs. After fertilization, some cells are plucked from the embryos and examined to identify those without carry the disease-causing abnormality.\u003c/p>\n\u003cp>That procedure looks for a specific problem in a few embryos, not entire genomes from dozens of them. If a couple wants to select a “super baby,” says Dr. Richard Scott Jr., a founding partner of Reproductive Medicine Associates of New Jersey, “we tell them we can’t do it.”\u003c/p>\n\u003cp>In fact, Scott and others say, even wide-ranging analysis would not provide a precise forecast of how a child will turn out.\u003c/p>\n\u003cp>[contextly_sidebar id=\"izPvBHygWyTNurqnYm1uuauGvc2JdDjo\"]If DNA is the hardware, there’s also the software: chemical modifications that determine when and where particular genes turn on and off. Much of this “epigenome” would develop after an embryo’s genes are sampled, Scott said.\u003c/p>\n\u003cp>“Your child may not turn out to be the three-sport All-American at Stanford,” because “the epigenome didn’t work out,” Scott said.\u003c/p>\n\u003cp>Greely agrees that predictions about behavioral traits like intelligence and athletic ability will be imprecise, because of epigenetics and because of basic uncertainties about what genes are involved and how they interact. And a person’s upbringing and life experiences have a big effect.\u003c/p>\n\u003cp>\u003cstrong>What Would Couples Do?\u003cbr>\n\u003c/strong>Even if the predictions aren’t perfect, would couples want to take steps to control their child’s genetics? Many experts doubt it.\u003c/p>\n\u003cp>Only a “very small minority” seek a perfect baby, says Stanford’s Hudgins. In her practice, she said she often finds women pass up all screening because they figure the baby’s fate is “in God’s hands.”\u003c/p>\n\u003cp>Dr. James Grifo of the New York University Fertility Center also questions how popular the idea would be.\u003c/p>\n\u003cp>“No patient has ever came to me and said, ’I want a designer baby,’” said Grifo, who’s performed in vitro fertilization since 1988.\u003c/p>\n\u003cp>[contextly_sidebar id=\"hN50KvG8BIKoBQkiV9DDiJW3PjvffZIF\"]Greely doubts that influencing brainpower or athleticism would be a major draw for parents. Instead, he thinks they would care most about avoiding awful diseases that strike in infancy or childhood. They’ll probably be less concerned about illnesses that might show up later in life, such as Alzheimer’s or Parkinson’s. For one thing, he says, parents-to-be may see them as becoming treatable by the time a child becomes vulnerable.\u003c/p>\n\u003cp>He thinks easy PGD is coming, and it would be better if properly handled. He says it should be proven safe, subsidized, monitored for long-term effects, and regulated so that parents can choose whether to use it and decide what embryonic traits to focus on. And he’d outlaw stealing somebody’s DNA and unwittingly making them a parent.\u003c/p>\n\u003cp>\u003cstrong>Others See Pitfalls\u003c/strong>\u003cbr>\nOnce the genetic profile is done, could it come back to haunt a child if, say, a life insurer or nursing home demanded to see it to assess disease risk? How would the large number of rejected embryos be handled ethically and politically?\u003c/p>\n\u003cp>Perhaps future regulation could limit the number of embryos created, as well as what traits a couple could select for, said I. Glenn Cohen, a Harvard law professor.\u003c/p>\n\u003cp>Lori B. Andrews, a professor at the Chicago-Kent College of Law, summed up her views in a review of Greely’s book.\u003c/p>\n\u003cp>“The idea of easy PGD,” she wrote, “should make us uneasy indeed.”\u003c/p>\n\u003cp>Still, even some who doubt the idea’s feasibility say Greely is right to raise the issue.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>“It’s certainly something we have to take seriously and think through now,” said Marcy Darnovsky, who writes on the politics of human biotechnology as executive director of the Center for Genetics and Society in Berkeley, California. “This is not just a technical or science question.”\u003cbr>\n__\u003cbr>\nThis Associated Press \u003ca href=\"https://apnews.com/tag/GeneticFrontiers\" target=\"_blank\" rel=\"noopener\">series\u003c/a> was produced in \u003ca href=\"https://www.ap.org/press-releases/2018/ap-hhmi-expand-collaboration-to-bolster-health-science-coverage\" target=\"_blank\" rel=\"noopener\">partnership\u003c/a> with the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.\u003c/p>\n\n",
"disqusIdentifier": "440861 https://ww2.kqed.org/futureofyou/?p=440861",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/04/20/parenting-of-the-future-converting-ordinary-cells-into-sperm-and-eggs/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1539,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 42
},
"modified": 1524244072,
"excerpt": "The tool may one day permit \"genetic parenthood\" for people who can’t make their own sperm or eggs.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The tool may one day permit "genetic parenthood" for people who can’t make their own sperm or eggs.",
"title": "Parenting of the Future: Converting Ordinary Cells Into Sperm and Eggs | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Parenting of the Future: Converting Ordinary Cells Into Sperm and Eggs",
"datePublished": "2018-04-20T10:07:52-07:00",
"dateModified": "2018-04-20T10:07:52-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "parenting-of-the-future-converting-ordinary-cells-into-sperm-and-eggs",
"status": "publish",
"nprByline": "Malcolm Ritter\u003cbr />The Associated Press",
"source": "DIY Health",
"path": "/futureofyou/440861/parenting-of-the-future-converting-ordinary-cells-into-sperm-and-eggs",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>So you want to have a baby.\u003c/p>\n\u003cp>Would you like a dark-haired girl with a high risk of someday getting colon cancer, but a good chance of above-average music ability?\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Or would you prefer a girl with a good prospect for high SAT scores and a good shot at being athletic, but who also is likely to run an above-average risk of bipolar disorder and lupus as an adult?\u003c/p>\n\u003cp>How about a boy with a good shot at having musical ability and dodging asthma, but who also would be predisposed to cataracts and type 2 diabetes?\u003c/p>\n\u003cp>Confused? You’re just getting started. There are dozens more choices for which of your embryos should be placed in the womb to become your child.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>That’s the future a biomedical ethics expert envisions for 20 to 40 years from now — soon enough that today’s children may face it when they start their own families.\u003c/p>\n\u003cp>“The majority of babies of people who have good health coverage will be conceived this way,” predicts Henry Greely, a Stanford University law professor who works in bioethics.\u003c/p>\n\u003cp>You’ve probably read about concerns over “designer babies,” whose DNA is shaped by gene editing. Greely is focused on a different technology that has gotten much less attention: In a startling bit of biological alchemy, scientists have shown that in mice, they can turn ordinary cells into sperm and eggs.\u003c/p>\n\u003cp class=\"caption\">\u003c/p>\u003cp>\u003c/p>\u003cp>A prominent biomedical ethics expert says that in 20 to 40 years, many prospective parents may choose from dozens of embryos to become their babies and would be provided with genetic information about each embryo to help make the choice. (April 18)\u003c/p>\n\u003cp>It’s too soon to know if it could be done in people. But if it can, it could become a powerful infertility treatment, permitting genetic parenthood for people who can’t make their own sperm or eggs.\u003c/p>\n\u003cp>It also would mean that a woman who wants to get pregnant could produce dozens more eggs per attempt than with the current procedure of harvesting some from her ovaries.\u003c/p>\n\u003cp>And that means a lot of choices.\u003c/p>\n\u003cp>\u003cstrong>An Array of Embryos\u003c/strong>\u003cbr>\nHere’s what Greely envisions: A man and woman walk into a fertility clinic. The man drops off some sperm. The woman leaves some skin cells, which are turned into eggs and fertilized with the man’s sperm.\u003c/p>\n\u003cp>Unlike in vitro fertilization today, which typically yields around eight eggs per try, the new method could result in 100 embryos.\u003c/p>\n\u003cp>The embryos’ complete library of DNA would be decoded and analyzed to reveal genetic predispositions, both for disease and personal traits. The man and woman would get dossiers on the embryos that pass minimum tests for suitability.\u003c/p>\n\u003cp>Out of, say, 80 suitable embryos, the couple would then choose one or two to implant.\u003c/p>\n\u003cp>The possibilities don’t stop there. The technology might also help open the door to same-sex couples having children genetically related to both of them, though the additional twist of making eggs from men or sperm from women would be a huge biological challenge.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>More worrisome is the so-called Brad Pitt scenario: We all shed a bit of sloughed-off DNA every day, like on the lip of a coffee cup. Such discarded material could be secretly snatched up to turn an unwitting celebrity into a genetic parent.\u003c/p>\n\u003cp>It is a long way in the future, but real life is already creeping toward it. Some scientists are trying to make human eggs and sperm in the lab. They are working with “iPS cells,” which are ordinary body cells that have been morphed into a malleable state.\u003c/p>\n\u003cp>Amander Clark of the University of California, Los Angeles, says her goal is to aid basic research into why some people are infertile. She acknowledges the technique might itself be used to treat some infertility, particularly in young people made sterile by cancer treatments.\u003c/p>\n\u003cp>As for decoding the complete DNA library of embryos, Dr. Louanne Hudgins, who studies prenatal genetic screening and diagnosis at Stanford, says some pregnant patients there say they’ve already had fertility clinics do that. They didn’t reveal why, Hudgins said.\u003c/p>\n\u003cp>Hudgins, who’s president of the American College of Medical Genetics and Genomics, said no national medical association has endorsed decoding all the DNA of an embryo, which is called its genome. So she believes no insurance company would pay for that now.\u003c/p>\n\u003cp>\u003cstrong>‘Easy' Prenatal Diagnosis\u003c/strong>\u003cbr>\nGreely, who lays out his ideas in a book called “The End of Sex and the Future of Human Reproduction,” calls his vision “easy PGD,” or prenatal genetic diagnosis.\u003c/p>\n\u003cp>Ordinary PGD has been done for decades. When a couple is known to be at risk for having a child with a specific genetic disorder, such as cystic fibrosis or sickle cell anemia, the woman undergoes a procedure to remove some eggs. After fertilization, some cells are plucked from the embryos and examined to identify those without carry the disease-causing abnormality.\u003c/p>\n\u003cp>That procedure looks for a specific problem in a few embryos, not entire genomes from dozens of them. If a couple wants to select a “super baby,” says Dr. Richard Scott Jr., a founding partner of Reproductive Medicine Associates of New Jersey, “we tell them we can’t do it.”\u003c/p>\n\u003cp>In fact, Scott and others say, even wide-ranging analysis would not provide a precise forecast of how a child will turn out.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>If DNA is the hardware, there’s also the software: chemical modifications that determine when and where particular genes turn on and off. Much of this “epigenome” would develop after an embryo’s genes are sampled, Scott said.\u003c/p>\n\u003cp>“Your child may not turn out to be the three-sport All-American at Stanford,” because “the epigenome didn’t work out,” Scott said.\u003c/p>\n\u003cp>Greely agrees that predictions about behavioral traits like intelligence and athletic ability will be imprecise, because of epigenetics and because of basic uncertainties about what genes are involved and how they interact. And a person’s upbringing and life experiences have a big effect.\u003c/p>\n\u003cp>\u003cstrong>What Would Couples Do?\u003cbr>\n\u003c/strong>Even if the predictions aren’t perfect, would couples want to take steps to control their child’s genetics? Many experts doubt it.\u003c/p>\n\u003cp>Only a “very small minority” seek a perfect baby, says Stanford’s Hudgins. In her practice, she said she often finds women pass up all screening because they figure the baby’s fate is “in God’s hands.”\u003c/p>\n\u003cp>Dr. James Grifo of the New York University Fertility Center also questions how popular the idea would be.\u003c/p>\n\u003cp>“No patient has ever came to me and said, ’I want a designer baby,’” said Grifo, who’s performed in vitro fertilization since 1988.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>Greely doubts that influencing brainpower or athleticism would be a major draw for parents. Instead, he thinks they would care most about avoiding awful diseases that strike in infancy or childhood. They’ll probably be less concerned about illnesses that might show up later in life, such as Alzheimer’s or Parkinson’s. For one thing, he says, parents-to-be may see them as becoming treatable by the time a child becomes vulnerable.\u003c/p>\n\u003cp>He thinks easy PGD is coming, and it would be better if properly handled. He says it should be proven safe, subsidized, monitored for long-term effects, and regulated so that parents can choose whether to use it and decide what embryonic traits to focus on. And he’d outlaw stealing somebody’s DNA and unwittingly making them a parent.\u003c/p>\n\u003cp>\u003cstrong>Others See Pitfalls\u003c/strong>\u003cbr>\nOnce the genetic profile is done, could it come back to haunt a child if, say, a life insurer or nursing home demanded to see it to assess disease risk? How would the large number of rejected embryos be handled ethically and politically?\u003c/p>\n\u003cp>Perhaps future regulation could limit the number of embryos created, as well as what traits a couple could select for, said I. Glenn Cohen, a Harvard law professor.\u003c/p>\n\u003cp>Lori B. Andrews, a professor at the Chicago-Kent College of Law, summed up her views in a review of Greely’s book.\u003c/p>\n\u003cp>“The idea of easy PGD,” she wrote, “should make us uneasy indeed.”\u003c/p>\n\u003cp>Still, even some who doubt the idea’s feasibility say Greely is right to raise the issue.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>“It’s certainly something we have to take seriously and think through now,” said Marcy Darnovsky, who writes on the politics of human biotechnology as executive director of the Center for Genetics and Society in Berkeley, California. “This is not just a technical or science question.”\u003cbr>\n__\u003cbr>\nThis Associated Press \u003ca href=\"https://apnews.com/tag/GeneticFrontiers\" target=\"_blank\" rel=\"noopener\">series\u003c/a> was produced in \u003ca href=\"https://www.ap.org/press-releases/2018/ap-hhmi-expand-collaboration-to-bolster-health-science-coverage\" target=\"_blank\" rel=\"noopener\">partnership\u003c/a> with the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/440861/parenting-of-the-future-converting-ordinary-cells-into-sperm-and-eggs",
"authors": [
"byline_futureofyou_440861"
],
"programs": [
"futureofyou_54"
],
"categories": [
"futureofyou_1060",
"futureofyou_1062",
"futureofyou_1",
"futureofyou_73",
"futureofyou_1064"
],
"tags": [
"futureofyou_221",
"futureofyou_927",
"futureofyou_466",
"futureofyou_61",
"futureofyou_347"
],
"collections": [
"futureofyou_1093",
"futureofyou_1094"
],
"featImg": "futureofyou_440862",
"label": "source_futureofyou_440861"
},
"futureofyou_440706": {
"type": "posts",
"id": "futureofyou_440706",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "440706",
"score": null,
"sort": [
1523300406000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1523300406,
"format": "standard",
"disqusTitle": "For Chronic Pain, A Change In Habits Can Beat Opioids For Relief",
"title": "For Chronic Pain, A Change In Habits Can Beat Opioids For Relief",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>It took several months and a team of half a dozen doctors, nurses and therapists to help Kim Brown taper off the opioid painkillers she'd been on for two years.\u003c/p>\n\u003cp>Brown, 57, had been taking the pills since a back injury in 2010. It wasn't until she met Dr. Dennis McManus, a neurologist who specializes in managing pain without drugs, that she learned she had some control over her pain.\u003c/p>\n\u003cp>\"That's when life changed,\" she said.\u003c/p>\n\u003cp>During a 12-week series of appointments at McManus' clinic in Peoria, Ill., Brown learned new ways to prevent and cope with pain, as she gradually reduced her opioid doses.\u003c/p>\n\u003caside class=\"pullquote alignright\">'In a single year, health care providers write enough opioid prescriptions for every adult in the U.S. to have a bottle of pills.’\u003c/aside>\n\u003cp>Roughly \u003ca href=\"http://www.nationalacademies.org/hmd/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research/Report-Brief.aspx\" target=\"_blank\" rel=\"noopener\">a third of Americans live with chronic pain\u003c/a>, and many of them become dependent on opioids prescribed to treat it. But there's a growing consensus among pain specialists that a low-tech approach focused on lifestyle changes can be more effective.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>This kind of treatment can be more expensive — and less convenient — than a bottle of pills. But pain experts say it can save money over the long term by helping patients get off addictive medications and improving their quality of life.\u003c/p>\n\u003cp>\"It's important to remember that the main treatments that are recommended for these pain conditions are not medication treatments,\" said Dr. Erin Krebs, a primary care physician and researcher at the Minneapolis VA Health Care System.[contextly_sidebar id=\"V0C48krhDpEf36aihsYishHMpftd4maj\"]\u003c/p>\n\u003cp>Recently, Krebs published the first \u003ca href=\"https://jamanetwork.com/journals/jama/article-abstract/2673971?redirect=true\" target=\"_blank\" rel=\"noopener\">long-term randomized trial of opioids\u003c/a> for treating chronic back pain and arthritis, and found that opioids are no better than nonopioid medications. She said drugs of any kind are the lesser choice for the vast majority of patients.\u003c/p>\n\u003cp>The gold standard for treatment, she said, is a combination of things like exercise, rehabilitation therapies, yoga and cognitive behavioral therapies.\u003c/p>\n\u003cp>This approach is consistent with the most recent guidelines \u003ca href=\"https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm\" target=\"_blank\" rel=\"noopener\">from the Centers for Disease Control and Prevention\u003c/a> for prescribing opioids for chronic pain. But it's still uncommon.\u003c/p>\n\u003cp>Brown's painkiller use started after she blew out a disk in her back.\u003c/p>\n\u003cp>\"It was the simplest thing,\" Brown said. \"I picked up a bag of garbage with my right hand, and I immediately knew something was wrong.\"[contextly_sidebar id=\"KxtsC3dvl0zmNmyhnx0NVfydGpZ8NYsa\"]\u003c/p>\n\u003cp>She was put on opioids, like so many others who see the doctor about pain. In a single year, health care providers write enough opioid prescriptions for \u003ca href=\"https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm\" target=\"_blank\" rel=\"noopener\">every adult in the U.S.\u003c/a> to have a bottle of pills.\u003c/p>\n\u003cp>Each time Brown came back, still in pain, another opioid was added to the list. She was eventually taking four different drugs — Percocet, Vicodin, morphine and Dilaudid — popping pills every two hours.\u003c/p>\n\u003cp>\"I was just drugged constantly,\" Brown said. \"And even with that, it didn't take care of the pain.\"\u003c/p>\n\u003cp>Not only did the drugs not help with the pain, the side effects made it worse. Brown had such severe abdominal pain from constipation she could hardly walk.\u003c/p>\n\u003cp>\"It kills your life. It totally robs you of every aspect,\" she said. \"I couldn't do anything because of the pain. But I couldn't do anything because of the pain meds. And I couldn't talk to anyone about it, because it was so embarrassing.\"[contextly_sidebar id=\"vuwfumTsjRlj4bRQzDECQ4gkdOYjrq9B\"]\u003c/p>\n\u003cp>Brown tried to quit on her own. But after nine days of nausea and fainting from withdrawal, she was back on the medications.\u003c/p>\n\u003cp>\"I finally went to my family doctor and said, 'I need help, I've got to get off this stuff. I can't live like this anymore,' \" she said.\u003c/p>\n\u003cp>That's when she was referred to McManus, director of the OSF Central Illinois Pain Center in Peoria. He specializes in helping chronic pain sufferers like Brown get off opioids.\u003c/p>\n\u003cp>\"From my perspective, if you stabilize the dose and slowly taper off, these patients do remarkably well,\" he said.\u003c/p>\n\u003cp>At the center, a team of providers works together to help patients make lifestyle changes that reduce pain during everyday activities.\u003c/p>\n\u003cp>The approach includes a combination of physical and occupational therapy, massage and nutrition counseling. Patients also participate in cognitive behavioral therapy to address the psychological issues that often accompany pain — such as overcoming fears of letting go of medications they've become dependent on. A nurse coordinator oversees all the moving parts and does follow-up assessments after the program is completed.\u003c/p>\n\u003cp>[contextly_sidebar id=\"prJEo6QPBRmwbqUUojWuQEFBS0fOvffp\"]At the clinic, Brown met occupational therapist Gabe Stickling, who taught her things like how to properly lift heavy objects and how to safely keep exercising even when she feels a twinge of pain.\u003c/p>\n\u003cp>Stickling said people with chronic pain often avoid physical activity \"because they're afraid they're going to injure themselves or damage their bodies.\" But inactivity can make the pain worse.\u003c/p>\n\u003cp>McManus said some of his chronic pain patients can taper off opioids with a less intensive treatment. But for some of his patients, the multidisciplinary program is most effective — if they're willing to commit to making change.\u003c/p>\n\u003cp>\"Most people just really want to have the magic wand that will get them all better,\" he said. \"And I'm just trying to say, I don't have a magic wand but I might have a way out of this jungle that you're in.\"[contextly_sidebar id=\"ljkiJf2Vl2dDfHJZPYML2MxBJQo2QVzo\"]\u003c/p>\n\u003cp>And because pain treatments that don't rely on drugs are hands-on and time-intensive, it can be hard to find a clinic that offers them — and to get insurance to cover them.\u003c/p>\n\u003cp>This wasn't always the case. Until the 1980s, the multidisciplinary approach was the go-to treatment for chronic pain, according to a \u003ca href=\"https://www.sciencedirect.com/science/article/pii/S0376871617300030#!\" target=\"_blank\" rel=\"noopener\">2016 review\u003c/a> on the history of chronic pain management. Its popularity declined as reimbursement rates went down and hospitals began to emphasize more lucrative procedures. Gradually, opioid treatment became the predominant strategy for pain treatment strategy.\u003c/p>\n\u003cp>Today, McManus said his practice spends a lot of time fighting to get the treatments covered. \"The pain program is not considered to be worthy of the price,\" McManus said.\u003c/p>\n\u003cp>Costs vary but run to several thousand dollars for a program like the one Kim Brown went through.\u003c/p>\n\u003cp>\"If you compare a fairly intensive multidisciplinary program to surgery and to drugs, the cost is not high,\" said Steven Kamper, a public health researcher at the University of Sydney in Australia. He's co-author of a \u003ca href=\"http://www.cochrane.org/CD000963/BACK_multidisciplinary-treatment-for-back-pain\" target=\"_blank\" rel=\"noopener\">2014 meta-analysis\u003c/a> that found modest benefits for multidisciplinary treatment programs for chronic low back pain.[contextly_sidebar id=\"t5KGSGdfaVMwNHpSdqorpggRmDpacuwm\"]\u003c/p>\n\u003cp>Kamper said, the costs are reasonable especially if you consider the long-term effects of living in pain. Many chronic pain sufferers are unable to work and become eligible for disability insurance.\u003c/p>\n\u003cp>\"The big costs of chronic pain are in productivity losses,\" Kamper said.\u003c/p>\n\u003cp>Krebs is hopeful non-drug therapies will regain popularity, as communities recognize the hidden costs of opioids.\u003c/p>\n\u003cp>\"It's not just the price of the pills,\" she said. \"It's also the price of the consequences when you over-rely on something.\"\u003c/p>\n\u003cp>Krebs and Kamper agree more research into pain treatment is needed. But when choosing between an addictive medication with no evidence of benefit, and low-tech therapies with some evidence of benefits, McManus said the choice is clear.\u003c/p>\n\u003cp>\"I did take an oath: First do no harm,\" McManus said. \"As a pain physician, I have a responsibility to use evidence-based medicine to manage my patients that have chronic pain.\"\u003c/p>\n\u003cp>Brown is thankful that the multidisciplinary approach helped her taper off opioids and get her life back, even though it's a different life than before her injury.\u003c/p>\n\u003cp>\"There's no such thing as a pain-free day for me,\" Brown said. \"It never, never fully goes away.\"\u003c/p>\n\u003cp>She has just learned how to manage life with it.\u003c/p>\n\u003chr>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>\u003cem>This story was produced by \u003c/em>\u003ca href=\"http://sideeffectspublicmedia.org/\" target=\"_blank\" rel=\"noopener\">Side Effects Public Media\u003c/a>, \u003cem>a news collaborative covering public health. You can follow Christine Herman on Twitter: \u003c/em>\u003ca href=\"https://twitter.com/CTHerman\" target=\"_blank\" rel=\"noopener\">@CTHerman\u003c/a>.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 Side Effects Public Media. To see more, visit \u003ca>Side Effects Public Media\u003c/a>.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=For+Chronic+Pain%2C+A+Change+In+Habits+Can+Beat+Opioids+For+Relief&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "440706 https://ww2.kqed.org/futureofyou/?p=440706",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/04/09/for-chronic-pain-a-change-in-habits-can-beat-opioids-for-relief/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1360,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 44
},
"modified": 1523299875,
"excerpt": "Pain specialists say a low-tech approach focused on lifestyle changes can be more effective than drugs.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Pain specialists say a low-tech approach focused on lifestyle changes can be more effective than drugs.",
"title": "For Chronic Pain, A Change In Habits Can Beat Opioids For Relief | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "For Chronic Pain, A Change In Habits Can Beat Opioids For Relief",
"datePublished": "2018-04-09T12:00:06-07:00",
"dateModified": "2018-04-09T11:51:15-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "for-chronic-pain-a-change-in-habits-can-beat-opioids-for-relief",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=599850185&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Christine Herman\u003cbr />NPR Shots",
"nprStoryDate": "Fri, 06 Apr 2018 12:42:54 -0400",
"nprLastModifiedDate": "Fri, 06 Apr 2018 13:11:50 -0400",
"nprHtmlLink": "https://www.npr.org/sections/health-shots/2018/04/06/599850185/for-chronic-pain-a-change-in-habits-can-beat-opioids-for-relief?ft=nprml&f=599850185",
"nprImageAgency": "Kyle Travers/WFYI",
"source": "Health",
"nprStoryId": "599850185",
"nprRetrievedStory": "1",
"nprPubDate": "Fri, 06 Apr 2018 13:11:00 -0400",
"path": "/futureofyou/440706/for-chronic-pain-a-change-in-habits-can-beat-opioids-for-relief",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>It took several months and a team of half a dozen doctors, nurses and therapists to help Kim Brown taper off the opioid painkillers she'd been on for two years.\u003c/p>\n\u003cp>Brown, 57, had been taking the pills since a back injury in 2010. It wasn't until she met Dr. Dennis McManus, a neurologist who specializes in managing pain without drugs, that she learned she had some control over her pain.\u003c/p>\n\u003cp>\"That's when life changed,\" she said.\u003c/p>\n\u003cp>During a 12-week series of appointments at McManus' clinic in Peoria, Ill., Brown learned new ways to prevent and cope with pain, as she gradually reduced her opioid doses.\u003c/p>\n\u003caside class=\"pullquote alignright\">'In a single year, health care providers write enough opioid prescriptions for every adult in the U.S. to have a bottle of pills.’\u003c/aside>\n\u003cp>Roughly \u003ca href=\"http://www.nationalacademies.org/hmd/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research/Report-Brief.aspx\" target=\"_blank\" rel=\"noopener\">a third of Americans live with chronic pain\u003c/a>, and many of them become dependent on opioids prescribed to treat it. But there's a growing consensus among pain specialists that a low-tech approach focused on lifestyle changes can be more effective.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>This kind of treatment can be more expensive — and less convenient — than a bottle of pills. But pain experts say it can save money over the long term by helping patients get off addictive medications and improving their quality of life.\u003c/p>\n\u003cp>\"It's important to remember that the main treatments that are recommended for these pain conditions are not medication treatments,\" said Dr. Erin Krebs, a primary care physician and researcher at the Minneapolis VA Health Care System.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Recently, Krebs published the first \u003ca href=\"https://jamanetwork.com/journals/jama/article-abstract/2673971?redirect=true\" target=\"_blank\" rel=\"noopener\">long-term randomized trial of opioids\u003c/a> for treating chronic back pain and arthritis, and found that opioids are no better than nonopioid medications. She said drugs of any kind are the lesser choice for the vast majority of patients.\u003c/p>\n\u003cp>The gold standard for treatment, she said, is a combination of things like exercise, rehabilitation therapies, yoga and cognitive behavioral therapies.\u003c/p>\n\u003cp>This approach is consistent with the most recent guidelines \u003ca href=\"https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm\" target=\"_blank\" rel=\"noopener\">from the Centers for Disease Control and Prevention\u003c/a> for prescribing opioids for chronic pain. But it's still uncommon.\u003c/p>\n\u003cp>Brown's painkiller use started after she blew out a disk in her back.\u003c/p>\n\u003cp>\"It was the simplest thing,\" Brown said. \"I picked up a bag of garbage with my right hand, and I immediately knew something was wrong.\"\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>She was put on opioids, like so many others who see the doctor about pain. In a single year, health care providers write enough opioid prescriptions for \u003ca href=\"https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm\" target=\"_blank\" rel=\"noopener\">every adult in the U.S.\u003c/a> to have a bottle of pills.\u003c/p>\n\u003cp>Each time Brown came back, still in pain, another opioid was added to the list. She was eventually taking four different drugs — Percocet, Vicodin, morphine and Dilaudid — popping pills every two hours.\u003c/p>\n\u003cp>\"I was just drugged constantly,\" Brown said. \"And even with that, it didn't take care of the pain.\"\u003c/p>\n\u003cp>Not only did the drugs not help with the pain, the side effects made it worse. Brown had such severe abdominal pain from constipation she could hardly walk.\u003c/p>\n\u003cp>\"It kills your life. It totally robs you of every aspect,\" she said. \"I couldn't do anything because of the pain. But I couldn't do anything because of the pain meds. And I couldn't talk to anyone about it, because it was so embarrassing.\"\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Brown tried to quit on her own. But after nine days of nausea and fainting from withdrawal, she was back on the medications.\u003c/p>\n\u003cp>\"I finally went to my family doctor and said, 'I need help, I've got to get off this stuff. I can't live like this anymore,' \" she said.\u003c/p>\n\u003cp>That's when she was referred to McManus, director of the OSF Central Illinois Pain Center in Peoria. He specializes in helping chronic pain sufferers like Brown get off opioids.\u003c/p>\n\u003cp>\"From my perspective, if you stabilize the dose and slowly taper off, these patients do remarkably well,\" he said.\u003c/p>\n\u003cp>At the center, a team of providers works together to help patients make lifestyle changes that reduce pain during everyday activities.\u003c/p>\n\u003cp>The approach includes a combination of physical and occupational therapy, massage and nutrition counseling. Patients also participate in cognitive behavioral therapy to address the psychological issues that often accompany pain — such as overcoming fears of letting go of medications they've become dependent on. A nurse coordinator oversees all the moving parts and does follow-up assessments after the program is completed.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>At the clinic, Brown met occupational therapist Gabe Stickling, who taught her things like how to properly lift heavy objects and how to safely keep exercising even when she feels a twinge of pain.\u003c/p>\n\u003cp>Stickling said people with chronic pain often avoid physical activity \"because they're afraid they're going to injure themselves or damage their bodies.\" But inactivity can make the pain worse.\u003c/p>\n\u003cp>McManus said some of his chronic pain patients can taper off opioids with a less intensive treatment. But for some of his patients, the multidisciplinary program is most effective — if they're willing to commit to making change.\u003c/p>\n\u003cp>\"Most people just really want to have the magic wand that will get them all better,\" he said. \"And I'm just trying to say, I don't have a magic wand but I might have a way out of this jungle that you're in.\"\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>And because pain treatments that don't rely on drugs are hands-on and time-intensive, it can be hard to find a clinic that offers them — and to get insurance to cover them.\u003c/p>\n\u003cp>This wasn't always the case. Until the 1980s, the multidisciplinary approach was the go-to treatment for chronic pain, according to a \u003ca href=\"https://www.sciencedirect.com/science/article/pii/S0376871617300030#!\" target=\"_blank\" rel=\"noopener\">2016 review\u003c/a> on the history of chronic pain management. Its popularity declined as reimbursement rates went down and hospitals began to emphasize more lucrative procedures. Gradually, opioid treatment became the predominant strategy for pain treatment strategy.\u003c/p>\n\u003cp>Today, McManus said his practice spends a lot of time fighting to get the treatments covered. \"The pain program is not considered to be worthy of the price,\" McManus said.\u003c/p>\n\u003cp>Costs vary but run to several thousand dollars for a program like the one Kim Brown went through.\u003c/p>\n\u003cp>\"If you compare a fairly intensive multidisciplinary program to surgery and to drugs, the cost is not high,\" said Steven Kamper, a public health researcher at the University of Sydney in Australia. He's co-author of a \u003ca href=\"http://www.cochrane.org/CD000963/BACK_multidisciplinary-treatment-for-back-pain\" target=\"_blank\" rel=\"noopener\">2014 meta-analysis\u003c/a> that found modest benefits for multidisciplinary treatment programs for chronic low back pain.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Kamper said, the costs are reasonable especially if you consider the long-term effects of living in pain. Many chronic pain sufferers are unable to work and become eligible for disability insurance.\u003c/p>\n\u003cp>\"The big costs of chronic pain are in productivity losses,\" Kamper said.\u003c/p>\n\u003cp>Krebs is hopeful non-drug therapies will regain popularity, as communities recognize the hidden costs of opioids.\u003c/p>\n\u003cp>\"It's not just the price of the pills,\" she said. \"It's also the price of the consequences when you over-rely on something.\"\u003c/p>\n\u003cp>Krebs and Kamper agree more research into pain treatment is needed. But when choosing between an addictive medication with no evidence of benefit, and low-tech therapies with some evidence of benefits, McManus said the choice is clear.\u003c/p>\n\u003cp>\"I did take an oath: First do no harm,\" McManus said. \"As a pain physician, I have a responsibility to use evidence-based medicine to manage my patients that have chronic pain.\"\u003c/p>\n\u003cp>Brown is thankful that the multidisciplinary approach helped her taper off opioids and get her life back, even though it's a different life than before her injury.\u003c/p>\n\u003cp>\"There's no such thing as a pain-free day for me,\" Brown said. \"It never, never fully goes away.\"\u003c/p>\n\u003cp>She has just learned how to manage life with it.\u003c/p>\n\u003chr>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cem>This story was produced by \u003c/em>\u003ca href=\"http://sideeffectspublicmedia.org/\" target=\"_blank\" rel=\"noopener\">Side Effects Public Media\u003c/a>, \u003cem>a news collaborative covering public health. You can follow Christine Herman on Twitter: \u003c/em>\u003ca href=\"https://twitter.com/CTHerman\" target=\"_blank\" rel=\"noopener\">@CTHerman\u003c/a>.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 Side Effects Public Media. To see more, visit \u003ca>Side Effects Public Media\u003c/a>.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=For+Chronic+Pain%2C+A+Change+In+Habits+Can+Beat+Opioids+For+Relief&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/440706/for-chronic-pain-a-change-in-habits-can-beat-opioids-for-relief",
"authors": [
"byline_futureofyou_440706"
],
"categories": [
"futureofyou_1060",
"futureofyou_1",
"futureofyou_73"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_440707",
"label": "source_futureofyou_440706"
},
"futureofyou_440672": {
"type": "posts",
"id": "futureofyou_440672",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "440672",
"score": null,
"sort": [
1523035067000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1523035067,
"format": "aside",
"disqusTitle": "When Daydreaming Gets In The Way Of Real Life",
"title": "When Daydreaming Gets In The Way Of Real Life",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>\u003ciframe width=\"640\" height=\"360\" src=\"https://www.youtube.com/embed/ckYSydGYKRU?feature=oembed\" frameborder=\"0\" allow=\"autoplay; encrypted-media\" allowfullscreen>\u003c/iframe>\u003c/p>\n\u003cp>\u003cem>Welcome to \u003c/em>Invisibilia\u003cem> Season 4! The NPR program and \u003c/em>\u003ca href=\"http://www.npr.org/podcasts/510307/invisibilia\" target=\"_blank\" rel=\"noopener\">podcast\u003c/a>\u003cem> explores the invisible forces that shape human behavior, and we here at Shots are joining in to probe the science of why we act the way we do. In Episode 5, they're investigating how it feels to live \"in between,\" to be in two worlds at once. In the episode, and in the animation above, we meet M, a woman who worries that her intense daydreaming is interfering with her actual life.\u003c/em>\u003c/p>\n\u003cp>The story of M begins innocently enough. She was a girl who felt isolated and misunderstood, so she began spending hours at a time on the swings in her backyard, daydreaming.\u003c/p>\n\u003cp>She imagined herself as many characters, blasting off to other planets, fighting crime and just generally saving the day. This made her feel loved, accepted, even understood.\u003c/p>\n\u003cp>[contextly_sidebar id=\"PN5qpfkUkdC6IDaS53jvI12s3Nkk5Y8D\"]M began to realize her daydreaming was not normal when her mother yelled at her and asked her why she was moving her lips. So she kept up her daydreaming in secret, hiding from friends at school, pretending to read a book, plugging in earphones to make it appear as if she was listening to music.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Then one day by chance, M met with a former classmate who drew her out. They fell in love, married and had a child, and for a while, the daydreams subsided.\u003c/p>\n\u003cp>But as life became more middle-class and mundane — dishwasher unloading, toothpaste in the sink — she found herself sneaking back into a world where she was the hero, the boss and every character in between.\u003c/p>\n\u003cp>[contextly_sidebar id=\"0rxdI3CFoOWSBss3ToB6u1S84tVyjhnE\"]M worries that she has a newly diagnosed condition known as \u003ca href=\"https://www.healthline.com/health/mental-health/maladaptive-daydreaming#complications\" target=\"_blank\" rel=\"noopener\">maladaptive daydreaming\u003c/a>. Now, it's not in the mental health bible, aka the \u003cem>Diagnostic and Statistical Manual of Mental Disorders,\u003c/em> and doctors don't know what causes it. There's no official treatment, although \u003ca href=\"https://www.ncbi.nlm.nih.gov/pubmed/19062309\" target=\"_blank\" rel=\"noopener\">one case study\u003c/a> suggests fluvoxamine, an OCD drug, may help control the daydreams.\u003c/p>\n\u003cp>Whatever maladaptive daydreaming is, it can have real effects on a person's daily life. People who say they have the condition report having trouble making friends or even leaving the house. M worries she is one of them. She carves out time to daydream away from her husband and son who know nothing of her secret life. In fact, she says she has never told anyone about it.\u003c/p>\n\u003cp>M loves her never-ending story, yet she acknowledges her secret is isolating.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\"As much as I hate the feeling of being torn and being in two places, I'm not ready to give up my daydreaming and I'm not ready to give up my characters and the feelings that those daydreams give me,\" she says.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Invisibilia%3A+When+Daydreaming+Gets+In+The+Way+Of+Real+Life&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "440672 https://ww2.kqed.org/futureofyou/?p=440672",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/04/06/when-daydreaming-gets-in-the-way-of-real-life/",
"stats": {
"hasVideo": true,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 468,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 13
},
"modified": 1523035260,
"excerpt": "An inside look at 'maladaptive daydreaming,' a newly diagnosed condition that can disrupt actual life.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "An inside look at 'maladaptive daydreaming,' a newly diagnosed condition that can disrupt actual life.",
"title": "When Daydreaming Gets In The Way Of Real Life | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "When Daydreaming Gets In The Way Of Real Life",
"datePublished": "2018-04-06T10:17:47-07:00",
"dateModified": "2018-04-06T10:21:00-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "when-daydreaming-gets-in-the-way-of-real-life",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=598365217&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Meredith Rizzo\u003cbr />NPR Shots",
"nprStoryDate": "Thu, 05 Apr 2018 08:00:00 -0400",
"nprLastModifiedDate": "Fri, 06 Apr 2018 10:35:30 -0400",
"nprHtmlLink": "https://www.npr.org/sections/health-shots/2018/04/05/598365217/invisibilia-when-daydreaming-gets-in-the-way-of-real-life?ft=nprml&f=598365217",
"nprAudio": "https://ondemand.npr.org/anon.npr-mp3/npr/invsb/2018/04/20180405_invsb_in_between.mp3?orgId=1&topicId=1128&d=2924&story=598365217&ft=nprml&f=598365217",
"nprImageAgency": "Lily Padula for NPR",
"source": "Health",
"nprAudioM3u": "http://api.npr.org/m3u/1600120047-b0e1d6.m3u?orgId=1&topicId=1128&d=2924&story=598365217&ft=nprml&f=598365217",
"nprStoryId": "598365217",
"nprRetrievedStory": "1",
"nprPubDate": "Fri, 06 Apr 2018 10:35:00 -0400",
"path": "/futureofyou/440672/when-daydreaming-gets-in-the-way-of-real-life",
"audioUrl": "https://ondemand.npr.org/anon.npr-mp3/npr/invsb/2018/04/20180405_invsb_in_between.mp3?orgId=1&topicId=1128&d=2924&story=598365217&ft=nprml&f=598365217",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003ciframe width=\"640\" height=\"360\" src=\"https://www.youtube.com/embed/ckYSydGYKRU?feature=oembed\" frameborder=\"0\" allow=\"autoplay; encrypted-media\" allowfullscreen>\u003c/iframe>\u003c/p>\n\u003cp>\u003cem>Welcome to \u003c/em>Invisibilia\u003cem> Season 4! The NPR program and \u003c/em>\u003ca href=\"http://www.npr.org/podcasts/510307/invisibilia\" target=\"_blank\" rel=\"noopener\">podcast\u003c/a>\u003cem> explores the invisible forces that shape human behavior, and we here at Shots are joining in to probe the science of why we act the way we do. In Episode 5, they're investigating how it feels to live \"in between,\" to be in two worlds at once. In the episode, and in the animation above, we meet M, a woman who worries that her intense daydreaming is interfering with her actual life.\u003c/em>\u003c/p>\n\u003cp>The story of M begins innocently enough. She was a girl who felt isolated and misunderstood, so she began spending hours at a time on the swings in her backyard, daydreaming.\u003c/p>\n\u003cp>She imagined herself as many characters, blasting off to other planets, fighting crime and just generally saving the day. This made her feel loved, accepted, even understood.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>M began to realize her daydreaming was not normal when her mother yelled at her and asked her why she was moving her lips. So she kept up her daydreaming in secret, hiding from friends at school, pretending to read a book, plugging in earphones to make it appear as if she was listening to music.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Then one day by chance, M met with a former classmate who drew her out. They fell in love, married and had a child, and for a while, the daydreams subsided.\u003c/p>\n\u003cp>But as life became more middle-class and mundane — dishwasher unloading, toothpaste in the sink — she found herself sneaking back into a world where she was the hero, the boss and every character in between.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>M worries that she has a newly diagnosed condition known as \u003ca href=\"https://www.healthline.com/health/mental-health/maladaptive-daydreaming#complications\" target=\"_blank\" rel=\"noopener\">maladaptive daydreaming\u003c/a>. Now, it's not in the mental health bible, aka the \u003cem>Diagnostic and Statistical Manual of Mental Disorders,\u003c/em> and doctors don't know what causes it. There's no official treatment, although \u003ca href=\"https://www.ncbi.nlm.nih.gov/pubmed/19062309\" target=\"_blank\" rel=\"noopener\">one case study\u003c/a> suggests fluvoxamine, an OCD drug, may help control the daydreams.\u003c/p>\n\u003cp>Whatever maladaptive daydreaming is, it can have real effects on a person's daily life. People who say they have the condition report having trouble making friends or even leaving the house. M worries she is one of them. She carves out time to daydream away from her husband and son who know nothing of her secret life. In fact, she says she has never told anyone about it.\u003c/p>\n\u003cp>M loves her never-ending story, yet she acknowledges her secret is isolating.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\"As much as I hate the feeling of being torn and being in two places, I'm not ready to give up my daydreaming and I'm not ready to give up my characters and the feelings that those daydreams give me,\" she says.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Invisibilia%3A+When+Daydreaming+Gets+In+The+Way+Of+Real+Life&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/440672/when-daydreaming-gets-in-the-way-of-real-life",
"authors": [
"byline_futureofyou_440672"
],
"categories": [
"futureofyou_1060",
"futureofyou_1"
],
"tags": [
"futureofyou_56",
"futureofyou_61",
"futureofyou_204",
"futureofyou_1224"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_440673",
"label": "source_futureofyou_440672"
},
"futureofyou_440512": {
"type": "posts",
"id": "futureofyou_440512",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "440512",
"score": null,
"sort": [
1522179023000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1522179023,
"format": "standard",
"disqusTitle": "Antibiotic Resistance is Globally On the Rise, Raising Alarms",
"title": "Antibiotic Resistance is Globally On the Rise, Raising Alarms",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>The development of antibiotics in the middle of the 20th century was one of the greatest achievements of modern medicine. Penicillin and its pharmaceutical cousins \u003ca href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/\" target=\"_blank\" rel=\"noopener\">saved millions\u003c/a> of lives. But like a magic potion given to the world by a stern fairy, antibiotics come with a catch — If you abuse them, you lose them.\u003c/p>\n\u003cp>For decades, scientists have been \u003ca href=\"https://www.kqed.org/futureofyou/100905/superbugs\" target=\"_blank\" rel=\"noopener\">warning that antibiotic resistance\u003c/a> is on the rise globally because of misuse of the drugs.\u003c/p>\n\u003cp>But a new report makes it clear that the world is not listening.[contextly_sidebar id=\"KJZOa7uMNIN4ArNMyMOA5manjU869PnC\"]\u003c/p>\n\u003cp>Between the year 2000 and 2015 human consumption of antibiotics globally rose 65 percent — to an astounding 42 billion doses a year. \"We wanted to examine global use of antibiotics because once resistance emerges in one place it can spread anywhere,\" says Eili Klein, a fellow at the Center for Disease Dynamics, Economics and Policy in Washington and the lead author of the new report, which was published Monday in the \u003ca href=\"http://www.pnas.org/content/early/2018/03/20/1717295115\" target=\"_blank\" rel=\"noopener\">Proceedings of the National Academy of Sciences\u003c/a>.\u003c/p>\n\u003cp>Along with his colleagues Klein found that there was a dramatic rise in antibiotic use over the last 15 years in low- and middle-income countries.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\"A place like India, which has one of the highest populations in the world, saw enormous gains in antibiotic use both overall and on a per capita gain basis,\" says Klein.[contextly_sidebar id=\"SmtZzzk0FHpRcMcZ48thm4EPcrSnAjnT\"]\u003c/p>\n\u003cp>Antibiotic use more than doubled in India between the year 2000 and 2015. It was up 79 percent in China and 65 percent in Pakistan. Some of that increase was due to population growth but it wasn't just that. Overall sales were up.\u003c/p>\n\u003cp>So the report makes it clear that the average person in India, China or Pakistan is taking far more antibiotics now than they were a decade and half ago.\u003c/p>\n\u003cp>Western countries didn't see the sharp rise in antibiotics but they also failed to cut overall consumption.\u003c/p>\n\u003cp>\"In high-income countries reducing inappropriate use has not really ... in most countries ... driven down per capita use rates in the last 15 years,\" Klein says.\u003c/p>\n\u003cp>Lance Price, director of the Antibiotic Resistance Action Center at George Washington University, is concerned about this increase in antibiotic use.[contextly_sidebar id=\"lnBKX8143Mq00xj3zZD6AuQQqZq3rGIR\"]\u003c/p>\n\u003cp>\"The biggest driver for the evolution of superbugs is the use of antibiotics,\" Price says. Every time a bacteria is exposed to an antibiotic but isn't killed by it, it has the potential to develop resistance. The evolutionary math is fairly simple. \"The more we use antibiotics,\" he explains, \"the more we are going to encourage the growth of these bacteria that are resistant to them.\"\u003c/p>\n\u003cp>Hospitals around the world increasingly have been reporting bacterial infections that don't respond to traditional antibiotics.\u003c/p>\n\u003cp>\"Then you have these extreme cases like the woman [in Nevada] just about a year ago who died of an infection that was resistant to 26 different antibiotics,\" Price says. \"So the bacteria are out there that are resistant to everything, and they are becoming more and more prevalent.\"\u003c/p>\n\u003cp>Health officials worry about so much growth in antibiotic use in low- and middle-income countries because these drugs are often available there without a prescription. So the potential for misuse is high. Also Price notes that poor sanitation in impoverished nations adds to the problem. If a superbug develops in a patient who only has access to an outhouse, that bug is far more likely to spread into the local water supply than if that patient had access to a toilet connected to a sewage treatment plant.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>So the antibiotic fairy is not happy: If we don't change our ways she's going to slowly make the potion less and less powerful until one day it disappears.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Surge+In+Antibiotics+Is+A+Boon+For+Superbugs&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "440512 https://ww2.kqed.org/futureofyou/?p=440512",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2018/03/27/antibiotic-resistance-is-globally-on-the-rise-raising-alarms/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 636,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 18
},
"modified": 1522179023,
"excerpt": "Hospitals around the world are reporting bacterial infections that don't respond to routine antibiotics.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Hospitals around the world are reporting bacterial infections that don't respond to routine antibiotics.",
"title": "Antibiotic Resistance is Globally On the Rise, Raising Alarms | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Antibiotic Resistance is Globally On the Rise, Raising Alarms",
"datePublished": "2018-03-27T12:30:23-07:00",
"dateModified": "2018-03-27T12:30:23-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "antibiotic-resistance-is-globally-on-the-rise-raising-alarms",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=597014559&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprStoryDate": "Mon, 26 Mar 2018 18:04:38 -0400",
"nprLastModifiedDate": "Mon, 26 Mar 2018 18:04:38 -0400",
"nprHtmlLink": "https://www.npr.org/sections/goatsandsoda/2018/03/26/597014559/surge-in-antibiotics-is-a-boon-for-superbugs?ft=nprml&f=597014559",
"nprAudio": "https://ondemand.npr.org/anon.npr-mp3/npr/atc/2018/03/20180326_atc_antiobiotic_use_is_skyrocketing.mp3?orgId=1&topicId=1001&d=191&p=2&story=597014559&ft=nprml&f=597014559",
"nprImageAgency": "NPR",
"source": "Health",
"nprAudioM3u": "http://api.npr.org/m3u/1597100833-ae8218.m3u?orgId=1&topicId=1001&d=191&p=2&story=597014559&ft=nprml&f=597014559",
"nprStoryId": "597014559",
"nprByline": "Jason Beaubien\u003cbr />NPR Goats and Soda",
"nprImageCredit": "Katie Park",
"nprRetrievedStory": "1",
"nprPubDate": "Mon, 26 Mar 2018 21:49:00 -0400",
"path": "/futureofyou/440512/antibiotic-resistance-is-globally-on-the-rise-raising-alarms",
"audioUrl": "https://ondemand.npr.org/anon.npr-mp3/npr/atc/2018/03/20180326_atc_antiobiotic_use_is_skyrocketing.mp3?orgId=1&topicId=1001&d=191&p=2&story=597014559&ft=nprml&f=597014559",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>The development of antibiotics in the middle of the 20th century was one of the greatest achievements of modern medicine. Penicillin and its pharmaceutical cousins \u003ca href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/\" target=\"_blank\" rel=\"noopener\">saved millions\u003c/a> of lives. But like a magic potion given to the world by a stern fairy, antibiotics come with a catch — If you abuse them, you lose them.\u003c/p>\n\u003cp>For decades, scientists have been \u003ca href=\"https://www.kqed.org/futureofyou/100905/superbugs\" target=\"_blank\" rel=\"noopener\">warning that antibiotic resistance\u003c/a> is on the rise globally because of misuse of the drugs.\u003c/p>\n\u003cp>But a new report makes it clear that the world is not listening.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Between the year 2000 and 2015 human consumption of antibiotics globally rose 65 percent — to an astounding 42 billion doses a year. \"We wanted to examine global use of antibiotics because once resistance emerges in one place it can spread anywhere,\" says Eili Klein, a fellow at the Center for Disease Dynamics, Economics and Policy in Washington and the lead author of the new report, which was published Monday in the \u003ca href=\"http://www.pnas.org/content/early/2018/03/20/1717295115\" target=\"_blank\" rel=\"noopener\">Proceedings of the National Academy of Sciences\u003c/a>.\u003c/p>\n\u003cp>Along with his colleagues Klein found that there was a dramatic rise in antibiotic use over the last 15 years in low- and middle-income countries.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\"A place like India, which has one of the highest populations in the world, saw enormous gains in antibiotic use both overall and on a per capita gain basis,\" says Klein.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Antibiotic use more than doubled in India between the year 2000 and 2015. It was up 79 percent in China and 65 percent in Pakistan. Some of that increase was due to population growth but it wasn't just that. Overall sales were up.\u003c/p>\n\u003cp>So the report makes it clear that the average person in India, China or Pakistan is taking far more antibiotics now than they were a decade and half ago.\u003c/p>\n\u003cp>Western countries didn't see the sharp rise in antibiotics but they also failed to cut overall consumption.\u003c/p>\n\u003cp>\"In high-income countries reducing inappropriate use has not really ... in most countries ... driven down per capita use rates in the last 15 years,\" Klein says.\u003c/p>\n\u003cp>Lance Price, director of the Antibiotic Resistance Action Center at George Washington University, is concerned about this increase in antibiotic use.\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\"The biggest driver for the evolution of superbugs is the use of antibiotics,\" Price says. Every time a bacteria is exposed to an antibiotic but isn't killed by it, it has the potential to develop resistance. The evolutionary math is fairly simple. \"The more we use antibiotics,\" he explains, \"the more we are going to encourage the growth of these bacteria that are resistant to them.\"\u003c/p>\n\u003cp>Hospitals around the world increasingly have been reporting bacterial infections that don't respond to traditional antibiotics.\u003c/p>\n\u003cp>\"Then you have these extreme cases like the woman [in Nevada] just about a year ago who died of an infection that was resistant to 26 different antibiotics,\" Price says. \"So the bacteria are out there that are resistant to everything, and they are becoming more and more prevalent.\"\u003c/p>\n\u003cp>Health officials worry about so much growth in antibiotic use in low- and middle-income countries because these drugs are often available there without a prescription. So the potential for misuse is high. Also Price notes that poor sanitation in impoverished nations adds to the problem. If a superbug develops in a patient who only has access to an outhouse, that bug is far more likely to spread into the local water supply than if that patient had access to a toilet connected to a sewage treatment plant.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>So the antibiotic fairy is not happy: If we don't change our ways she's going to slowly make the potion less and less powerful until one day it disappears.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2018 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Surge+In+Antibiotics+Is+A+Boon+For+Superbugs&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/440512/antibiotic-resistance-is-globally-on-the-rise-raising-alarms",
"authors": [
"byline_futureofyou_440512"
],
"categories": [
"futureofyou_1060",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_1184",
"futureofyou_952",
"futureofyou_61",
"futureofyou_177",
"futureofyou_173"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_440513",
"label": "source_futureofyou_440512"
}
},
"podcastsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"podcasts": {}
},
"radioProgramsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"radioPrograms": {}
},
"radioSearchSegmentsReducer": {},
"programsReducer": {
"all-things-considered": {
"id": "all-things-considered",
"title": "All Things Considered",
"info": "Every weekday, \u003cem>All Things Considered\u003c/em> hosts Robert Siegel, Audie Cornish, Ari Shapiro, and Kelly McEvers present the program's trademark mix of news, interviews, commentaries, reviews, and offbeat features. Michel Martin hosts on the weekends.",
"airtime": "MON-FRI 1pm-2pm, 4:30pm-6:30pm\u003cbr />SAT-SUN 5pm-6pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/All-Things-Considered-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/all-things-considered/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/all-things-considered"
},
"american-suburb-podcast": {
"id": "american-suburb-podcast",
"title": "American Suburb: The Podcast",
"tagline": "The flip side of gentrification, told through one town",
"info": "Gentrification is changing cities across America, forcing people from neighborhoods they have long called home. Call them the displaced. Now those priced out of the Bay Area are looking for a better life in an unlikely place. American Suburb follows this migration to one California town along the Delta, 45 miles from San Francisco. But is this once sleepy suburb ready for them?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/American-Suburb-Podcast-Tile-703x703-1.jpg",
"officialWebsiteLink": "/news/series/american-suburb-podcast",
"meta": {
"site": "news",
"source": "kqed",
"order": 19
},
"link": "/news/series/american-suburb-podcast/",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/RBrW",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=1287748328",
"tuneIn": "https://tunein.com/radio/American-Suburb-p1086805/",
"rss": "https://ww2.kqed.org/news/series/american-suburb-podcast/feed/podcast",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMzMDExODgxNjA5"
}
},
"baycurious": {
"id": "baycurious",
"title": "Bay Curious",
"tagline": "Exploring the Bay Area, one question at a time",
"info": "KQED’s new podcast, Bay Curious, gets to the bottom of the mysteries — both profound and peculiar — that give the Bay Area its unique identity. And we’ll do it with your help! You ask the questions. You decide what Bay Curious investigates. And you join us on the journey to find the answers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Bay-Curious-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Bay Curious",
"officialWebsiteLink": "/news/series/baycurious",
"meta": {
"site": "news",
"source": "kqed",
"order": 3
},
"link": "/podcasts/baycurious",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/bay-curious/id1172473406",
"npr": "https://www.npr.org/podcasts/500557090/bay-curious",
"rss": "https://ww2.kqed.org/news/category/bay-curious-podcast/feed/podcast",
"amazon": "https://music.amazon.com/podcasts/9a90d476-aa04-455d-9a4c-0871ed6216d4/bay-curious",
"stitcher": "https://www.stitcher.com/podcast/kqed/bay-curious",
"spotify": "https://open.spotify.com/show/6O76IdmhixfijmhTZLIJ8k"
}
},
"bbc-world-service": {
"id": "bbc-world-service",
"title": "BBC World Service",
"info": "The day's top stories from BBC News compiled twice daily in the week, once at weekends.",
"airtime": "MON-FRI 9pm-10pm, TUE-FRI 1am-2am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/BBC-World-Service-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.bbc.co.uk/sounds/play/live:bbc_world_service",
"meta": {
"site": "news",
"source": "BBC World Service"
},
"link": "/radio/program/bbc-world-service",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/global-news-podcast/id135067274?mt=2",
"tuneIn": "https://tunein.com/radio/BBC-World-Service-p455581/",
"rss": "https://podcasts.files.bbci.co.uk/p02nq0gn.rss"
}
},
"californiareport": {
"id": "californiareport",
"title": "The California Report",
"tagline": "California, day by day",
"info": "KQED’s statewide radio news program providing daily coverage of issues, trends and public policy decisions.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report",
"officialWebsiteLink": "/californiareport",
"meta": {
"site": "news",
"source": "kqed",
"order": 8
},
"link": "/californiareport",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-the-california-report/id79681292",
"amazon": "https://music.amazon.com/podcasts/26099305-72af-4542-9dde-ac1807fe36d5/kqed-s-the-california-report",
"npr": "https://www.npr.org/podcasts/432285393/the-california-report",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-the-california-report-podcast-8838",
"rss": "https://ww2.kqed.org/news/tag/tcram/feed/podcast"
}
},
"californiareportmagazine": {
"id": "californiareportmagazine",
"title": "The California Report Magazine",
"tagline": "Your state, your stories",
"info": "Every week, The California Report Magazine takes you on a road trip for the ears: to visit the places and meet the people who make California unique. The in-depth storytelling podcast from the California Report.",
"airtime": "FRI 4:30pm-5pm, 6:30pm-7pm, 11pm-11:30pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Magazine-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report Magazine",
"officialWebsiteLink": "/californiareportmagazine",
"meta": {
"site": "news",
"source": "kqed",
"order": 10
},
"link": "/californiareportmagazine",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-california-report-magazine/id1314750545",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM3NjkwNjk1OTAz",
"npr": "https://www.npr.org/podcasts/564733126/the-california-report-magazine",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-california-report-magazine",
"rss": "https://ww2.kqed.org/news/tag/tcrmag/feed/podcast"
}
},
"city-arts": {
"id": "city-arts",
"title": "City Arts & Lectures",
"info": "A one-hour radio program to hear celebrated writers, artists and thinkers address contemporary ideas and values, often discussing the creative process. Please note: tapes or transcripts are not available",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/cityartsandlecture-300x300.jpg",
"officialWebsiteLink": "https://www.cityarts.net/",
"airtime": "SUN 1pm-2pm, TUE 10pm, WED 1am",
"meta": {
"site": "news",
"source": "City Arts & Lectures"
},
"link": "https://www.cityarts.net",
"subscribe": {
"tuneIn": "https://tunein.com/radio/City-Arts-and-Lectures-p692/",
"rss": "https://www.cityarts.net/feed/"
}
},
"closealltabs": {
"id": "closealltabs",
"title": "Close All Tabs",
"tagline": "Your irreverent guide to the trends redefining our world",
"info": "Close All Tabs breaks down how digital culture shapes our world through thoughtful insights and irreverent humor.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/02/CAT_2_Tile-scaled.jpg",
"imageAlt": "KQED Close All Tabs",
"officialWebsiteLink": "/podcasts/closealltabs",
"meta": {
"site": "news",
"source": "kqed",
"order": 1
},
"link": "/podcasts/closealltabs",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/close-all-tabs/id214663465",
"rss": "https://feeds.megaphone.fm/KQINC6993880386",
"amazon": "https://music.amazon.com/podcasts/92d9d4ac-67a3-4eed-b10a-fb45d45b1ef2/close-all-tabs",
"spotify": "https://open.spotify.com/show/6LAJFHnGK1pYXYzv6SIol6?si=deb0cae19813417c"
}
},
"code-switch-life-kit": {
"id": "code-switch-life-kit",
"title": "Code Switch / Life Kit",
"info": "\u003cem>Code Switch\u003c/em>, which listeners will hear in the first part of the hour, has fearless and much-needed conversations about race. Hosted by journalists of color, the show tackles the subject of race head-on, exploring how it impacts every part of society — from politics and pop culture to history, sports and more.\u003cbr />\u003cbr />\u003cem>Life Kit\u003c/em>, which will be in the second part of the hour, guides you through spaces and feelings no one prepares you for — from finances to mental health, from workplace microaggressions to imposter syndrome, from relationships to parenting. The show features experts with real world experience and shares their knowledge. Because everyone needs a little help being human.\u003cbr />\u003cbr />\u003ca href=\"https://www.npr.org/podcasts/510312/codeswitch\">\u003cem>Code Switch\u003c/em> offical site and podcast\u003c/a>\u003cbr />\u003ca href=\"https://www.npr.org/lifekit\">\u003cem>Life Kit\u003c/em> offical site and podcast\u003c/a>\u003cbr />",
"airtime": "SUN 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Code-Switch-Life-Kit-Podcast-Tile-360x360-1.jpg",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/code-switch-life-kit",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/1112190608?mt=2&at=11l79Y&ct=nprdirectory",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93d3cubnByLm9yZy9yc3MvcG9kY2FzdC5waHA_aWQ9NTEwMzEy",
"spotify": "https://open.spotify.com/show/3bExJ9JQpkwNhoHvaIIuyV",
"rss": "https://feeds.npr.org/510312/podcast.xml"
}
},
"commonwealth-club": {
"id": "commonwealth-club",
"title": "Commonwealth Club of California Podcast",
"info": "The Commonwealth Club of California is the nation's oldest and largest public affairs forum. As a non-partisan forum, The Club brings to the public airwaves diverse viewpoints on important topics. The Club's weekly radio broadcast - the oldest in the U.S., dating back to 1924 - is carried across the nation on public radio stations and is now podcasting. Our website archive features audio of our recent programs, as well as selected speeches from our long and distinguished history. This podcast feed is usually updated twice a week and is always un-edited.",
"airtime": "THU 10pm, FRI 1am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Commonwealth-Club-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.commonwealthclub.org/podcasts",
"meta": {
"site": "news",
"source": "Commonwealth Club of California"
},
"link": "/radio/program/commonwealth-club",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/commonwealth-club-of-california-podcast/id976334034?mt=2",
"google": "https://podcasts.google.com/feed/aHR0cDovL3d3dy5jb21tb253ZWFsdGhjbHViLm9yZy9hdWRpby9wb2RjYXN0L3dlZWtseS54bWw",
"tuneIn": "https://tunein.com/radio/Commonwealth-Club-of-California-p1060/"
}
},
"forum": {
"id": "forum",
"title": "Forum",
"tagline": "The conversation starts here",
"info": "KQED’s live call-in program discussing local, state, national and international issues, as well as in-depth interviews.",
"airtime": "MON-FRI 9am-11am, 10pm-11pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Forum-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Forum with Mina Kim and Alexis Madrigal",
"officialWebsiteLink": "/forum",
"meta": {
"site": "news",
"source": "kqed",
"order": 9
},
"link": "/forum",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-forum/id73329719",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM5NTU3MzgxNjMz",
"npr": "https://www.npr.org/podcasts/432307980/forum",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-forum-podcast",
"rss": "https://feeds.megaphone.fm/KQINC9557381633"
}
},
"freakonomics-radio": {
"id": "freakonomics-radio",
"title": "Freakonomics Radio",
"info": "Freakonomics Radio is a one-hour award-winning podcast and public-radio project hosted by Stephen Dubner, with co-author Steve Levitt as a regular guest. It is produced in partnership with WNYC.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/freakonomicsRadio.png",
"officialWebsiteLink": "http://freakonomics.com/",
"airtime": "SUN 1am-2am, SAT 3pm-4pm",
"meta": {
"site": "radio",
"source": "WNYC"
},
"link": "/radio/program/freakonomics-radio",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/us/podcast/freakonomics-radio/id354668519",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/Freakonomics-Radio-p272293/",
"rss": "https://feeds.feedburner.com/freakonomicsradio"
}
},
"fresh-air": {
"id": "fresh-air",
"title": "Fresh Air",
"info": "Hosted by Terry Gross, \u003cem>Fresh Air from WHYY\u003c/em> is the Peabody Award-winning weekday magazine of contemporary arts and issues. One of public radio's most popular programs, Fresh Air features intimate conversations with today's biggest luminaries.",
"airtime": "MON-FRI 7pm-8pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Fresh-Air-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/fresh-air/",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/fresh-air",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=214089682&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Fresh-Air-p17/",
"rss": "https://feeds.npr.org/381444908/podcast.xml"
}
},
"here-and-now": {
"id": "here-and-now",
"title": "Here & Now",
"info": "A live production of NPR and WBUR Boston, in collaboration with stations across the country, Here & Now reflects the fluid world of news as it's happening in the middle of the day, with timely, in-depth news, interviews and conversation. Hosted by Robin Young, Jeremy Hobson and Tonya Mosley.",
"airtime": "MON-THU 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Here-And-Now-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://www.wbur.org/hereandnow",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/here-and-now",
"subsdcribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=426698661",
"tuneIn": "https://tunein.com/radio/Here--Now-p211/",
"rss": "https://feeds.npr.org/510051/podcast.xml"
}
},
"hidden-brain": {
"id": "hidden-brain",
"title": "Hidden Brain",
"info": "Shankar Vedantam uses science and storytelling to reveal the unconscious patterns that drive human behavior, shape our choices and direct our relationships.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/hiddenbrain.jpg",
"officialWebsiteLink": "https://www.npr.org/series/423302056/hidden-brain",
"airtime": "SUN 7pm-8pm",
"meta": {
"site": "news",
"source": "NPR"
},
"link": "/radio/program/hidden-brain",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/hidden-brain/id1028908750?mt=2",
"tuneIn": "https://tunein.com/podcasts/Science-Podcasts/Hidden-Brain-p787503/",
"rss": "https://feeds.npr.org/510308/podcast.xml"
}
},
"how-i-built-this": {
"id": "how-i-built-this",
"title": "How I Built This with Guy Raz",
"info": "Guy Raz dives into the stories behind some of the world's best known companies. How I Built This weaves a narrative journey about innovators, entrepreneurs and idealists—and the movements they built.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/howIBuiltThis.png",
"officialWebsiteLink": "https://www.npr.org/podcasts/510313/how-i-built-this",
"airtime": "SUN 7:30pm-8pm",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/how-i-built-this",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/3zxy",
"apple": "https://itunes.apple.com/us/podcast/how-i-built-this-with-guy-raz/id1150510297?mt=2",
"tuneIn": "https://tunein.com/podcasts/Arts--Culture-Podcasts/How-I-Built-This-p910896/",
"rss": "https://feeds.npr.org/510313/podcast.xml"
}
},
"hyphenacion": {
"id": "hyphenacion",
"title": "Hyphenación",
"tagline": "Where conversation and cultura meet",
"info": "What kind of no sabo word is Hyphenación? For us, it’s about living within a hyphenation. Like being a third-gen Mexican-American from the Texas border now living that Bay Area Chicano life. Like Xorje! Each week we bring together a couple of hyphenated Latinos to talk all about personal life choices: family, careers, relationships, belonging … everything is on the table. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/03/Hyphenacion_FinalAssets_PodcastTile.png",
"imageAlt": "KQED Hyphenación",
"officialWebsiteLink": "/podcasts/hyphenacion",
"meta": {
"site": "news",
"source": "kqed",
"order": 15
},
"link": "/podcasts/hyphenacion",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/hyphenaci%C3%B3n/id1191591838",
"spotify": "https://open.spotify.com/show/2p3Fifq96nw9BPcmFdIq0o?si=39209f7b25774f38",
"youtube": "https://www.youtube.com/c/kqedarts",
"amazon": "https://music.amazon.com/podcasts/6c3dd23c-93fb-4aab-97ba-1725fa6315f1/hyphenaci%C3%B3n",
"rss": "https://feeds.megaphone.fm/KQINC2275451163"
}
},
"jerrybrown": {
"id": "jerrybrown",
"title": "The Political Mind of Jerry Brown",
"tagline": "Lessons from a lifetime in politics",
"info": "The Political Mind of Jerry Brown brings listeners the wisdom of the former Governor, Mayor, and presidential candidate. Scott Shafer interviewed Brown for more than 40 hours, covering the former governor's life and half-century in the political game – and Brown has some lessons he'd like to share. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Political-Mind-of-Jerry-Brown-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Political Mind of Jerry Brown",
"officialWebsiteLink": "/podcasts/jerrybrown",
"meta": {
"site": "news",
"source": "kqed",
"order": 18
},
"link": "/podcasts/jerrybrown",
"subscribe": {
"npr": "https://www.npr.org/podcasts/790253322/the-political-mind-of-jerry-brown",
"apple": "https://itunes.apple.com/us/podcast/id1492194549",
"rss": "https://ww2.kqed.org/news/series/jerrybrown/feed/podcast/",
"tuneIn": "http://tun.in/pjGcK",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-political-mind-of-jerry-brown",
"spotify": "https://open.spotify.com/show/54C1dmuyFyKMFttY6X2j6r?si=K8SgRCoISNK6ZbjpXrX5-w",
"amazon": "https://music.amazon.com/podcasts/44420f75-3b0e-4301-ab3b-16da6b09e543/the-political-mind-of-jerry-brown"
}
},
"latino-usa": {
"id": "latino-usa",
"title": "Latino USA",
"airtime": "MON 1am-2am, SUN 6pm-7pm",
"info": "Latino USA, the radio journal of news and culture, is the only national, English-language radio program produced from a Latino perspective.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/latinoUsa.jpg",
"officialWebsiteLink": "http://latinousa.org/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/latino-usa",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/xtTd",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=79681317&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Latino-USA-p621/",
"rss": "https://feeds.npr.org/510016/podcast.xml"
}
},
"marketplace": {
"id": "marketplace",
"title": "Marketplace",
"info": "Our flagship program, helmed by Kai Ryssdal, examines what the day in money delivered, through stories, conversations, newsworthy numbers and more. Updated Monday through Friday at about 3:30 p.m. PT.",
"airtime": "MON-FRI 4pm-4:30pm, MON-WED 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Marketplace-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.marketplace.org/",
"meta": {
"site": "news",
"source": "American Public Media"
},
"link": "/radio/program/marketplace",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201853034&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/APM-Marketplace-p88/",
"rss": "https://feeds.publicradio.org/public_feeds/marketplace-pm/rss/rss"
}
},
"masters-of-scale": {
"id": "masters-of-scale",
"title": "Masters of Scale",
"info": "Masters of Scale is an original podcast in which LinkedIn co-founder and Greylock Partner Reid Hoffman sets out to describe and prove theories that explain how great entrepreneurs take their companies from zero to a gazillion in ingenious fashion.",
"airtime": "Every other Wednesday June 12 through October 16 at 8pm (repeats Thursdays at 2am)",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Masters-of-Scale-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://mastersofscale.com/",
"meta": {
"site": "radio",
"source": "WaitWhat"
},
"link": "/radio/program/masters-of-scale",
"subscribe": {
"apple": "http://mastersofscale.app.link/",
"rss": "https://rss.art19.com/masters-of-scale"
}
},
"mindshift": {
"id": "mindshift",
"title": "MindShift",
"tagline": "A podcast about the future of learning and how we raise our kids",
"info": "The MindShift podcast explores the innovations in education that are shaping how kids learn. Hosts Ki Sung and Katrina Schwartz introduce listeners to educators, researchers, parents and students who are developing effective ways to improve how kids learn. We cover topics like how fed-up administrators are developing surprising tactics to deal with classroom disruptions; how listening to podcasts are helping kids develop reading skills; the consequences of overparenting; and why interdisciplinary learning can engage students on all ends of the traditional achievement spectrum. This podcast is part of the MindShift education site, a division of KQED News. KQED is an NPR/PBS member station based in San Francisco. You can also visit the MindShift website for episodes and supplemental blog posts or tweet us \u003ca href=\"https://twitter.com/MindShiftKQED\">@MindShiftKQED\u003c/a> or visit us at \u003ca href=\"/mindshift\">MindShift.KQED.org\u003c/a>",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Mindshift-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED MindShift: How We Will Learn",
"officialWebsiteLink": "/mindshift/",
"meta": {
"site": "news",
"source": "kqed",
"order": 12
},
"link": "/podcasts/mindshift",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/mindshift-podcast/id1078765985",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM1NzY0NjAwNDI5",
"npr": "https://www.npr.org/podcasts/464615685/mind-shift-podcast",
"stitcher": "https://www.stitcher.com/podcast/kqed/stories-teachers-share",
"spotify": "https://open.spotify.com/show/0MxSpNYZKNprFLCl7eEtyx"
}
},
"morning-edition": {
"id": "morning-edition",
"title": "Morning Edition",
"info": "\u003cem>Morning Edition\u003c/em> takes listeners around the country and the world with multi-faceted stories and commentaries every weekday. Hosts Steve Inskeep, David Greene and Rachel Martin bring you the latest breaking news and features to prepare you for the day.",
"airtime": "MON-FRI 3am-9am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Morning-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/morning-edition/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/morning-edition"
},
"onourwatch": {
"id": "onourwatch",
"title": "On Our Watch",
"tagline": "Deeply-reported investigative journalism",
"info": "For decades, the process for how police police themselves has been inconsistent – if not opaque. In some states, like California, these proceedings were completely hidden. After a new police transparency law unsealed scores of internal affairs files, our reporters set out to examine these cases and the shadow world of police discipline. On Our Watch brings listeners into the rooms where officers are questioned and witnesses are interrogated to find out who this system is really protecting. Is it the officers, or the public they've sworn to serve?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/On-Our-Watch-Podcast-Tile-703x703-1.jpg",
"imageAlt": "On Our Watch from NPR and KQED",
"officialWebsiteLink": "/podcasts/onourwatch",
"meta": {
"site": "news",
"source": "kqed",
"order": 11
},
"link": "/podcasts/onourwatch",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/id1567098962",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5ucHIub3JnLzUxMDM2MC9wb2RjYXN0LnhtbD9zYz1nb29nbGVwb2RjYXN0cw",
"npr": "https://rpb3r.app.goo.gl/onourwatch",
"spotify": "https://open.spotify.com/show/0OLWoyizopu6tY1XiuX70x",
"tuneIn": "https://tunein.com/radio/On-Our-Watch-p1436229/",
"stitcher": "https://www.stitcher.com/show/on-our-watch",
"rss": "https://feeds.npr.org/510360/podcast.xml"
}
},
"on-the-media": {
"id": "on-the-media",
"title": "On The Media",
"info": "Our weekly podcast explores how the media 'sausage' is made, casts an incisive eye on fluctuations in the marketplace of ideas, and examines threats to the freedom of information and expression in America and abroad. For one hour a week, the show tries to lift the veil from the process of \"making media,\" especially news media, because it's through that lens that we see the world and the world sees us",
"airtime": "SUN 2pm-3pm, MON 12am-1am",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/onTheMedia.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/otm",
"meta": {
"site": "news",
"source": "wnyc"
},
"link": "/radio/program/on-the-media",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/on-the-media/id73330715?mt=2",
"tuneIn": "https://tunein.com/radio/On-the-Media-p69/",
"rss": "http://feeds.wnyc.org/onthemedia"
}
},
"pbs-newshour": {
"id": "pbs-newshour",
"title": "PBS NewsHour",
"info": "Analysis, background reports and updates from the PBS NewsHour putting today's news in context.",
"airtime": "MON-FRI 3pm-4pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/PBS-News-Hour-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pbs.org/newshour/",
"meta": {
"site": "news",
"source": "pbs"
},
"link": "/radio/program/pbs-newshour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pbs-newshour-full-show/id394432287?mt=2",
"tuneIn": "https://tunein.com/radio/PBS-NewsHour---Full-Show-p425698/",
"rss": "https://www.pbs.org/newshour/feeds/rss/podcasts/show"
}
},
"perspectives": {
"id": "perspectives",
"title": "Perspectives",
"tagline": "KQED's series of daily listener commentaries since 1991",
"info": "KQED's series of daily listener commentaries since 1991.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/01/Perspectives_Tile_Final.jpg",
"imageAlt": "KQED Perspectives",
"officialWebsiteLink": "/perspectives/",
"meta": {
"site": "radio",
"source": "kqed",
"order": 14
},
"link": "/perspectives",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/id73801135",
"npr": "https://www.npr.org/podcasts/432309616/perspectives",
"rss": "https://ww2.kqed.org/perspectives/category/perspectives/feed/",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93dzIua3FlZC5vcmcvcGVyc3BlY3RpdmVzL2NhdGVnb3J5L3BlcnNwZWN0aXZlcy9mZWVkLw"
}
},
"planet-money": {
"id": "planet-money",
"title": "Planet Money",
"info": "The economy explained. Imagine you could call up a friend and say, Meet me at the bar and tell me what's going on with the economy. Now imagine that's actually a fun evening.",
"airtime": "SUN 3pm-4pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/planetmoney.jpg",
"officialWebsiteLink": "https://www.npr.org/sections/money/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/planet-money",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/M4f5",
"apple": "https://itunes.apple.com/us/podcast/planet-money/id290783428?mt=2",
"tuneIn": "https://tunein.com/podcasts/Business--Economics-Podcasts/Planet-Money-p164680/",
"rss": "https://feeds.npr.org/510289/podcast.xml"
}
},
"politicalbreakdown": {
"id": "politicalbreakdown",
"title": "Political Breakdown",
"tagline": "Politics from a personal perspective",
"info": "Political Breakdown is a new series that explores the political intersection of California and the nation. Each week hosts Scott Shafer and Marisa Lagos are joined with a new special guest to unpack politics -- with personality — and offer an insider’s glimpse at how politics happens.",
"airtime": "THU 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Political-Breakdown-2024-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Political Breakdown",
"officialWebsiteLink": "/podcasts/politicalbreakdown",
"meta": {
"site": "radio",
"source": "kqed",
"order": 5
},
"link": "/podcasts/politicalbreakdown",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/political-breakdown/id1327641087",
"amazon": "https://music.amazon.com/podcasts/e0c2d153-ad36-4c8d-901d-f1da6a724824/political-breakdown",
"npr": "https://www.npr.org/podcasts/572155894/political-breakdown",
"stitcher": "https://www.stitcher.com/podcast/kqed/political-breakdown",
"spotify": "https://open.spotify.com/show/07RVyIjIdk2WDuVehvBMoN",
"rss": "https://ww2.kqed.org/news/tag/political-breakdown/feed/podcast"
}
},
"possible": {
"id": "possible",
"title": "Possible",
"info": "Possible is hosted by entrepreneur Reid Hoffman and writer Aria Finger. Together in Possible, Hoffman and Finger lead enlightening discussions about building a brighter collective future. The show features interviews with visionary guests like Trevor Noah, Sam Altman and Janette Sadik-Khan. Possible paints an optimistic portrait of the world we can create through science, policy, business, art and our shared humanity. It asks: What if everything goes right for once? How can we get there? Each episode also includes a short fiction story generated by advanced AI GPT-4, serving as a thought-provoking springboard to speculate how humanity could leverage technology for good.",
"airtime": "SUN 2pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Possible-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.possible.fm/",
"meta": {
"site": "news",
"source": "Possible"
},
"link": "/radio/program/possible",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/possible/id1677184070",
"spotify": "https://open.spotify.com/show/730YpdUSNlMyPQwNnyjp4k"
}
},
"pri-the-world": {
"id": "pri-the-world",
"title": "PRI's The World: Latest Edition",
"info": "Each weekday, host Marco Werman and his team of producers bring you the world's most interesting stories in an hour of radio that reminds us just how small our planet really is.",
"airtime": "MON-FRI 2pm-3pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-World-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pri.org/programs/the-world",
"meta": {
"site": "news",
"source": "PRI"
},
"link": "/radio/program/pri-the-world",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pris-the-world-latest-edition/id278196007?mt=2",
"tuneIn": "https://tunein.com/podcasts/News--Politics-Podcasts/PRIs-The-World-p24/",
"rss": "http://feeds.feedburner.com/pri/theworld"
}
},
"radiolab": {
"id": "radiolab",
"title": "Radiolab",
"info": "A two-time Peabody Award-winner, Radiolab is an investigation told through sounds and stories, and centered around one big idea. In the Radiolab world, information sounds like music and science and culture collide. Hosted by Jad Abumrad and Robert Krulwich, the show is designed for listeners who demand skepticism, but appreciate wonder. WNYC Studios is the producer of other leading podcasts including Freakonomics Radio, Death, Sex & Money, On the Media and many more.",
"airtime": "SUN 12am-1am, SAT 2pm-3pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/radiolab1400.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/radiolab/",
"meta": {
"site": "science",
"source": "WNYC"
},
"link": "/radio/program/radiolab",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/radiolab/id152249110?mt=2",
"tuneIn": "https://tunein.com/radio/RadioLab-p68032/",
"rss": "https://feeds.wnyc.org/radiolab"
}
},
"reveal": {
"id": "reveal",
"title": "Reveal",
"info": "Created by The Center for Investigative Reporting and PRX, Reveal is public radios first one-hour weekly radio show and podcast dedicated to investigative reporting. Credible, fact based and without a partisan agenda, Reveal combines the power and artistry of driveway moment storytelling with data-rich reporting on critically important issues. The result is stories that inform and inspire, arming our listeners with information to right injustices, hold the powerful accountable and improve lives.Reveal is hosted by Al Letson and showcases the award-winning work of CIR and newsrooms large and small across the nation. In a radio and podcast market crowded with choices, Reveal focuses on important and often surprising stories that illuminate the world for our listeners.",
"airtime": "SAT 4pm-5pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/reveal300px.png",
"officialWebsiteLink": "https://www.revealnews.org/episodes/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/reveal",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/reveal/id886009669",
"tuneIn": "https://tunein.com/radio/Reveal-p679597/",
"rss": "http://feeds.revealradio.org/revealpodcast"
}
},
"rightnowish": {
"id": "rightnowish",
"title": "Rightnowish",
"tagline": "Art is where you find it",
"info": "Rightnowish digs into life in the Bay Area right now… ish. Journalist Pendarvis Harshaw takes us to galleries painted on the sides of liquor stores in West Oakland. We'll dance in warehouses in the Bayview, make smoothies with kids in South Berkeley, and listen to classical music in a 1984 Cutlass Supreme in Richmond. Every week, Pen talks to movers and shakers about how the Bay Area shapes what they create, and how they shape the place we call home.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Rightnowish-Podcast-Tile-500x500-1.jpg",
"imageAlt": "KQED Rightnowish with Pendarvis Harshaw",
"officialWebsiteLink": "/podcasts/rightnowish",
"meta": {
"site": "arts",
"source": "kqed",
"order": 16
},
"link": "/podcasts/rightnowish",
"subscribe": {
"npr": "https://www.npr.org/podcasts/721590300/rightnowish",
"rss": "https://ww2.kqed.org/arts/programs/rightnowish/feed/podcast",
"apple": "https://podcasts.apple.com/us/podcast/rightnowish/id1482187648",
"stitcher": "https://www.stitcher.com/podcast/kqed/rightnowish",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMxMjU5MTY3NDc4",
"spotify": "https://open.spotify.com/show/7kEJuafTzTVan7B78ttz1I"
}
},
"science-friday": {
"id": "science-friday",
"title": "Science Friday",
"info": "Science Friday is a weekly science talk show, broadcast live over public radio stations nationwide. Each week, the show focuses on science topics that are in the news and tries to bring an educated, balanced discussion to bear on the scientific issues at hand. Panels of expert guests join host Ira Flatow, a veteran science journalist, to discuss science and to take questions from listeners during the call-in portion of the program.",
"airtime": "FRI 11am-1pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Science-Friday-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/science-friday",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/science-friday",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=73329284&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Science-Friday-p394/",
"rss": "http://feeds.wnyc.org/science-friday"
}
},
"snap-judgment": {
"id": "snap-judgment",
"title": "Snap Judgment",
"tagline": "Real stories with killer beats",
"info": "The Snap Judgment radio show and podcast mixes real stories with killer beats to produce cinematic, dramatic radio. Snap's musical brand of storytelling dares listeners to see the world through the eyes of another. This is storytelling... with a BEAT!! Snap first aired on public radio stations nationwide in July 2010. Today, Snap Judgment airs on over 450 public radio stations and is brought to the airwaves by KQED & PRX.",
"airtime": "SAT 1pm-2pm, 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/05/Snap-Judgment-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Snap Judgment",
"officialWebsiteLink": "https://snapjudgment.org",
"meta": {
"site": "arts",
"source": "kqed",
"order": 4
},
"link": "https://snapjudgment.org",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/snap-judgment/id283657561",
"npr": "https://www.npr.org/podcasts/449018144/snap-judgment",
"stitcher": "https://www.pandora.com/podcast/snap-judgment/PC:241?source=stitcher-sunset",
"spotify": "https://open.spotify.com/show/3Cct7ZWmxHNAtLgBTqjC5v",
"rss": "https://snap.feed.snapjudgment.org/"
}
},
"soldout": {
"id": "soldout",
"title": "SOLD OUT: Rethinking Housing in America",
"tagline": "A new future for housing",
"info": "Sold Out: Rethinking Housing in America",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Sold-Out-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Sold Out: Rethinking Housing in America",
"officialWebsiteLink": "/podcasts/soldout",
"meta": {
"site": "news",
"source": "kqed",
"order": 13
},
"link": "/podcasts/soldout",
"subscribe": {
"npr": "https://www.npr.org/podcasts/911586047/s-o-l-d-o-u-t-a-new-future-for-housing",
"apple": "https://podcasts.apple.com/us/podcast/introducing-sold-out-rethinking-housing-in-america/id1531354937",
"rss": "https://feeds.megaphone.fm/soldout",
"spotify": "https://open.spotify.com/show/38dTBSk2ISFoPiyYNoKn1X",
"stitcher": "https://www.stitcher.com/podcast/kqed/sold-out-rethinking-housing-in-america",
"tunein": "https://tunein.com/radio/SOLD-OUT-Rethinking-Housing-in-America-p1365871/"
}
},
"spooked": {
"id": "spooked",
"title": "Spooked",
"tagline": "True-life supernatural stories",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/10/Spooked-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Spooked",
"officialWebsiteLink": "https://spookedpodcast.org/",
"meta": {
"site": "news",
"source": "kqed",
"order": 7
},
"link": "https://spookedpodcast.org/",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/spooked/id1279361017",
"npr": "https://www.npr.org/podcasts/549547848/snap-judgment-presents-spooked",
"spotify": "https://open.spotify.com/show/76571Rfl3m7PLJQZKQIGCT",
"rss": "https://feeds.simplecast.com/TBotaapn"
}
},
"tech-nation": {
"id": "tech-nation",
"title": "Tech Nation Radio Podcast",
"info": "Tech Nation is a weekly public radio program, hosted by Dr. Moira Gunn. Founded in 1993, it has grown from a simple interview show to a multi-faceted production, featuring conversations with noted technology and science leaders, and a weekly science and technology-related commentary.",
"airtime": "FRI 10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Tech-Nation-Radio-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://technation.podomatic.com/",
"meta": {
"site": "science",
"source": "Tech Nation Media"
},
"link": "/radio/program/tech-nation",
"subscribe": {
"rss": "https://technation.podomatic.com/rss2.xml"
}
},
"ted-radio-hour": {
"id": "ted-radio-hour",
"title": "TED Radio Hour",
"info": "The TED Radio Hour is a journey through fascinating ideas, astonishing inventions, fresh approaches to old problems, and new ways to think and create.",
"airtime": "SUN 3pm-4pm, SAT 10pm-11pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/tedRadioHour.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/ted-radio-hour/?showDate=2018-06-22",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/ted-radio-hour",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/8vsS",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=523121474&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/TED-Radio-Hour-p418021/",
"rss": "https://feeds.npr.org/510298/podcast.xml"
}
},
"thebay": {
"id": "thebay",
"title": "The Bay",
"tagline": "Local news to keep you rooted",
"info": "Host Devin Katayama walks you through the biggest story of the day with reporters and newsmakers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Bay-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Bay",
"officialWebsiteLink": "/podcasts/thebay",
"meta": {
"site": "radio",
"source": "kqed",
"order": 2
},
"link": "/podcasts/thebay",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-bay/id1350043452",
"amazon": "https://music.amazon.com/podcasts/d800ea4c-7a2c-42f2-b861-edaf78a5db0b/the-bay",
"npr": "https://www.npr.org/podcasts/586725995/the-bay",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-bay",
"spotify": "https://open.spotify.com/show/4BIKBKIujizLHlIlBNaAqQ",
"rss": "https://feeds.megaphone.fm/KQINC8259786327"
}
},
"thelatest": {
"id": "thelatest",
"title": "The Latest",
"tagline": "Trusted local news in real time",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/05/The-Latest-2025-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Latest",
"officialWebsiteLink": "/thelatest",
"meta": {
"site": "news",
"source": "kqed",
"order": 6
},
"link": "/thelatest",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-latest-from-kqed/id1197721799",
"npr": "https://www.npr.org/podcasts/1257949365/the-latest-from-k-q-e-d",
"spotify": "https://open.spotify.com/show/5KIIXMgM9GTi5AepwOYvIZ?si=bd3053fec7244dba",
"rss": "https://feeds.megaphone.fm/KQINC9137121918"
}
},
"theleap": {
"id": "theleap",
"title": "The Leap",
"tagline": "What if you closed your eyes, and jumped?",
"info": "Stories about people making dramatic, risky changes, told by award-winning public radio reporter Judy Campbell.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Leap-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Leap",
"officialWebsiteLink": "/podcasts/theleap",
"meta": {
"site": "news",
"source": "kqed",
"order": 17
},
"link": "/podcasts/theleap",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-leap/id1046668171",
"npr": "https://www.npr.org/podcasts/447248267/the-leap",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-leap",
"spotify": "https://open.spotify.com/show/3sSlVHHzU0ytLwuGs1SD1U",
"rss": "https://ww2.kqed.org/news/programs/the-leap/feed/podcast"
}
},
"the-moth-radio-hour": {
"id": "the-moth-radio-hour",
"title": "The Moth Radio Hour",
"info": "Since its launch in 1997, The Moth has presented thousands of true stories, told live and without notes, to standing-room-only crowds worldwide. Moth storytellers stand alone, under a spotlight, with only a microphone and a roomful of strangers. The storyteller and the audience embark on a high-wire act of shared experience which is both terrifying and exhilarating. Since 2008, The Moth podcast has featured many of our favorite stories told live on Moth stages around the country. For information on all of our programs and live events, visit themoth.org.",
"airtime": "SAT 8pm-9pm and SUN 11am-12pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/theMoth.jpg",
"officialWebsiteLink": "https://themoth.org/",
"meta": {
"site": "arts",
"source": "prx"
},
"link": "/radio/program/the-moth-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/the-moth-podcast/id275699983?mt=2",
"tuneIn": "https://tunein.com/radio/The-Moth-p273888/",
"rss": "http://feeds.themoth.org/themothpodcast"
}
},
"the-new-yorker-radio-hour": {
"id": "the-new-yorker-radio-hour",
"title": "The New Yorker Radio Hour",
"info": "The New Yorker Radio Hour is a weekly program presented by the magazine's editor, David Remnick, and produced by WNYC Studios and The New Yorker. Each episode features a diverse mix of interviews, profiles, storytelling, and an occasional burst of humor inspired by the magazine, and shaped by its writers, artists, and editors. This isn't a radio version of a magazine, but something all its own, reflecting the rich possibilities of audio storytelling and conversation. Theme music for the show was composed and performed by Merrill Garbus of tUnE-YArDs.",
"airtime": "SAT 10am-11am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-New-Yorker-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/tnyradiohour",
"meta": {
"site": "arts",
"source": "WNYC"
},
"link": "/radio/program/the-new-yorker-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/id1050430296",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/New-Yorker-Radio-Hour-p803804/",
"rss": "https://feeds.feedburner.com/newyorkerradiohour"
}
},
"the-sam-sanders-show": {
"id": "the-sam-sanders-show",
"title": "The Sam Sanders Show",
"info": "One of public radio's most dynamic voices, Sam Sanders helped launch The NPR Politics Podcast and hosted NPR's hit show It's Been A Minute. Now, the award-winning host returns with something brand new, The Sam Sanders Show. Every week, Sam Sanders and friends dig into the culture that shapes our lives: what's driving the biggest trends, how artists really think, and even the memes you can't stop scrolling past. Sam is beloved for his way of unpacking the world and bringing you up close to fresh currents and engaging conversations. The Sam Sanders Show is smart, funny and always a good time.",
"airtime": "FRI 12-1pm AND SAT 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/11/The-Sam-Sanders-Show-Podcast-Tile-400x400-1.jpg",
"officialWebsiteLink": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"meta": {
"site": "arts",
"source": "KCRW"
},
"link": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"subscribe": {
"rss": "https://feed.cdnstream1.com/zjb/feed/download/ac/28/59/ac28594c-e1d0-4231-8728-61865cdc80e8.xml"
}
},
"the-splendid-table": {
"id": "the-splendid-table",
"title": "The Splendid Table",
"info": "\u003cem>The Splendid Table\u003c/em> hosts our nation's conversations about cooking, sustainability and food culture.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Splendid-Table-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.splendidtable.org/",
"airtime": "SUN 10-11 pm",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/the-splendid-table"
},
"this-american-life": {
"id": "this-american-life",
"title": "This American Life",
"info": "This American Life is a weekly public radio show, heard by 2.2 million people on more than 500 stations. Another 2.5 million people download the weekly podcast. It is hosted by Ira Glass, produced in collaboration with Chicago Public Media, delivered to stations by PRX The Public Radio Exchange, and has won all of the major broadcasting awards.",
"airtime": "SAT 12pm-1pm, 7pm-8pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/thisAmericanLife.png",
"officialWebsiteLink": "https://www.thisamericanlife.org/",
"meta": {
"site": "news",
"source": "wbez"
},
"link": "/radio/program/this-american-life",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201671138&at=11l79Y&ct=nprdirectory",
"rss": "https://www.thisamericanlife.org/podcast/rss.xml"
}
},
"tinydeskradio": {
"id": "tinydeskradio",
"title": "Tiny Desk Radio",
"info": "We're bringing the best of Tiny Desk to the airwaves, only on public radio.",
"airtime": "SUN 8pm and SAT 9pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/04/300x300-For-Member-Station-Logo-Tiny-Desk-Radio-@2x.png",
"officialWebsiteLink": "https://www.npr.org/series/g-s1-52030/tiny-desk-radio",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/tinydeskradio",
"subscribe": {
"rss": "https://feeds.npr.org/g-s1-52030/rss.xml"
}
},
"wait-wait-dont-tell-me": {
"id": "wait-wait-dont-tell-me",
"title": "Wait Wait... Don't Tell Me!",
"info": "Peter Sagal and Bill Kurtis host the weekly NPR News quiz show alongside some of the best and brightest news and entertainment personalities.",
"airtime": "SUN 10am-11am, SAT 11am-12pm, SAT 6pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Wait-Wait-Podcast-Tile-300x300-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/wait-wait-dont-tell-me/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/wait-wait-dont-tell-me",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/Xogv",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=121493804&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Wait-Wait-Dont-Tell-Me-p46/",
"rss": "https://feeds.npr.org/344098539/podcast.xml"
}
},
"weekend-edition-saturday": {
"id": "weekend-edition-saturday",
"title": "Weekend Edition Saturday",
"info": "Weekend Edition Saturday wraps up the week's news and offers a mix of analysis and features on a wide range of topics, including arts, sports, entertainment, and human interest stories. The two-hour program is hosted by NPR's Peabody Award-winning Scott Simon.",
"airtime": "SAT 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-saturday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-saturday"
},
"weekend-edition-sunday": {
"id": "weekend-edition-sunday",
"title": "Weekend Edition Sunday",
"info": "Weekend Edition Sunday features interviews with newsmakers, artists, scientists, politicians, musicians, writers, theologians and historians. The program has covered news events from Nelson Mandela's 1990 release from a South African prison to the capture of Saddam Hussein.",
"airtime": "SUN 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-sunday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-sunday"
}
},
"racesReducer": {},
"racesGenElectionReducer": {},
"racesGenElection2026Reducer": {},
"radioSchedulesReducer": {},
"listsReducer": {
"posts/futureofyou?category=diy-health": {
"isFetching": false,
"latestQuery": {
"from": 96,
"size": 12
},
"vitalsOnly": false,
"totalRequested": 12,
"isLoading": false,
"isLoadingMore": true,
"total": {
"value": 290,
"relation": "eq"
},
"items": [
"futureofyou_441705",
"futureofyou_441697",
"futureofyou_441680",
"futureofyou_440840",
"futureofyou_441435",
"futureofyou_441354",
"futureofyou_441322",
"futureofyou_441018",
"futureofyou_440861",
"futureofyou_440706",
"futureofyou_440672",
"futureofyou_440512"
],
"complete": true
}
},
"recallGuideReducer": {
"intros": {},
"policy": {},
"candidates": {}
},
"savedArticleReducer": {
"articles": [],
"status": {}
},
"newslettersReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"newsletters": {},
"isSubscribing": false,
"isUnsubscribing": false,
"subscribedNewsletters": {}
},
"termsReducer": {
"about": {
"name": "About",
"type": "terms",
"id": "about",
"slug": "about",
"link": "/about",
"taxonomy": "site"
},
"arts": {
"name": "Arts & Culture",
"grouping": [
"arts",
"pop",
"trulyca"
],
"description": "KQED Arts provides daily in-depth coverage of the Bay Area's music, art, film, performing arts, literature and arts news, as well as cultural commentary and criticism.",
"type": "terms",
"id": "arts",
"slug": "arts",
"link": "/arts",
"taxonomy": "site"
},
"artschool": {
"name": "Art School",
"parent": "arts",
"type": "terms",
"id": "artschool",
"slug": "artschool",
"link": "/artschool",
"taxonomy": "site"
},
"bayareabites": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "bayareabites",
"slug": "bayareabites",
"link": "/food",
"taxonomy": "site"
},
"bayareahiphop": {
"name": "Bay Area Hiphop",
"type": "terms",
"id": "bayareahiphop",
"slug": "bayareahiphop",
"link": "/bayareahiphop",
"taxonomy": "site"
},
"campaign21": {
"name": "Campaign 21",
"type": "terms",
"id": "campaign21",
"slug": "campaign21",
"link": "/campaign21",
"taxonomy": "site"
},
"careers": {
"name": "Careers",
"type": "terms",
"id": "careers",
"slug": "careers",
"link": "/careers",
"taxonomy": "site"
},
"checkplease": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "checkplease",
"slug": "checkplease",
"link": "/food",
"taxonomy": "site"
},
"education": {
"name": "Education",
"grouping": [
"education"
],
"type": "terms",
"id": "education",
"slug": "education",
"link": "/education",
"taxonomy": "site"
},
"elections": {
"name": "Elections",
"type": "terms",
"id": "elections",
"slug": "elections",
"link": "/elections",
"taxonomy": "site"
},
"events": {
"name": "Events",
"type": "terms",
"id": "events",
"slug": "events",
"link": "/events",
"taxonomy": "site"
},
"event": {
"name": "Event",
"alias": "events",
"type": "terms",
"id": "event",
"slug": "event",
"link": "/event",
"taxonomy": "site"
},
"filmschoolshorts": {
"name": "Film School Shorts",
"type": "terms",
"id": "filmschoolshorts",
"slug": "filmschoolshorts",
"link": "/filmschoolshorts",
"taxonomy": "site"
},
"food": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"type": "terms",
"id": "food",
"slug": "food",
"link": "/food",
"taxonomy": "site"
},
"forum": {
"name": "Forum",
"relatedContentQuery": "posts/forum?",
"parent": "news",
"type": "terms",
"id": "forum",
"slug": "forum",
"link": "/forum",
"taxonomy": "site"
},
"futureofyou": {
"name": "Future of You",
"grouping": [
"science",
"futureofyou"
],
"parent": "science",
"type": "terms",
"id": "futureofyou",
"slug": "futureofyou",
"link": "/futureofyou",
"taxonomy": "site"
},
"jpepinheart": {
"name": "KQED food",
"relatedContentQuery": "posts/food,bayareabites,checkplease",
"parent": "food",
"type": "terms",
"id": "jpepinheart",
"slug": "jpepinheart",
"link": "/food",
"taxonomy": "site"
},
"liveblog": {
"name": "Live Blog",
"type": "terms",
"id": "liveblog",
"slug": "liveblog",
"link": "/liveblog",
"taxonomy": "site"
},
"livetv": {
"name": "Live TV",
"parent": "tv",
"type": "terms",
"id": "livetv",
"slug": "livetv",
"link": "/livetv",
"taxonomy": "site"
},
"lowdown": {
"name": "The Lowdown",
"relatedContentQuery": "posts/lowdown?",
"parent": "news",
"type": "terms",
"id": "lowdown",
"slug": "lowdown",
"link": "/lowdown",
"taxonomy": "site"
},
"mindshift": {
"name": "Mindshift",
"parent": "news",
"description": "MindShift explores the future of education by highlighting the innovative – and sometimes counterintuitive – ways educators and parents are helping all children succeed.",
"type": "terms",
"id": "mindshift",
"slug": "mindshift",
"link": "/mindshift",
"taxonomy": "site"
},
"news": {
"name": "News",
"grouping": [
"news",
"forum"
],
"type": "terms",
"id": "news",
"slug": "news",
"link": "/news",
"taxonomy": "site"
},
"newsletters": {
"name": "newsletters",
"type": "terms",
"id": "newsletters",
"slug": "newsletters",
"link": "/newsletters",
"taxonomy": "site"
},
"perspectives": {
"name": "Perspectives",
"parent": "radio",
"type": "terms",
"id": "perspectives",
"slug": "perspectives",
"link": "/perspectives",
"taxonomy": "site"
},
"podcasts": {
"name": "Podcasts",
"type": "terms",
"id": "podcasts",
"slug": "podcasts",
"link": "/podcasts",
"taxonomy": "site"
},
"pop": {
"name": "Pop",
"parent": "arts",
"type": "terms",
"id": "pop",
"slug": "pop",
"link": "/pop",
"taxonomy": "site"
},
"pressroom": {
"name": "Pressroom",
"type": "terms",
"id": "pressroom",
"slug": "pressroom",
"link": "/pressroom",
"taxonomy": "site"
},
"quest": {
"name": "Quest",
"parent": "science",
"type": "terms",
"id": "quest",
"slug": "quest",
"link": "/quest",
"taxonomy": "site"
},
"radio": {
"name": "Radio",
"grouping": [
"forum",
"perspectives"
],
"description": "Listen to KQED Public Radio – home of Forum and The California Report – on 88.5 FM in San Francisco, 89.3 FM in Sacramento, 88.3 FM in Santa Rosa and 88.1 FM in Martinez.",
"type": "terms",
"id": "radio",
"slug": "radio",
"link": "/radio",
"taxonomy": "site"
},
"root": {
"name": "KQED",
"image": "https://ww2.kqed.org/app/uploads/2020/02/KQED-OG-Image@1x.png",
"imageWidth": 1200,
"imageHeight": 630,
"headData": {
"title": "KQED | News, Radio, Podcasts, TV | Public Media for Northern California",
"description": "KQED provides public radio, television, and independent reporting on issues that matter to the Bay Area. We’re the NPR and PBS member station for Northern California."
},
"type": "terms",
"id": "root",
"slug": "root",
"link": "/root",
"taxonomy": "site"
},
"science": {
"name": "Science",
"grouping": [
"science",
"futureofyou"
],
"description": "KQED Science brings you award-winning science and environment coverage from the Bay Area and beyond.",
"type": "terms",
"id": "science",
"slug": "science",
"link": "/science",
"taxonomy": "site"
},
"stateofhealth": {
"name": "State of Health",
"parent": "science",
"type": "terms",
"id": "stateofhealth",
"slug": "stateofhealth",
"link": "/stateofhealth",
"taxonomy": "site"
},
"support": {
"name": "Support",
"type": "terms",
"id": "support",
"slug": "support",
"link": "/support",
"taxonomy": "site"
},
"thedolist": {
"name": "The Do List",
"parent": "arts",
"type": "terms",
"id": "thedolist",
"slug": "thedolist",
"link": "/thedolist",
"taxonomy": "site"
},
"trulyca": {
"name": "Truly CA",
"grouping": [
"arts",
"pop",
"trulyca"
],
"parent": "arts",
"type": "terms",
"id": "trulyca",
"slug": "trulyca",
"link": "/trulyca",
"taxonomy": "site"
},
"tv": {
"name": "TV",
"type": "terms",
"id": "tv",
"slug": "tv",
"link": "/tv",
"taxonomy": "site"
},
"voterguide": {
"name": "Voter Guide",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "voterguide",
"slug": "voterguide",
"link": "/voterguide",
"taxonomy": "site"
},
"guiaelectoral": {
"name": "Guia Electoral",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "guiaelectoral",
"slug": "guiaelectoral",
"link": "/guiaelectoral",
"taxonomy": "site"
},
"futureofyou_category_diy-health": {
"isLoading": true
},
"futureofyou_1060": {
"type": "terms",
"id": "futureofyou_1060",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1060",
"found": true
},
"relationships": {},
"featImg": null,
"name": "DIY Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "DIY Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1060,
"slug": "diy-health",
"isLoading": false,
"link": "/futureofyou/category/diy-health"
},
"source_futureofyou_441705": {
"type": "terms",
"id": "source_futureofyou_441705",
"meta": {
"override": true
},
"name": "Health",
"isLoading": false
},
"source_futureofyou_441697": {
"type": "terms",
"id": "source_futureofyou_441697",
"meta": {
"override": true
},
"name": "Health",
"isLoading": false
},
"source_futureofyou_441680": {
"type": "terms",
"id": "source_futureofyou_441680",
"meta": {
"override": true
},
"name": "Health",
"isLoading": false
},
"source_futureofyou_440840": {
"type": "terms",
"id": "source_futureofyou_440840",
"meta": {
"override": true
},
"name": "DIY Health",
"isLoading": false
},
"source_futureofyou_441354": {
"type": "terms",
"id": "source_futureofyou_441354",
"meta": {
"override": true
},
"name": "Health",
"isLoading": false
},
"source_futureofyou_441322": {
"type": "terms",
"id": "source_futureofyou_441322",
"meta": {
"override": true
},
"name": "Health",
"isLoading": false
},
"source_futureofyou_440861": {
"type": "terms",
"id": "source_futureofyou_440861",
"meta": {
"override": true
},
"name": "DIY Health",
"isLoading": false
},
"source_futureofyou_440706": {
"type": "terms",
"id": "source_futureofyou_440706",
"meta": {
"override": true
},
"name": "Health",
"isLoading": false
},
"source_futureofyou_440672": {
"type": "terms",
"id": "source_futureofyou_440672",
"meta": {
"override": true
},
"name": "Health",
"isLoading": false
},
"source_futureofyou_440512": {
"type": "terms",
"id": "source_futureofyou_440512",
"meta": {
"override": true
},
"name": "Health",
"isLoading": false
},
"futureofyou_1": {
"type": "terms",
"id": "futureofyou_1",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED Future Of You",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED Future Of You Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1,
"slug": "future-of-you",
"isLoading": false,
"link": "/futureofyou/category/future-of-you"
},
"futureofyou_56": {
"type": "terms",
"id": "futureofyou_56",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "56",
"found": true
},
"relationships": {},
"featImg": null,
"name": "brain",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "brain Archives | KQED Arts",
"ogDescription": null
},
"ttid": 56,
"slug": "brain",
"isLoading": false,
"link": "/futureofyou/tag/brain"
},
"futureofyou_952": {
"type": "terms",
"id": "futureofyou_952",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "952",
"found": true
},
"relationships": {},
"featImg": null,
"name": "drugs",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "drugs Archives | KQED Arts",
"ogDescription": null
},
"ttid": 952,
"slug": "drugs",
"isLoading": false,
"link": "/futureofyou/tag/drugs"
},
"futureofyou_1432": {
"type": "terms",
"id": "futureofyou_1432",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1432",
"found": true
},
"relationships": {},
"featImg": null,
"name": "psychadelics",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "psychadelics Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1432,
"slug": "psychadelics",
"isLoading": false,
"link": "/futureofyou/tag/psychadelics"
},
"futureofyou_1093": {
"type": "terms",
"id": "futureofyou_1093",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1093",
"found": true
},
"relationships": {},
"featImg": null,
"name": "DIY Health",
"description": null,
"taxonomy": "collection",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "DIY Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1093,
"slug": "diy-health",
"isLoading": false,
"link": "/futureofyou/collection/diy-health"
},
"futureofyou_73": {
"type": "terms",
"id": "futureofyou_73",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "73",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED News",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED News Archives | KQED Arts",
"ogDescription": null
},
"ttid": 73,
"slug": "kqed-news",
"isLoading": false,
"link": "/futureofyou/category/kqed-news"
},
"futureofyou_38": {
"type": "terms",
"id": "futureofyou_38",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "38",
"found": true
},
"relationships": {},
"featImg": null,
"name": "FDA",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "FDA Archives | KQED Arts",
"ogDescription": null
},
"ttid": 38,
"slug": "fda",
"isLoading": false,
"link": "/futureofyou/tag/fda"
},
"futureofyou_61": {
"type": "terms",
"id": "futureofyou_61",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "61",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Health",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 61,
"slug": "health",
"isLoading": false,
"link": "/futureofyou/tag/health"
},
"futureofyou_1056": {
"type": "terms",
"id": "futureofyou_1056",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1056",
"found": true
},
"relationships": {},
"featImg": null,
"name": "medical treatment",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "medical treatment Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1056,
"slug": "medical-treatment",
"isLoading": false,
"link": "/futureofyou/tag/medical-treatment"
},
"futureofyou_1407": {
"type": "terms",
"id": "futureofyou_1407",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1407",
"found": true
},
"relationships": {},
"featImg": null,
"name": "migraine",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "migraine Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1407,
"slug": "migraine",
"isLoading": false,
"link": "/futureofyou/tag/migraine"
},
"futureofyou_312": {
"type": "terms",
"id": "futureofyou_312",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "312",
"found": true
},
"relationships": {},
"featImg": null,
"name": "blood sugar",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "blood sugar Archives | KQED Arts",
"ogDescription": null
},
"ttid": 312,
"slug": "blood-sugar",
"isLoading": false,
"link": "/futureofyou/tag/blood-sugar"
},
"futureofyou_309": {
"type": "terms",
"id": "futureofyou_309",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "309",
"found": true
},
"relationships": {},
"featImg": null,
"name": "diabetes",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "diabetes Archives | KQED Arts",
"ogDescription": null
},
"ttid": 309,
"slug": "diabetes",
"isLoading": false,
"link": "/futureofyou/tag/diabetes"
},
"futureofyou_426": {
"type": "terms",
"id": "futureofyou_426",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "426",
"found": true
},
"relationships": {},
"featImg": null,
"name": "food",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "food Archives | KQED Arts",
"ogDescription": null
},
"ttid": 426,
"slug": "food",
"isLoading": false,
"link": "/futureofyou/tag/food"
},
"futureofyou_1071": {
"type": "terms",
"id": "futureofyou_1071",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1071",
"found": true
},
"relationships": {},
"featImg": null,
"name": "insulin",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "insulin Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1071,
"slug": "insulin",
"isLoading": false,
"link": "/futureofyou/tag/insulin"
},
"futureofyou_80": {
"type": "terms",
"id": "futureofyou_80",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "80",
"found": true
},
"relationships": {},
"featImg": null,
"name": "kqedscience",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "kqedscience Archives | KQED Arts",
"ogDescription": null
},
"ttid": 80,
"slug": "kqedscience",
"isLoading": false,
"link": "/futureofyou/tag/kqedscience"
},
"futureofyou_447": {
"type": "terms",
"id": "futureofyou_447",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "447",
"found": true
},
"relationships": {},
"featImg": null,
"name": "STDs",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "STDs Archives | KQED Arts",
"ogDescription": null
},
"ttid": 447,
"slug": "stds",
"isLoading": false,
"link": "/futureofyou/tag/stds"
},
"futureofyou_452": {
"type": "terms",
"id": "futureofyou_452",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "452",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Health Policy",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Health Policy Archives | KQED Arts",
"ogDescription": null
},
"ttid": 452,
"slug": "health-policy",
"isLoading": false,
"link": "/futureofyou/category/health-policy"
},
"futureofyou_651": {
"type": "terms",
"id": "futureofyou_651",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "651",
"found": true
},
"relationships": {},
"featImg": null,
"name": "HIV",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "HIV Archives | KQED Arts",
"ogDescription": null
},
"ttid": 651,
"slug": "hiv",
"isLoading": false,
"link": "/futureofyou/tag/hiv"
},
"futureofyou_931": {
"type": "terms",
"id": "futureofyou_931",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "931",
"found": true
},
"relationships": {},
"featImg": null,
"name": "pharmaceuticals",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "pharmaceuticals Archives | KQED Arts",
"ogDescription": null
},
"ttid": 931,
"slug": "pharmaceuticals",
"isLoading": false,
"link": "/futureofyou/tag/pharmaceuticals"
},
"futureofyou_828": {
"type": "terms",
"id": "futureofyou_828",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "828",
"found": true
},
"relationships": {},
"featImg": null,
"name": "addiction",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "addiction Archives | KQED Arts",
"ogDescription": null
},
"ttid": 828,
"slug": "addiction",
"isLoading": false,
"link": "/futureofyou/tag/addiction"
},
"futureofyou_190": {
"type": "terms",
"id": "futureofyou_190",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "190",
"found": true
},
"relationships": {},
"featImg": null,
"name": "doctors",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "doctors Archives | KQED Arts",
"ogDescription": null
},
"ttid": 190,
"slug": "doctors",
"isLoading": false,
"link": "/futureofyou/tag/doctors"
},
"futureofyou_938": {
"type": "terms",
"id": "futureofyou_938",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "938",
"found": true
},
"relationships": {},
"featImg": null,
"name": "opioids",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "opioids Archives | KQED Arts",
"ogDescription": null
},
"ttid": 938,
"slug": "opioids",
"isLoading": false,
"link": "/futureofyou/tag/opioids"
},
"futureofyou_141": {
"type": "terms",
"id": "futureofyou_141",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "141",
"found": true
},
"relationships": {},
"featImg": null,
"name": "disease",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "disease Archives | KQED Arts",
"ogDescription": null
},
"ttid": 141,
"slug": "disease",
"isLoading": false,
"link": "/futureofyou/tag/disease"
},
"futureofyou_759": {
"type": "terms",
"id": "futureofyou_759",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "759",
"found": true
},
"relationships": {},
"featImg": null,
"name": "lyme disease",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "lyme disease Archives | KQED Arts",
"ogDescription": null
},
"ttid": 759,
"slug": "lyme-disease",
"isLoading": false,
"link": "/futureofyou/tag/lyme-disease"
},
"futureofyou_1062": {
"type": "terms",
"id": "futureofyou_1062",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1062",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Hope/Hype",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Hope/Hype Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1062,
"slug": "hopehype",
"isLoading": false,
"link": "/futureofyou/category/hopehype"
},
"futureofyou_1575": {
"type": "terms",
"id": "futureofyou_1575",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1575",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Science Podcast",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Science Podcast Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1575,
"slug": "science-podcast",
"isLoading": false,
"link": "/futureofyou/category/science-podcast"
},
"futureofyou_1275": {
"type": "terms",
"id": "futureofyou_1275",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1275",
"found": true
},
"relationships": {},
"featImg": null,
"name": "featured",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "featured Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1275,
"slug": "featured",
"isLoading": false,
"link": "/futureofyou/tag/featured"
},
"futureofyou_1493": {
"type": "terms",
"id": "futureofyou_1493",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1493",
"found": true
},
"relationships": {},
"featImg": null,
"name": "food intolerance",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "food intolerance Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1493,
"slug": "food-intolerance",
"isLoading": false,
"link": "/futureofyou/tag/food-intolerance"
},
"futureofyou_1492": {
"type": "terms",
"id": "futureofyou_1492",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1492",
"found": true
},
"relationships": {},
"featImg": null,
"name": "food sensitivity",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "food sensitivity Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1492,
"slug": "food-sensitivity",
"isLoading": false,
"link": "/futureofyou/tag/food-sensitivity"
},
"futureofyou_798": {
"type": "terms",
"id": "futureofyou_798",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "798",
"found": true
},
"relationships": {},
"featImg": null,
"name": "home health care",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "home health care Archives | KQED Arts",
"ogDescription": null
},
"ttid": 798,
"slug": "home-health-care",
"isLoading": false,
"link": "/futureofyou/tag/home-health-care"
},
"futureofyou_1484": {
"type": "terms",
"id": "futureofyou_1484",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1484",
"found": true
},
"relationships": {},
"featImg": null,
"name": "home test",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "home test Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1484,
"slug": "home-test",
"isLoading": false,
"link": "/futureofyou/tag/home-test"
},
"futureofyou_102": {
"type": "terms",
"id": "futureofyou_102",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "102",
"found": true
},
"relationships": {},
"featImg": null,
"name": "kqed science",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "kqed science Archives | KQED Arts",
"ogDescription": null
},
"ttid": 102,
"slug": "kqed-science",
"isLoading": false,
"link": "/futureofyou/tag/kqed-science"
},
"futureofyou_1496": {
"type": "terms",
"id": "futureofyou_1496",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1496",
"found": true
},
"relationships": {},
"featImg": null,
"name": "shark tank",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "shark tank Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1496,
"slug": "shark-tank",
"isLoading": false,
"link": "/futureofyou/tag/shark-tank"
},
"futureofyou_54": {
"type": "terms",
"id": "futureofyou_54",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "54",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Future of You",
"description": null,
"taxonomy": "program",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Future of You Archives | KQED Arts",
"ogDescription": null
},
"ttid": 54,
"slug": "future-of-you",
"isLoading": false,
"link": "/futureofyou/program/future-of-you"
},
"futureofyou_1064": {
"type": "terms",
"id": "futureofyou_1064",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1064",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Your Genes",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Your Genes Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1064,
"slug": "your-genes",
"isLoading": false,
"link": "/futureofyou/category/your-genes"
},
"futureofyou_221": {
"type": "terms",
"id": "futureofyou_221",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "221",
"found": true
},
"relationships": {},
"featImg": null,
"name": "baby",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "baby Archives | KQED Arts",
"ogDescription": null
},
"ttid": 221,
"slug": "baby",
"isLoading": false,
"link": "/futureofyou/tag/baby"
},
"futureofyou_927": {
"type": "terms",
"id": "futureofyou_927",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "927",
"found": true
},
"relationships": {},
"featImg": null,
"name": "embryos",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "embryos Archives | KQED Arts",
"ogDescription": null
},
"ttid": 927,
"slug": "embryos",
"isLoading": false,
"link": "/futureofyou/tag/embryos"
},
"futureofyou_466": {
"type": "terms",
"id": "futureofyou_466",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "466",
"found": true
},
"relationships": {},
"featImg": null,
"name": "family",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "family Archives | KQED Arts",
"ogDescription": null
},
"ttid": 466,
"slug": "family",
"isLoading": false,
"link": "/futureofyou/tag/family"
},
"futureofyou_347": {
"type": "terms",
"id": "futureofyou_347",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "347",
"found": true
},
"relationships": {},
"featImg": null,
"name": "reproductive health",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "reproductive health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 347,
"slug": "reproductive-health",
"isLoading": false,
"link": "/futureofyou/tag/reproductive-health"
},
"futureofyou_1094": {
"type": "terms",
"id": "futureofyou_1094",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1094",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Your Genes",
"description": null,
"taxonomy": "collection",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Your Genes Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1094,
"slug": "your-genes",
"isLoading": false,
"link": "/futureofyou/collection/your-genes"
},
"futureofyou_204": {
"type": "terms",
"id": "futureofyou_204",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "204",
"found": true
},
"relationships": {},
"featImg": null,
"name": "mental health",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "mental health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 204,
"slug": "mental-health",
"isLoading": false,
"link": "/futureofyou/tag/mental-health"
},
"futureofyou_1224": {
"type": "terms",
"id": "futureofyou_1224",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1224",
"found": true
},
"relationships": {},
"featImg": null,
"name": "psychology",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "psychology Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1224,
"slug": "psychology",
"isLoading": false,
"link": "/futureofyou/tag/psychology"
},
"futureofyou_1184": {
"type": "terms",
"id": "futureofyou_1184",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1184",
"found": true
},
"relationships": {},
"featImg": null,
"name": "antibiotic resistance",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "antibiotic resistance Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1184,
"slug": "antibiotic-resistance",
"isLoading": false,
"link": "/futureofyou/tag/antibiotic-resistance"
},
"futureofyou_177": {
"type": "terms",
"id": "futureofyou_177",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "177",
"found": true
},
"relationships": {},
"featImg": null,
"name": "hospitals",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "hospitals Archives | KQED Arts",
"ogDescription": null
},
"ttid": 177,
"slug": "hospitals",
"isLoading": false,
"link": "/futureofyou/tag/hospitals"
},
"futureofyou_173": {
"type": "terms",
"id": "futureofyou_173",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "173",
"found": true
},
"relationships": {},
"featImg": null,
"name": "medicine",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "medicine Archives | KQED Arts",
"ogDescription": null
},
"ttid": 173,
"slug": "medicine",
"isLoading": false,
"link": "/futureofyou/tag/medicine"
}
},
"userPermissionsReducer": {
"wpLoggedIn": false
},
"eventsReducer": {},
"fssReducer": {},
"tvDailyScheduleReducer": {},
"tvWeeklyScheduleReducer": {},
"tvPrimetimeScheduleReducer": {},
"tvMonthlyScheduleReducer": {},
"userAccountReducer": {
"user": {
"email": null,
"emailStatus": "EMAIL_UNVALIDATED",
"loggedStatus": "LOGGED_OUT",
"loggingChecked": false,
"articles": [],
"firstName": null,
"lastName": null,
"phoneNumber": null,
"fetchingMembership": false,
"membershipError": false,
"memberships": [
{
"id": null,
"startDate": null,
"firstName": null,
"lastName": null,
"familyNumber": null,
"memberNumber": null,
"memberSince": null,
"expirationDate": null,
"pfsEligible": false,
"isSustaining": false,
"membershipLevel": "Prospect",
"membershipStatus": "Non Member",
"lastGiftDate": null,
"renewalDate": null,
"lastDonationAmount": null
}
]
},
"authModal": {
"isOpen": false,
"view": "LANDING_VIEW"
},
"error": null
},
"youthMediaReducer": {},
"checkPleaseReducer": {
"filterData": {
"region": {
"key": "Restaurant Region",
"filters": [
"Any Region"
]
},
"cuisine": {
"key": "Restaurant Cuisine",
"filters": [
"Any Cuisine"
]
}
},
"restaurantDataById": {},
"restaurantIdsSorted": [],
"error": null
},
"userAgentReducer": {
"userAgent": "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)",
"isBot": true
}
}
